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Adam Beach, PhD 
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This thesis describes studies that have resulted in uncovering molecular and cellular 
mechanisms underlying the essential role of mitochondria in chronological aging of the baker’s 
yeast, Saccharomyces cerevisiae. The Titorenko laboratory has recently identified lithocholic 
acid (LCA), a bile acid and a natural compound that operates synergistically with caloric 
restriction (CR) to cause a substantial increase in yeast chronological lifespan under longevity-
extending CR conditions. As a first step towards establishing a mechanism by which LCA 
extends longevity of chronologically aging yeast limited in calorie supply, I investigated the 
distribution of LCA within yeast cells. I found that exogenously added LCA enters yeast cells, is 
sorted only to mitochondria, resides mainly in the inner mitochondrial membrane and also 
associates with the outer membrane of mitochondria. I demonstrated that LCA-elicited changes 
in the membrane lipidome of mitochondria trigger age-related alterations in mitochondrial 
respiration, membrane potential, reactive oxygen species (ROS) quantity, oxidative 
macromolecular damage, respiratory complexes composition and ATP concentration. My 
findings provided evidence that the longevity-extending potential of LCA is due in part to its 
ability to alter the age-related dynamics of mitochondrially produced ROS in both 
chronologically ʺyoungʺ and ʺoldʺ cells, thus reducing the damaging effect of these ROS in 
ʺyoungʺ cells and amplifying their ʺhormeticʺ effect in ʺoldʺ cells. I demonstrated that LCA 
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alters the age-related dynamics of changes in the levels of many mitochondrial proteins, as well 
as numerous proteins in cellular locations outside of mitochondria. My findings imply that LCA-
driven changes in the mitochondrial lipidome alter the mitochondrial proteome and functionality, 
thereby enabling mitochondria to operate as signaling organelles that orchestrate the 
establishment of an anti-aging transcriptional program for many longevity-defining nuclear 
genes. Based on these findings, I proposed a model for how such LCA-driven changes early and 
late in the life of chronologically aging yeast cause a stepwise development of an anti-aging 
cellular pattern and its maintenance throughout lifespan. Moreover, I provided evidence that 
mitophagy, a selective autophagic degradation of aged and dysfunctional mitochondria, is a 
longevity assurance process that in chronologically aging yeast underlies the synergistic 
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The functional state of mitochondria is crucial for organismal physiology in all eukaryotes 
1-5
. This is in part because mitochondria produce the bulk of cellular ATP and synthesize (or 
generate biosynthetic intermediates for) amino acids, lipids and nucleotides 
3-7
. This is also 
because mitochondria can operate as intracellular signaling compartments and organizing 
platforms whose different functional states and dynamic communications with other organelles 
orchestrate a range of cellular responses to changes in various physiological conditions 
1, 3, 5, 7-28
. 
Several mechanistically diverse strategies have been implicated in enabling mitochondria to 
function as such signaling compartments and organizing platforms within eukaryotic cells; these 
strategies are depicted in Figure 1.1 and outlined below. 
          First strategy: mitochondria can respond to variations in cellular energy status by altering 
NAD
+
/NADH, AMP/ATP and acetyl-CoA/CoA ratios inside and outside of these organelles 
3, 23, 
29
 (Figure 1.1). Such alterations in the relative levels of the key mitochondria-derived metabolites 
modulate activities of several protein sensors (including sirtuins Sirt1, Sirt3 and Sirt5 as well as 
the AMP-activated protein kinase and histone acetyltransferase GCN5), which then amend the 
extent of acetylation and phosphorylation (and thereby activities) of many downstream protein 
targets; this elicits a remodeling of a network of anabolic and catabolic pathways defining 
cellular energy status 
3, 19, 23, 29-38
.     
          Second strategy: mitochondria can generate reactive oxygen species (ROS) – mainly as 
by-products of mitochondrial respiration in all eukaryotes, but also via oxidation of cytochrome c 
by the inter-membrane space protein p66
shc
 in mice 
39-41
 (Figure 1.1). If the concentration of ROS 
released from mitochondria exceeds a toxic threshold, ROS impair many vital cellular processes 
by eliciting health-demoting oxidative damage to proteins, lipids and nucleic acids in various 
cellular locations 
39-43
. However, if the concentration of ROS released from mitochondria is 
sustained at a sub-lethal (hormetic) level, ROS operate as potent signaling molecules that 
modulate activities of some protein sensors 
18, 19, 39, 42-47
. Among these ROS-modulated sensors 
are several protein kinases, transcription factors and antioxidant enzymes; they respond to ROS 
by altering activities of a network of downstream protein targets to stimulate a number of vital 
health-promoting cellular processes 
18, 19, 39, 42-53
. 
          Third strategy: mitochondria can synthesize and assemble iron-sulfur clusters (ISC); ISCs 
are cofactors of many proteins that reside in mitochondria as well as in the cytosol, nucleus and 
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endoplasmic reticulum (ER) 
54-59
 (Figure 1.1). Mitochondrial ISC proteins are essential 
components of the tricarboxylic acid (TCA) cycle and electron transport chain (ETC); they are 
also involved in the synthesis of some amino acids, heme, molybdenum cofactor, lipoic acid and 
biotin within mitochondria 
54-59
. Cytosolic ISC proteins have been implicated in nucleotide 
metabolism, amino acid synthesis, iron homeostasis regulation, xenobiotic metabolism, 
translation initiation, tRNA modification and receptor tyrosine kinase signaling 
54-59
. Nuclear 
ISC proteins function in DNA replication and repair, telomere maintenance, gene expression 
regulation, rRNA processing, and ribosome assembly 
54-63
. 
          Fourth strategy: mitochondria can respond to various stress conditions inside and outside 
of these organelles by releasing signaling peptides, proteins, mitochondrial DNA (mtDNA) and 
mtDNA fragments that act intracellularly and extracellularly to elicit cellular and organismal 
responses to such conditions (Figure 1.1). These mitochondria-derived stress signaling 
macromolecules include the following: (1) peptides formed due to the proteolytic degradation of 
unfolded and misfolded proteins excessively accumulated within the mitochondrial matrix; after 
being released from mitochondria, these peptides trigger several unfolded protein response 
(UPR
mt
) pathways of mitochondria-to-nucleus communications that stimulate transcription of 
nuclear genes involved in mitochondrial quality control and metabolism 
18, 19, 53, 64-73
; (2) 
humanin, an N-formylated peptide; after being synthesized and released by dysfunctional 
mitochondria in the "host" cells, humanin acts in a cell-autonomous manner to suppress 
apoptosis of these cells as well as in a cell-non-autonomous fashion to promote survival, reduce 
inflammation and maintain metabolic homeostasis of the distal cells in other tissues 
72, 74-81
; (3) 
signaling macromolecules that belong to the "mitochondrial damage-associated molecular 
pattern" (mitochondrial DAMP or MTD) family and include some N-formylated peptides, 
several proteins, mtDNA and mtDNA fragments; these MTDs function cell-autonomously and 
cell-non-autonomously to stimulate inflammation and elicit the innate immune response by 
activating transcription of nuclear genes coding for pro-inflammatory cytokines 
10, 12, 72, 82-89
; (4) 
cytochrome c and other pro-apoptotic proteins; after being released from mitochondria in 
excessively stressed cells, these mitochondria-derived proteins either trigger caspase-dependent 
and caspase-independent pathways of programmed apoptotic cell death or control such non-
apoptotic processes as cell metabolism, cell cycle progression, inflammation, innate immune 
response, autophagy and programmed necrotic cell death 
3, 9, 10, 12, 13, 16, 17, 23, 24
; (5) the pyruvate 
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dehydrogenase complex, which in cultured human cells exposed to serum, epidermal growth 
factor or mitochondrial stress can move from the mitochondria to the nucleus to synthesize 
acetyl-CoA used for histone acetylation, S phase entry and cell-cycle progression 
90
; and (6) 
mitokines in the nematode Caenorhabditis elegans; after these diffusible factors of unknown 
chemical nature exit mildly stressed mitochondria in neuronal cells, they act in an endocrine-like 
fashion to activate the longevity-extending UPR
mt
 pathway of mitochondria-to-nucleus 
communication in intestinal cells 
72, 91, 92
.  
          Fifth strategy: the surface of mitochondria can provide an organizing platform for 
assembly and disassembly of several multi-protein complexes (Figure 1.1). A regulated 
remodeling of these protein complexes on the outer face of mitochondria has been implicated in 
many vital processes, including (1) cell metabolism, signaling, immune response, hypoxic 
response, differentiation and death; and (2) mitochondrial fusion, fission, motility, inheritance, 
autophagic degradation  and DNA maintenance 
1, 3, 9, 14, 16, 21-24, 26, 93-99
.  
          Sixth strategy: the outer mitochondrial membrane can form zones of close apposition to 
the mitochondria-associated membrane (MAM) domains of other organellar and cellular 
membranes, including the ER, peroxisomes, vacuoles, autophagosomes, melanosomes and 
plasma membrane 
3, 27, 28, 100-108
 (Figure 1.1). The MAM domains are known to play essential 
roles in ATP and ROS production, mitochondrial biogenesis and morphology, mitochondrial 
fission and motility, ER stress regulation, cellular Ca
2+
 homeostasis, membrane phospholipids 
metabolism and transfer, autophagosome biogenesis, innate immune and inflammatory 
responses, and programmed apoptotic cell death 
3, 16, 18, 21, 24-28, 100-115
. 
          Seventh strategy: mitochondria can form small vesicles that transport distinct subsets of 
mitochondrial proteins and lipids to peroxisomes and lysosomes (Figure 1.1). Such vesicular 
transport of mitochondria-derived protein and lipid cargos has been implicated in mitochondrial 
quality control; it may also play a role in peroxisome biogenesis and function 
116-121
.      
          Because mitochondrial functionality is vital to organismal physiology and health, 
mitochondrial dysfunction is a cause of numerous human mitochondrial disorders; these inborn 
disorders are due to mutations in nuclear genes and/or mtDNA, affect various tissues and organs, 
and exhibit a wide spectrum of clinical features 
3, 4, 122-125
. Furthermore, mitochondrial 
dysfunction has been implicated in a variety of common human disorders, such as metabolic 




5, 10, 15, 34, 126-131
. Most of these common human disorders are aging-associated pathologies; 
moreover, a gradual deterioration of mitochondrial function is a distinctive and, likely, a 
causative feature of aging in eukaryotic organisms across phyla 
2, 10, 18, 19, 132, 133
. Therefore, an 
age-related progressive decline in mitochondrial function is considered as one of the hallmarks 
of cellular and organismal aging in evolutionarily distant eukaryotes 
133
. Studies of the budding 
yeast Saccharomyces cerevisiae, a unicellular eukaryote, have provided insights into 






Figure 1.1. Seven strategies allow mitochondria to operate as intracellular signaling compartments and 
organizing platforms that orchestrate cellular responses to changes in physiological conditions.  
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Strategy 1: mitochondria can change NAD+/NADH, AMP/ATP and acetyl-CoA/CoA ratios inside and outside of 
mitochondria, thus enabling these key metabolites to modulate activities of several protein sensors. These sensors 
then alter cellular energy status by amending activities of proteins involved in various metabolic pathways. Strategy 
2: mitochondria can generate and release reactive oxygen species (ROS). If the concentration of ROS released from 
mitochondria surpasses a toxic threshold, ROS cause health-demoting oxidative damage to cellular macromolecules. 
In contrast, if it is maintained at a sub-lethal (hormetic) level, ROS modulate activities of several protein sensors, 
which then alter activities of many protein targets to accelerate health-promoting cellular processes. Strategy 3: 
mitochondria can synthesize and assemble iron-sulfur clusters (ISC). ISCs are essential cofactors of numerous 
proteins located inside and outside of mitochondria; these proteins are involved in many cellular processes. Strategy 
4: mitochondria can release peptides, proteins, mitochondrial DNA (mtDNA) and mtDNA fragments. These 
mitochondria-derived signaling macromolecules act in a cell-autonomous and cell-non-autonomous manner to elicit 
changes in vital processes that take place within the "host" cells and within the distal cells in other tissues. Strategy 
5: mitochondrial surface can serve as an organizing platform for assembly and disassembly of multi-protein 
complexes implicated in a number of essential processes. Strategy 6: mitochondria can form zones of close 
apposition to the mitochondria-associated membrane (MAM) domains of other organellar and cellular membranes. 
These MAM domains are known for their essential roles in many cellular processes. Strategy 7: mitochondria can 
form small vesicles. These vesicles deliver certain proteins and lipids to lysosomes and peroxisomes, thereby 
enabling mitochondrial quality control and playing a role in peroxisome biogenesis and function. See the text for 
additional details. 
 
1.1.1 The yeast S. cerevisiae is a beneficial model organism for elucidating mechanisms of 
cellular aging in multicellular eukaryotes    
 
Aging of budding yeast is studied using robust assays. These assays are carried out under 
controllable laboratory conditions and measure two different aspects of the aging process in S. 
cerevisiae. Some of these assays monitor the replicative lifespan of yeast by measuring how 
many asymmetric mitotic divisions a mother cell could undergo before cell cycle arrest; 
replicative aging of yeast is believed to model aging of mitotic (i.e. capable of dividing) human 
cell types, such as fibroblasts, granulocytes, monocytes, lymphocytes and stem cells from 
amniotic fluid 
137, 141-144
. Other assays monitor the chronological lifespan of yeast by measuring 
how long a cell remains viable after cell cycle arrest; chronological aging of yeast is likely to 
mimic aging of post-mitotic (i.e. incapable of dividing) human cell types, such as mature 
neurons, adipocytes and mature muscle cells 
137, 143, 145-147
. S. cerevisiae has relatively short 
replicative and chronological lifespans; moreover, it is amenable to comprehensive biochemical, 
molecular biological and cell biological analyses 
137, 142, 146, 148-151
. Because of these beneficial 
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features of S. cerevisiae as a model for unveiling mechanisms of aging in multicellular 
eukaryotes, the baker’s yeast has is an invaluable tool employed to discover genes, signaling 
pathways and chemical compounds that govern longevity-defining cellular processes in 
eukaryotic organisms across phyla 
18-20, 137, 143, 144, 146, 147, 150, 152-162
. 
 
1.1.2 Mitochondria are signaling organelles that establish the rate of cellular aging in 
yeast by orchestrating many processes outside of mitochondria 
A body of recent evidence implies that alterations in certain traits of mitochondrial 
functionality early in life of replicatively or chronologically aging yeast impact many cellular 
processes outside of mitochondria, thereby orchestrating a stepwise development of a longevity-
defining cellular pattern and its maintenance throughout lifespan. The molecular mechanisms 
underlying the essential role of mitochondria as signaling organelles in yeast aging have begun to 
emerge; they involve unidirectional and bidirectional communications between mitochondria and 
other cellular compartments. These mechanisms are discussed below. 
 
1.1.3 Mechanisms underlying the essential role of mitochondria in yeast replicative aging 
A mitotically competent mother yeast cell progresses through three consecutive stages of 
replicative aging before becoming unable to produce daughter cells; these stages are called "early 
age", "intermediate age" and "late age" 
20, 144
. Characteristic features of the intermediate-age 
stage of replicative aging include a decline in mitochondrial respiration and the resulting 
reduction of mitochondrial membrane potential 
20, 144, 163
 (Figure 1.2A). A replicatively aging 
mother yeast cell responds to such reduction of mitochondrial membrane potential by activating 
the Rtg2 protein in the cytosol; a mechanism underlying such activation remains to be 
established 
136, 138, 164
. Rtg2 is essential for reducing the rate of yeast replicative aging because 
this protein (1) triggers the mitochondrial retrograde signaling pathway by stimulating nuclear 
import of the Rtg1-Rtg3 heterodimeric transcription factor; this factor then orchestrates an anti-
aging transcriptional program by activating expression of many nuclear genes involved in 
carbohydrate and nitrogen metabolism, peroxisomal fatty acid oxidation and anaplerotic 
reactions, peroxisome proliferation, stabilization of nuclear and mitochondrial genomes, and 
stress response 
136, 138, 164
; and (2) is imported into the nucleus, where it increases genome 
stability and also slows down the synthesis of extrachromosomal rDNA circles known to be one 
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of the "aging factors" limiting the replicative lifespan of the mother cell 
136, 138, 164
 (Figure 1.2A). 
The reduction of mitochondrial membrane potential during the intermediate-age stage of 
replicative aging slows down the aging process not only by activating the two Rtg2-driven 
mechanisms but also by inhibiting the target of rapamycin (TOR) complex 1 protein kinase 
activity 
136, 138, 164
 (Figure 1.2A); a mechanism of such inhibition of this key component of the 
pro-aging TOR signaling pathway is unknown. Moreover, the decline in mitochondrial 
membrane potential during the intermediate-age stage of replicative aging also decelerates 
mitochondrial synthesis of ISCs and/or slows down their efflux from mitochondria 
60
 (Figure 
1.2A). Because ISCs are essential cofactors of nuclear proteins that in yeast are involved in DNA 
replication, DNA repair and telomere maintenance, their reduced quantity in replicatively aging 
yeast compromises genome integrity 
18, 20, 60, 62
. Moreover, because ISCs mitigate activity and/or 
decelerate nuclear import of the transcription activator Aft1, their reduced quantity in 
replicatively aging yeast allows Aft1 to stimulate expression of nuclear genes needed for iron 
entry into and distribution within the cell; the ensuing rise in free intracellular iron accelerates 
replicative aging by promoting iron-driven oxidative damage of many cellular proteins 
18, 56, 60
. 
          During the intermediate-age stage of replicative aging, mitochondria in the mother cell not 
only exhibit reduced membrane potential but also generate elevated quantities of ROS and 
undergo fragmentation; during the subsequent late-age stage of replicative aging, the 
functionality of mitochondria is further declined as these organelles accumulate excessive levels 
of ROS, aggregate and fail to keep mtDNA 
18, 20, 144, 163, 165-168
 (Figure 1.2B). The dysfunctional 
mitochondria exhibiting these age-related traits of deteriorated functionality are known to be one 
of the aging factors limiting the replicative lifespan of the mother cell 
20, 137, 141, 144, 161, 163
. A 
mechanism exists for retaining these dysfunctional mitochondria within the mother cell, thus 
preventing their transmission into the daughter cell. In this mechanism, the dysfunctional 
mitochondria move from the mother cell to the daughter cell slower than their fully functional 
counterparts; such movement of mitochondria on actin cables is driven by the sirtuin Sir2 and 
type V myosin motor Myo2 
20, 165, 169-171
 (Figure 1.2B). 
          The rate of yeast replicative aging is also modulated by the quantity of the Afo1 protein 
component of the large subunit of the mitochondrial ribosome; such modulation is not due to an 
effect of variations in Afo1 quantities on the efficiency of protein synthesis in mitochondria 
2, 18, 
172, 173
. The absence of Afo1 in mitochondria of replicatively aging yeast elicits the following 
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alterations in two signaling pathways of longevity regulation: (1) the anti-aging "back signaling" 
pathway is activated, thus enabling the Sfp1 protein to stimulate transcription of nuclear genes 
coding for protein components of cytoplasmic ribosomes 
2, 18, 172
; and (2) the pro-aging TOR 
signaling pathway is inhibited, thus allowing to slow down the pro-aging process of protein 
synthesis in the cytosol and also to accelerate the anti-aging processes of autophagy, protein 
synthesis in mitochondria and transcription of many nuclear genes involved in cellular stress 
response 
2, 18, 172
 (Figure 1.2C). 
          Another group of mitochondrial processes that contribute to yeast replicative aging include 
the processing, stabilization and translational activation of mRNAs encoded by mtDNA; these 
processes are orchestrated by mitochondrial proteins constituting the so-called mitochondrial 
translation control (MTC) module 
18, 173-177
 (Figure 1.2D). In the absence of any of these MTC 
proteins, the replicative aging of yeast is decelerated via the following two mechanisms: (1) the 
Pnc1- and Sir2-driven inhibition of the synthesis of extrachromosomal rDNA circles, one of the 
aging factors known to limit the replicative lifespan of the mother cell 
18, 176
; and (2) a decrease 
in the cellular concentration of cAMP and the ensuing attenuation of the cAMP-dependent 
protein kinase A (PKA) activity known to decelerate the anti-aging processes of autophagy and 
transcription of many stress-response genes in the nucleus as well as to accelerate the pro-aging 
process of protein synthesis in the cytosol 
18, 137, 173, 176
 (Figure 1.2D).    
          The maintenance of protein homeostasis (proteostasis) in mitochondria also contributes to 
the essential role of these organelles as signaling compartments in yeast replicative aging 
2, 18, 20, 
178-180
. One of the mitochondrial protein components implicated in maintaining mitochondrial 
proteostasis is the m-AAA protease Afg3. It is actively involved in several proteostatic processes 
within the inner mitochondrial membrane – including degradation of misfolded proteins, 
assembly of several ETC protein complexes and processing of a protein component of the large 
subunit of the mitochondrial ribosome 
178, 179
 (Figure 1.2E). These Afg3-driven proteostatic 
processes in mitochondria increase the rate of yeast replicative aging, likely because of their 
demonstrated ability to promote such pro-aging processes outside of mitochondria as protein 






Figure 1.2. Mechanisms underlying the essential role of mitochondria in yeast replicative aging.  
(A) A decline in the mitochondrial electron transport chain (ETC) and the resulting reduction of mitochondrial 
membrane potential (ΔΨ) delay replicative aging in yeast by: (1) stimulating Rtg2-dependent nuclear import of the 
Rtg1-Rtg3 heterodimeric transcription factor, thereby activating the mitochondrial retrograde signaling pathway; (2) 
promoting the import of Rtg2 into the nucleus, where it increases genome stability; and (3) reducing a protein kinase 
activity of the target of rapamycin protein 1 (Tor1). The reduction of ΔΨ also attenuates mitochondrial synthesis 
and/or export of iron-sulfur clusters (ISC), which are needed for maintaining genome stability and inhibiting the 
Aft1-diven transcription of nuclear genes involved in iron entry into the cell. (B) A transition from the early-age 
stage to the intermediate-age stage of replicative aging coincides with a rise of mitochondrial reactive oxygen 
species (ROS) and fragmentation of mitochondria in the mother cell; these fragmented mitochondria produce more 
ROS, aggregate and lose mitochondrial DNA (mtDNA) during the subsequent late-age stage of replicative aging. 
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The dysfunctional mitochondria formed during the intermediate-age and late-age stages of replicative aging are so-
called ″aging factors″. They limit the replicative lifespan of the mother cell; their Sir2- and Myo2-driven movement 
to the daughter cell occurs slower than that of fully functional mitochondria. (C) A reduction in the quantity of the 
Afo1 protein component of the large subunit of the mitochondrial ribosome delays replicative aging in yeast by: (1) 
stimulating Sfp1-driven transcription of nuclear genes encoding protein components of cytoplasmic ribosomes; and 
(2) attenuating the TOR signaling pathway, which accelerates the pro-aging process of protein synthesis in the 
cytosol and also slows down the anti-aging processes of autophagy and transcription of stress-response genes in the 
nucleus. (D) Mitochondrial translation control (MTC) proteins assist in processing, stabilization and translation of 
mRNAs encoded by mtDNA. A reduction in the quantity of MTC proteins slows down replicative aging in yeast by: 
(1) triggering the Pnc1- and Sir2-dependent inhibition of the synthesis of extrachromosomal rDNA circles; and (2) 
reducing the cellular concentration of cAMP and thus attenuating the cAMP-dependent protein kinase A (PKA) 
activity, which decelerates the anti-aging processes of autophagy and transcription of stress-response genes in the 
nucleus and also accelerates the pro-aging process of protein synthesis in the cytosol. (E) Afg3 is a mitochondrial 
protease involved in maintaining protein homeostasis (proteostasis) in mitochondria. The Afg3-driven processes in 
mitochondria include degradation of misfolded proteins, assembly of ETC protein complexes and processing of a 
protein component of the large subunit of the mitochondrial ribosome; these proteostatic processes within 
mitochondria stimulate such pro-aging processes outside of these organelles as protein synthesis in the cytosol and 
the accumulation of unfolded proteins in the endoplasmic reticulum (ER). (F) The Uth1 protein in the outer 
mitochondrial membrane is a pro-aging factor that accelerates replicative aging in yeast by concurrently weakening 
macromitophagic degradation of dysfunctional mitochondria and enhancing micromitophagic degradation of 
functional mitochondria. Activation arrows and inhibition bars denote pro-aging processes (displayed in blue color) 
or anti-aging processes (displayed in red color). See the text for additional details. 
 
          Finally, it seems that the quantity of the Uth1 protein in the outer mitochondrial membrane 
is inversely proportional to the efficiency with which only dysfunctional mitochondria exhibiting 
the age-related traits of deteriorated functionality are degraded within vacuoles of replicatively 
aging yeast. Indeed, it has been shown that lack of Uth1 (1) impairs micromitophagy, an 
autophagic mode of non-selective vacuolar degradation of both functional and dysfunctional 
mitochondria; and (2) does not affect macromitophagy, an autophagic mode of selective vacuolar 
degradation of only dysfunctional mitochondria 
181-183
. Importantly, lack of Uth1 also extends 
longevity of replicatively aging yeast 
181-183
. Thus, Uth1 may function as a pro-aging protein 
factor on the surface of mitochondria; any intervention that reduces its abundance is therefore 
expected to delay replicative aging in yeast by concomitantly enhancing macromitophagic 
degradation of dysfunctional mitochondria and weakening micromitophagic degradation of 
functional mitochondria 
18, 182
 (Figure 1.2F). 
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1.1.4 Mechanisms by which mitochondrial functionality impacts chronological aging of 
yeast 
A culture of chronologically aging yeast in a liquid medium progresses through a series 
of critical lifespan periods that define its longevity; we have recently proposed to use the term 
"lifespan checkpoint" (or simply "checkpoint") for describing each of these consecutive periods 
of yeast chronological lifespan 
18-20, 145, 184
. The early-life checkpoints exist in logarithmic (L), 
diauxic (D) and post-diauxic (PD) growth phases; the late-life checkpoints take place in 
stationary (ST) phase of culturing 
19, 20, 184
. A recently proposed concept of a "biomolecular 
network" posits that the rate and efficiency of progression through each of these lifespan 
checkpoints are monitored and/or modulated by a distinct set of checkpoint-specific "master 
regulator" proteins and protein complexes; a synergistic action of such master regulators defines 
longevity of chronologically aging yeast by orchestrating a stepwise development of a pro- or 
anti-aging cellular pattern 
19, 20, 184
. A body of recent evidence supports the notion that different, 
age-related functional states of mitochondria define longevity of chronologically aging yeast by 
playing essential roles at several of the early-life and late-life checkpoints; this evidence is 
discussed below. 
          It seems that the earliest lifespan checkpoint defined by certain traits of mitochondrial 
functionality exists in L growth phase 
19, 20, 145, 155, 184-188
; we call it "checkpoint 1". At checkpoint 
1, the rapamycin-sensitive protein kinase TOR1 (a key component of the pro-aging TOR 
pathway) attenuates mitochondrial synthesis of oxidative phosphorylation (OXPHOS) enzymes 
that are encoded by mtDNA 
185-188
. The extent of such attenuation (1) is modulated by variations 
in cellular energy status; and (2) establishes a certain rate of coupled mitochondrial respiration 
and a certain value of mitochondrial membrane potential; both these key traits of mitochondrial 
functionality define longevity of chronologically aging yeast cells - in part by influencing stress 
resistance of such cells 
19, 20, 145, 155, 185-188
. The rate of coupled mitochondrial respiration and the 
value of mitochondrial membrane potential at checkpoint 1 are also modulated by caloric 
restriction, a longevity-extending dietary regimen whose impact on these characteristic traits of 
mitochondrial functionality at checkpoint 1 is mediated in part by its inhibitory effect on Tor1 
19, 
20, 137, 155, 185-188
.   
          Mitochondria, along with the pentose phosphate pathway, generate NADPH 
189-191
. In 
mitochondria of chronologically "young" yeast cells, this primary source of cellular reducing 
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equivalents is produced in two reactions of the TCA cycle as well as in reactions catalyzed by an 
acetaldehyde dehydrogenase and an NADH kinase 
189-191
. NADPH drives reductive reactions of 
the biosynthetic pathways for amino acids, fatty acids and sterols 
189-191
; moreover, NADPH is 
also an electron donor for thioredoxin and glutathione reductase systems that maintain cellular 
redox homeostasis 
189, 191
. At lifespan checkpoint 2, which exists in D and PD growth phases, 
these two enzymatic systems play essential roles in delaying yeast chronological aging because 
they both reduce the extent of oxidative damage to many thiol-containing proteins in the 
mitochondria, nucleus and cytosol 
19, 20, 191
. 
          The rate of coupled mitochondrial respiration in yeast cells progressing through D and PD 
growth phases defines their chronological lifespan in part by modulating cellular concentration 
of trehalose 
19, 20, 145, 188, 192
. A lifespan checkpoint at which coupled mitochondrial respiration is 
linked to the maintenance of cellular trehalose homeostasis is called checkpoint 3 
19, 20
. Trehalose 
is a non-reducing disaccharide that controls cellular proteostasis (i.e. a dynamic balance between 
protein folding, misfolding, unfolding, refolding, oxidative damage, solubility and aggregation) 
throughout lifespan of chronologically aging yeast 
19, 192
.        
          A distinct lifespan checkpoint, which we call checkpoint 4, is defined by the concentration 
of ROS produced by and released from mitochondria in chronologically "young" yeast cells; this 
checkpoint exists in D and PD growth phases 
19, 20, 139, 140, 145, 193-195
. If the concentration of 
mitochondria-derived ROS in such cells is maintained at a hormetic level, these ROS act as 
signaling molecules that extend yeast longevity by: (1) stimulating the transcription factors Gis1, 
Msn2 and Msn4, which respond by activating expression of many nuclear genes known for their 
essential longevity-extending roles in nutrient sensing, carbohydrate metabolism, stress 
resistance and survival 
140, 194-197
; and (2) triggering the anti-aging Tel1-Rad53-Rph1 signaling 
pathway, which in response reduces the extent of damage to telomeric DNA by attenuating 
transcription of subtelomeric chromatin regions in the nucleus 
140, 194, 195
.     
          The abilities of mitochondria to convert some of the intermediates of the TCA cycle into 
amino acids and to release these amino acids 
189, 190, 198
 define lifespan checkpoint 5, which exists 
in D and PD growth phases 
18, 19
. Following their release from mitochondria, some of these 
amino acids stimulate protein kinase Tor1; the ensuing activation of the pro-aging TOR signaling 
pathway accelerates chronological aging by promoting protein synthesis in the cytosol, 
attenuating protein synthesis in mitochondria, slowing down transcription of many nuclear genes 
13 
 
involved in stress response, and hindering autophagic degradation of dysfunctional organelles 
and macromolecules 
18, 19, 185, 186, 198-203
. Transcription of stress-response genes in the nucleus and 
autophagy in the cytoplasm are also attenuated by the pro-aging cAMP/PKA (cAMP/protein 
kinase A) signaling pathway, which overlaps with the TOR pathway 
18, 19, 137, 154, 201, 203
. 
          The fragmentation of a tubular mitochondrial network into individual mitochondria and 
the efflux of some proteins (including cytochrome c as well as the "moonlighting" endonucleases 
Aif1 and Nuc1) from the fragmented mitochondria take place in chronologically "old" yeast cells 
that enter ST growth phase; these characteristic changes in mitochondrial morphology limit yeast 
chronological lifespan by eliciting the caspase-dependent and caspase-independent pathways of 
apoptotic programmed cell death (PCD) 
19, 145, 155, 204-209
. A lifespan checkpoint at which such 
age-related changes in mitochondrial morphology are linked to age-related forms of 
mitochondria-controlled apoptotic PCD exists in ST growth phase; we call it checkpoint 6 
19, 20, 
145
.     
          A lifespan checkpoint at which several distinct traits of mitochondrial functionality and 
homeostasis are linked to an age-related "liponecrotic" form of PCD is called checkpoint 7; it 
exists in ST growth phase 
19, 20, 210, 211
. These traits include (1) the efficiency with which 
mitochondria generate energy needed for the detoxification of non-esterified fatty acids through 
their incorporation into neutral lipids; an age-related decline in such efficiency accelerates age-
related liponecrotic PCD by causing the excessive accumulation of monounsaturated fatty acids 
in cellular membranes; (2) the efficiencies with which mitochondria produce and release ROS;  
an age-related rise in such efficiencies above a threshold accelerates age-related liponecrotic 
PCD by causing oxidative damage to cellular macromolecules and organelles; and (3) the 
efficiency with which aged and dysfunctional mitochondria undergo an Atg32- and Aup1-driven 
selective autophagic degradation; an age-related decline in such efficiency accelerates age-
related liponecrotic PCD by impairing the maintenance of a healthy population of fully 
functional mitochondria 
18-20, 158, 159, 182, 210-215
.      
          Some traits of mitochondrial functionality have not been linked to a particular lifespan 
checkpoint yet and may be associated with more than one of such checkpoints in chronologically 
aging yeast. One of these traits is the maintenance of mitochondrial genome integrity and copy 
number; the essential role of this trait in defining the rate of chronological aging depends on the 
mitochondrial base-excision repair enzyme Ntg1 
195
. It seems conceivable that an aging-
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associated mitigation of the Ntg1-governed pathway for maintaining mitochondrial genome 
integrity and copy number may underlie such longevity-shortening process observed in 
chronologically aging yeast as an age-related rise in the rates of mtDNA fragments migration to 
the nucleus and in their insertion into nuclear DNA 
216, 217
. The ensuing reduction of nuclear 
genome stability is an important contributing factor to chronological aging in yeast 
18, 19, 195, 216, 
217
. Of note, the Ntg1-governed pathway: (1) overlaps with a branch of the pro-aging TOR 
signaling pathway which at checkpoint 1 operates in attenuating mitochondrial synthesis of 
mtDNA-encoded OXPHOS enzymes; (2) modulates the anti-aging Tel1-Rad53-Rph1 signaling 
pathway which at checkpoint 4 responses to hormetic concentrations of mitochondria-generated 
ROS by decreasing the extent of damage to telomeric DNA 
140, 194, 195
. These observations further 
support the notion that the Ntg1-dependent maintenance of mitochondrial genome integrity and 
copy number is a trait of mitochondrial functionality that may be associated with more than one 
of the lifespan checkpoints in chronologically aging yeast. 




Figure 1.3. A chronologically aging culture of yeast cells progresses through at least seven consecutive 
″checkpoints″, each of which defines yeast longevity.  
Checkpoint 1: The protein kinase Tor1 mitigates the synthesis of mitochondrial DNA-encoded enzymes of the 
oxidative phosphorylation (OXPHOS) system in mitochondria, thereby allowing to set up a certain rate of electron 
flow through the mitochondrial electron transport chain (ETC) and a certain value of mitochondrial membrane 
potential (ΔΨ). These two traits of mitochondrial functionality establish a magnitude of cell resistance to stresses 
and, thus, define the chronological lifespan of yeast. Caloric restriction extends yeast chronological lifespan by 
suppressing Tor1. Checkpoint 2: Mitochondria-generated NADPH is an electron donor for thioredoxin and 
glutathione reductase (TRR and GLR, respectively) systems outside of mitochondria. Both these systems delay yeast 
chronological aging by reducing the degree of oxidative damage to many proteins in various cellular locations. 
16 
 
Checkpoint 3: The efficiency of coupled mitochondrial respiration defines the cellular concentration of trehalose, 
which in chronologically ″young″ yeast cells acts as a longevity-extending metabolite by enhancing cellular 
proteostasis. Checkpoint 4: If mitochondria-generated reactive oxygen species (ROS) in chronologically "young" 
yeast cells are maintained at a "hormetic" level, ROS extend chronological lifespan by: (1) activating the 
transcription factors Gis1, Msn2 and Msn4, which promote expression of many longevity-extending nuclear genes; 
and (2) stimulating the longevity-extending Tel1-Rad53-Rph1 signaling pathway, which reduces the extent of 
damage to telomeric DNA in the nucleus. Checkpoint 5: Amino acids that are synthesized in and released from 
mitochondria activate the TOR signaling pathway, which accelerates chronological aging by simulating protein 
synthesis in the cytosol, attenuating transcription of many stress-response genes in the nucleus, and suppressing 
autophagy of dysfunctional organelles and macromolecules. Checkpoint 6: A release of cytochrome c, Aif1 and 
Nuc1 from fragmented mitochondria in chronologically "old" yeast cells stimulates caspase-dependent and caspase-
independent modes of apoptotic cell death, thus limiting yeast chronological lifespan. Checkpoint 7: Yeast 
chronological lifespan is shortened by "liponecrosis", a mode of cell death that in chronologically "old" yeast cells is 
triggered due to (1) a reduced ability of mitochondria to generate ATP for the incorporation of non-esterified 
(″free″) fatty acids (FFA) into neutral lipids (NL); (2) a decline in the efficiency of an autophagic degradation of 
aged and dysfunctional mitochondria; and (3) a rise in the efficiencies with which mitochondria generate and release 
ROS. Activation arrows and inhibition bars denote pro-aging processes (displayed in blue color) or anti-aging 
processes (displayed in red color). See the text for additional details. 
 
          Another trait of mitochondrial functionality that may define more than one of the lifespan 
checkpoints in chronologically aging yeast is the lipid compositions of both mitochondrial 
membranes. Indeed, lithocholic bile acid (LCA) extends yeast chronological lifespan by eliciting 
an age-related remodeling of the mitochondrial membrane lipidome 
139, 193, 218
. Such remodeling 
is likely to be responsible for the age-related changes in mitochondrial size, number and 
morphology observed in chronologically aging yeast cells exposed to LCA, as well as for LCA-
driven alterations in the age-related dynamics of mitochondrial respiration, membrane potential, 
ATP synthesis and ROS homeostasis seen in these cells 
139, 193, 218
. Recent data suggest that these 
characteristic changes in the mitochondrial membrane lipidome and functionality elicited by 
LCA in chronologically aging yeast cells enable mitochondria to operate as signaling organelles 
that modulate activities of several transcription factors linked to some of the above lifespan 
checkpoints; these factors respond by altering transcription of many longevity-defining nuclear 






1.2 Thesis outline and contributions of colleagues 
Chapter 2 describes how I used a combination of subcellular fractionation by differential 
centrifugation, organelle separation by equilibrium density gradient centrifugation, fractionation 
of purified mitochondria into various subcompartments and quantitative mass spectrometric 
analysis to make an initial step towards establishing a mechanism by which lithocholic bile acid 
(LCA) extends longevity of chronologically aging yeast limited in calorie supply. I carried out 
all of the experiments described in this chapter of my thesis and wrote the first draft of it. 
Findings described in Chapter 2 provide evidence that exogenously added LCA enters yeast 
cells, is sorted only to mitochondria, resides mainly in the inner mitochondrial membrane and 
also associates with the outer membrane of mitochondria. All findings described in Chapter 2 
have been published in Aging: Beach, A., Richard, V.R., Leonov, A., Burstein, M.T., Bourque, 
S.D., Koupaki, O., Juneau, M., Feldman, R., Iouk, T., Titorenko, V.I. Mitochondrial membrane 
lipidome defines yeast longevity. Aging  5, 551–574 (2013), along with data that were attained 
by other co-authors on the manuscript and that are not presented in Chapter 2 of this thesis. Dr. 
Titorenko provided intellectual leadership of this project; he also edited the first draft of Chapter 
2 and the entire manuscript of the above article. 
          Findings presented in Chapter 3 support the validity of my hypothesis that the LCA-
elicited changes in the membrane lipidome of mitochondria alter the age-related dynamics of 
several longevity-defining mitochondrial processes. These processes include mitochondrial 
respiration, maintenance of mitochondrial membrane potential and ROS homeostasis, prevention 
of excessive oxidative damage to mitochondrial macromolecules, preservation of certain 
respiratory supercomplexes in the inner mitochondrial membrane, and ATP synthesis. All 
findings described in Chapter 3, along with data attained by others and therefore not presented 
here, are included into a manuscript that is currently in preparation and will be submitted for 
publication in May or June of 2015. Dr. Titorenko provided intellectual leadership of this 
project; he also edited the first draft of Chapter 3. 
          Findings described in Chapter 4 provide conclusive evidence in strong support of my 
hypothesis in which the longevity-extending potential of LCA is due in part to its ability to alter 
the age-related dynamics of mitochondrially produced ROS in both chronologically ʺyoungʺ and 
ʺoldʺ cells, thus reducing the damaging effect of these ROS in ʺyoungʺ cells and amplifying their 
ʺhormeticʺ effect in ʺoldʺ cells. All findings described in Chapter 4, along with data attained by 
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others and therefore not presented here, are included into a manuscript that is currently in 
preparation and will be submitted for publication in May or June of 2015. Dr. Titorenko 
provided intellectual leadership of this project; he also edited the first draft of Chapter 4. 
          Chapter 5 describes how, using quantitative mass spectrometry, I demonstrated that LCA 
alters the age-related dynamics of changes in levels of many mitochondrial proteins, as well as 
numerous proteins in cellular locations outside of mitochondria. Findings presented in this 
Chapter suggest that LCA-driven changes in mitochondrial lipidome alter mitochondrial 
proteome and functionality, thereby enabling mitochondria to operate as signaling organelles that 
orchestrate an establishment of an anti-aging transcriptional program for many longevity-
defining nuclear genes. Based on these findings, in Chapter 5 of my thesis I proposed a model 
for how such LCA-driven changes early and late in life of chronologically aging yeast cause a 
stepwise development of an anti-aging cellular pattern and its maintenance throughout lifespan. 
All findings described in Chapter 5, along with data attained by others and therefore not 
presented here, are included into a manuscript that has been recently submitted to Cell Cycle. Dr. 
Titorenko provided intellectual leadership of this project; he also edited the first draft of Chapter 
5. 
          Findings presented in Chapter 6 imply that mitophagy, a selective autophagic degradation 
of aged and dysfunctional mitochondria, is a longevity assurance process that in chronologically 
aging yeast underlies the synergistic beneficial effects of anti-aging dietary and pharmacological 
interventions (such as caloric restriction and LCA) on lifespan. All findings described in this 
Chapter of my thesis have been published in Aging: Richard, V.R., Leonov, A., Beach, A., 
Burstein M.T., Koupaki, O., Gomez-Perez, A., Levy, S., Pluska, L., Mattie, S., Rafesh, R., Iouk, 
T., Sheibani, S., Greenwood, M., Vali, H., Titorenko, V.I. Macromitophagy is a longevity 
assurance process that in chronologically aging yeast limited in calorie supply sustains functional 
mitochondria and maintains cellular lipid homeostasis. Aging (Albany NY) 5, 234–269 (2013), 
along with data that were attained by other co-authors on the manuscript and that are not 
presented in Chapter 6 of this thesis. Dr. Titorenko provided intellectual leadership of this 
project; he also edited the first draft of Chapter 6 and the entire manuscript of the above article. 
          In Chapter 7 of my thesis I summarized the evidence that peroxisomes are dynamically 
integrated into an endomembrane system that governs cellular aging, discussed various strategies 
through which peroxisomes are integrated into such endomembrane system, critically evaluated 
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mechanisms underlying each of these strategies, and analyzed the age-related dynamics of 
communications between peroxisomes and other cellular compartments composing the 
longevity-defining endomembrane system. In this Chapter, I also outlined recent progress in 
understanding how communications between peroxisomes and other cellular compartments 
within this endomembrane system influence the development of a pro- or anti-aging cellular 
pattern. Based on the available evidence, I proposed a model for the integration of peroxisomes 
into the endomembrane system governing cellular aging. Chapter 7 has been published as a 
review article in Frontiers in Physiology: Beach, A., Burstein, M.T., Richard, V.R., Leonov, A., 
Levy, S., Titorenko, V.I. Integration of peroxisomes into an endomembrane system that governs 
cellular aging. Front Physiol 3, 283 (2012). Dr. Titorenko provided intellectual leadership of this 
project; he also edited the first draft of Chapter 7 and the entire manuscript of the above review 
article. 
All of the abbreviations, citations, and the numbering of figures and tables that have been 
taken from either published papers or manuscripts in preparation have been edited to match the 



























2 Exogenously added lithocholic acid (LCA) enters yeast cells, is sorted to mitochondria, 




The Titorenko laboratory has recently identified lithocholic acid (LCA), a bile acid, as a 
natural compound that acts synergistically with caloric restriction (CR) to cause a substantial 
increase in yeast chronological lifespan under longevity-extending CR conditions 
155
. This 
chapter summarizes my studies that led to the establishment of the mechanism through which 
LCA extends longevity by altering lipid compositions of mitochondrial membranes and 
amending mitochondrial functionality in chronologically aging yeast.   
 
2.2 Materials and methods 
2.2.1 Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) was used in this study. Media components were as follows: (1) YEPD (0.2% glucose), 
1% yeast extract, 2% peptone, 0.2% glucose; and (2) YEPD (2% glucose), 1% yeast extract, 2% 
peptone, 2% glucose.  
 
2.2.2 A plating assay for the analysis of chronological lifespan 
 Cells were grown in YEPD (0.2% glucose) medium at 30
o
C with rotational shaking at 
200 rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. A sample of cells 
was removed from each culture at various time points. A fraction of the cell sample was diluted 
in order to determine the total number of cells per ml of culture using a hemacytometer. 10 l of 
serial dilutions (1:10 to 1:10
3
) of cells were applied to the hemacytometer, where each large 
square is calibrated to hold 0.1 l. The number of cells in 4 large squares was then counted and 
an average was taken in order to ensure greater accuracy. The concentration of cells was 
calculated as follows: number of cells per large square x dilution factor x 10 x 1,000 = total 





) of cells were plated onto YEPD (2% glucose) plates in triplicate in 
order to count the number of viable cells per ml of each culture. 100 l of diluted culture was 
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plated onto each plate. After a 48-h incubation at 30
o
C, the number of colonies per plate was 
counted. The number of colony forming units (CFU) equals to the number of viable cells in a 
sample. Therefore, the number of viable cells was calculated as follows: number of colonies x 
dilution factor x 10 = number of viable cells per ml. For each culture assayed, % viability of the 
cells was calculated as follows: number of viable cells per ml / total number of cells per ml x 
100%. The % viability of cells in mid-logarithmic phase was set at 100% viability for that 
particular culture. The life span curves for wild-type and some of the mutant strains were also 
validated using a LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's 
instructions for stationary-phase cultures.   
 
2.2.3 Pharmacological manipulation of chronological lifespan 
Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA) bile acid was from Sigma. The stock solution of LCA in DMSO was made on 
the day of adding this compound to cell cultures. LCA was added to growth medium at the final 
concentration of 50 µM immediately following cell inoculation into the medium. The final 
concentration of DMSO in yeast cultures supplemented with LCA (and in the corresponding 
control cultures supplemented with drug vehicle) was 1% (v/v). 
 
2.2.4 Quantitative analysis of LCA associated with cells or remaining in the cultural 
medium 
Yeast cells cultured in the presence of LCA were pelleted by centrifugation for 5 min at 
3,000 × g at room temperature. The recovered supernatant of the cultural medium was stored at 
room temperature. The recovered pellet of cells was washed twice with distilled water; the 
supernatant recovered after each centrifugation was combined with the cultural medium. 
Established procedures 
151, 220
 were used for lipid extraction from the washed cells and from the 
cultural medium combined with the two washes. Mass spectrometric identification and 






2.2.5 Quantitative analysis of LCA recovered in subcellular fractions separated by 
differential centrifugation 
Subcellular fractionation of yeast cell homogenates through sequential centrifugation 
steps of increasing force and duration 
222
, lipid extraction from the recovered subcellular 
fractions 
220
, and mass spectrometric identification and quantitation of LCA in the extracts of 
lipids 
151, 221
 were performed according to established procedures. 
 
2.2.6 Quantitative analysis of LCA recovered in organelles pelleted by centrifugation at 
12,000 × g and then separated by equilibrium density gradient centrifugation 
A mix of mitochondria, endoplasmic reticulum, Golgi, vacuoles, plasma membrane and 
nuclei was recovered in a 12,000 × g pellet by sequential centrifugation of yeast cell 
homogenates at 1,000 × g and 12,000 × g as previously described 
222
. An established procedure 
223
 was used for separating the recovered mix of organelles by centrifugation to equilibrium in a 
sucrose density gradient. Lipid extraction from equal volumes of gradient fractions 
220
, and mass 
spectrometric identification and quantitation of LCA in the extracts of lipids 
151, 221
 were 
performed according to established procedures. 
 
2.2.7 Subfractionation of purified mitochondria using a swell-shrink procedure and 
equilibrium density gradient centrifugation 
Mitochondria purified as previously described 
223
 were subjected to subfractionation 
using a modified swell-shrink procedure and subsequent equilibrium density gradient 
centrifugation 
224
. Briefly, the purified mitochondria were resuspended in hypotonic buffer KH 
(10 mM KCl, 2 mM HEPES, pH 7.2) at 2 mg/ml with gentle agitation for 20 min on ice. This 
caused the mitochondria to swell, ruptured the outer mitochondrial membrane (OMM) and 
resulted in the formation of mitoplasts consisting of mitochondrial matrix surrounded by the 
intact inner mitochondrial membrane (IMM). One-third volume of hypertonic buffer SAMH (1.8 
M sucrose, 2 mM ATP, 2 mM MgSO4, 2 mM HEPES, pH 7.2) was then added and the 
mitoplasts attached to ruptured OMM vesicles were subjected to gentle homogenization for an 
additional 10 min. This caused the mitoplasts to shrink, disrupted the OMM/IMM contact sites 
and resulted in the release of ruptured OMM vesicles. The swollen/shrunk mitochondrial 
suspension was then subjected to centrifugation on a discontinuous sucrose (26, 34.2, 45.2 and 
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61.6%; wt/v in KH buffer) gradient at 75,000 × g for 3 h at 4°C in a SW28 rotor (Beckman 
Coulter). 19 fractions of 2 ml each were collected. Equal volumes of gradient fractions were 
subjected to SDS-PAGE and immunoblotting with antibodies to Por1p (a protein marker of the 
OMM fraction), Ccp1p (a protein marker of the intermembrane space 
IMS
 fraction), Cox2p (a 
protein marker of the IMM fraction) and Mge1p (a protein marker of the matrix fraction). Lipid 
extraction from equal volumes of gradient fractions 
220
, and mass spectrometric identification 
and quantitation of LCA in the extracts of lipids 
151, 221
 were performed according to established 
procedures. 
    
2.2.8 Subfractionation of purified mitochondria using sonication and differential 
centrifugation 
Mitochondria purified as previously described 
223
 were subjected to subfractionation using a 
modified procedure of sonication and subsequent differential centrifugation 
224
. The procedure 
results in a reconstruction of so-called submitochondrial particles (SMP) depleted of protein and 
other components of the mitochondrial matrix and IMS; these vesicular particles are surrounded 
by the IMM and OMM that are resealed in the inside-out orientation 
224
. To reconstruct SMP, the 
purified mitochondria were gently resuspended in buffer SEH (250 mM sucrose, 2 mM EGTA, 5 
mM HEPES, pH 7.2) at 2 mg/ml on ice. The suspension of mitochondria was sonicated 3 × 1 
min on ice with 1 min intervals. The sonicated suspension was then subjected to centrifugation 
for 10 min at 12,000 × g at 4oC to remove unbroken mitochondria. The recovered supernatant 
was spun for 45 min at 120,000 × g at 4oC to yield the pellet of SMP and the supernatant 
containing protein and other components of the mitochondrial matrix and IMS. The pellet of 
SMP was gently resuspended in ice-cold SEH buffer and spun for 45 min at 120,000 × g at 4
o
C 
to wash and re-pellet SMP. 
 
2.2.9 Analysis of lipids by mass spectrometry 
Extraction of lipids from purified mitochondria, ER and PM and following mass 
spectrometric identification and quantitation of various lipid species were carried out as 
previously described 
151, 220, 221
. Mass spectrometric analyses were performed with a Thermo 
OrbitrapVelos mass spectrometer equipped with a HESI-II ion source (#10145339; Thermo 
Scientific) operating at a flow rate of 5 μl/min. Numerous lipid species were separated by Fourier 
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transform tandem mass spectrometry. Mass spectra were converted to an open format (mzXML, 
mzML) using the ProteoWizard MSConvert software freely available from 
http://proteowizard.sourceforge.net/. The raw data were then imported into the open source 
software LipidXplorer (freely available from https://wiki.mpi-
cbg.de/wiki/lipidx/index.php/Main_Page) for the automated detection and quantitation of lipid 
species. 
 
2.2.10 Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated using an unpaired 
two-tailed t test. 
 
2.3 Results and Discussion 
2.3.1 LCA enters yeast cells 
In the high-throughput screen that led to the identification of LCA as an anti-aging 
molecule, all of the tested chemical compounds derived from several commercial libraries were 
dissolved in dimethyl sulfoxide (DMSO) and the final concentration of this solvent in yeast 
cultures was 1% (v/v) 
155
. Due to the well-known ability of DMSO to create pores in the 
hydrophobic core of a membrane bilayer and to increase its fluidity, this amphiphilic enhancer of 
cell membrane permeability for drugs and DNA is traditionally used as a vehicle for delivering 
various chemical compounds into a cell 
225
. If LCA was first dissolved in DMSO and then added 
to growth medium at a final concentration of 50 µM immediately following cell inoculation into 
the medium, this bile acid significantly extended the chronological lifespan (CLS) of yeast cells 
that were cultured under caloric restriction (CR) conditions on 0.2% glucose (Figure 2.1A) 
155
.     
          Noteworthy, LCA at a final concentration of 50 µM displayed a similar strong beneficial 
effect on the CLS of yeast cells cultured under CR at 0.2% glucose if it was added to growth 
medium in water, i.e., under conditions that are unlikely to enhance cell membrane permeability 
for exogenous chemical compounds (Figure 2.1B) 
221
. This observation suggested that, akin to 
the established mechanism underlying an anti-tumor effect of LCA in cultured human cells 
226
, a 
mechanism by which this bile acid extends longevity of chronologically aging yeast under CR 
conditions does not involve its delivery into cells. As a first step towards addressing this 
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important spatial aspect of the longevity-extending effect of exogenously added LCA, I used a 
quantitative mass spectrometric analysis to compare the relative level of cell-associated LCA to 
that of LCA in the cultural medium. My analysis of the age-related dynamics of changes in the 
levels of LCA associated with cells or remaining in the cultural medium revealed that in yeast 
cultures incubated with exogenously added 50 µM LCA in the presence of DMSO, only a minor 
portion of this bile acid (from 6.1% to 14.6% at different periods of chronological lifespan) was 
present in a cell-associated form (Figure 2.1C). In contrast, in yeast cultures incubated with 
exogenously added 50 µM LCA in the absence of DMSO, the major portion of this bile acid 
(from 76.7% to 94.8%, depending on a period of chronological lifespan) was associated with 
cells (Figure 2.1D). 
          I then used subcellular fractionation by differential centrifugation (Figure 2.1G) followed 
by mass spectrometric quantitation of LCA to assess its relative levels in various subcellular 
fractions. I found that in yeast cultured with exogenously added LCA in the presence of DMSO 
1) LCA was present mostly (from 71.3% to 90.2%, depending on a period of chronological 
lifespan) in the cytosolic (100KgS) fraction; 2) from 5.2% to 21.6% of LCA was recovered in the 
12KgP fraction containing mitochondria, endoplasmic reticulum (ER), Golgi, vacuoles, plasma 
membrane (PM) and nuclei; and 3) from 4.2% to 7.1% of LCA was associated with cell surface, 
as it was recovered in the 1KgP fraction known to consist of unspheroplasted cells and cell 
debris (Figure 2.1E). In contrast, in yeast cultured with exogenously added LCA in the absence 
of DMSO 1) LCA was mostly (from 73.3% to 92.2%) associated with cell surface (1KgP 
fraction); 2) from 4.1% to 23.6% of LCA was recovered in the 12KgP fraction consisting of 
mitochondria, ER, Golgi, vacuoles, PM and nuclei; and 3) only a minor portion (from 2.9% to 
4.4%) of LCA was present in the cytosolic (100KgS) fraction (Figure 2.1F). 
          In sum, my quantitative analysis of LCA recovered in various subcellular fractions 
separated by differential centrifugation implies that in yeast cultured with exogenously added 
LCA in the presence of DMSO, this bile acid is evenly distributed between the cultural medium 
and the cytosol – perhaps because of its high solubility in DMSO present in the cultural medium 
and the cytosol and probably due to its passive diffusion through pores in the PM created by 
DMSO. Importantly, in yeast cultured with LCA in the presence of DMSO, up to 21.6% of the 
intracellular pool of this bile acid is confined to the 12KgP fraction containing mitochondria, ER, 
Golgi, vacuoles, PM and nuclei. Furthermore, in yeast cultured with exogenously added LCA in 
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the absence of DMSO, this most hydrophobic molecular form of bile acids 
155
 associates mainly 
with cell surface – possibly because of its low solubility in water leading to its adhesion to the 
cell wall and perhaps due to lack of pores in the PM. Yet, even in yeast cultured with LCA in the 
absence of DMSO, up to 28% of this bile acid enters yeast cells and associates mainly with the 






Figure 2.1. In yeast cultured with exogenously added LCA in the presence or absence of DMSO, this bile acid 
enters cells and accumulates in a subcellular fraction consisting of mitochondria, ER, Golgi, vacuoles, PM 
and nuclei.  
(A and B) Cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with 50 µM LCA or 
without it, in the presence of 1% DMSO (A) or in its absence (B). Survival curves of chronologically aging yeast are 
shown; data are presented as means ± SEM (n = 11-14). (C and D) The age-related dynamics of changes in the 
levels of LCA associated with cells or remaining in the cultural medium in yeast cultures that were incubated with 
exogenously added 50 µM LCA in the presence of 1% DMSO (C) or in its absence (D); data are presented as means 
± SEM (n = 5-6). (E and F) The age-related dynamics of changes in the levels of LCA recovered in various 
subcellular fractions that were separated by differential centrifugation of yeast cell homogenates; data for subcellular 
fractions recovered from yeast cultures that were incubated with exogenously added 50 µM LCA in the presence of 
DMSO (E) or in its absence (F) are presented as means ± SEM (n = 4). The efficacy of spheroplast formation is also 
shown as means ± SEM (n = 4). (G) Outline of a procedure for subcellular fractionation of yeast cell homogenates 
through sequential centrifugation steps of increasing force and duration. Abbreviations: Diauxic (D), logarithmic 
(L), post-diauxic (PD) or stationary (ST) growth phase. 
 
2.3.2 Intracellular LCA accumulates in mitochondria 
To elucidate in which organelle or organelles present in the 12KgP subcellular fraction 
LCA resides, I subjected the mix of mitochondria, ER, Golgi, vacuoles, PM and nuclei recovered 
in this organellar fraction to separation by centrifugation to equilibrium in a sucrose density 
gradient. The shape of this gradient has been previously optimized for the purification of 
mitochondria devoid of contamination by other organelles present in the 12KgP fraction (Figure 
2.) 
223
.  My mass spectrometric identification and quantitation of LCA in gradient fractions 
revealed that the 12KgP-associated pool of LCA is almost exclusively confined to mitochondria 
of yeast cultured with this bile acid in the presence of DMSO (Figures 2.2A and 2.2B) or in its 
absence (Figures 2.2C and 2.2D). I therefore concluded that, regardless of the presence of 
DMSO in yeast cultures containing exogenously added LCA, the only kind of cellular organelle 





Figure 2.2. Intracellular LCA accumulates in mitochondria.  
Cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with exogenously added 50 
µM LCA in the presence of 1% DMSO (A and B) or in its absence (C and D). Homogenates of cells that were taken 
at day 4 (A and C) or 7 (B and D) of cell culturing were subjected to subcellular fractionation to recover a mix of 
mitochondria, endoplasmic reticulum (ER), Golgi, vacuoles, plasma membrane (PM) and nuclei in a 12,000 × g 
pellet. The recovered mix of organelles was fractionated using centrifugation to equilibrium in a sucrose density 
gradient. The percent recoveries of loaded protein and LCA in sucrose gradient fractions are presented. Equal 
volumes of gradient fractions were subjected to lipid extraction followed by mass spectrometric identification and 
quantitation of LCA in the extracts of lipids. Equal volumes of gradient fractions were also analyzed by 
immunoblotting with antibodies to Por1p (a protein marker of mitochondria), Nsp1p (a protein marker of the 
nucleus), Dpm1p (a protein marker of the ER), Vps10p (a protein marker of the Golgi), Pma1p (a protein marker of 
the PM) and Pho8p (a protein marker of the vacuole). 
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2.3.3 Mitochondria-associated LCA resides mainly in the inner mitochondrial membrane 
(IMM) 
To examine in which mitochondrial sub-compartment LCA resides, I first subjected 
purified mitochondria to fractionation using a swell-shrink procedure and subsequent equilibrium 
density gradient centrifugation. This fractionation approach enables to separate mitochondria 
into the intact outer mitochondrial membrane (OMM) fraction, the intact intermembrane space 
(IMS) fraction and the mitoplast fraction consisting of mitochondrial matrix surrounded by the 
intact IMM 
224
. I found that, regardless of the presence of DMSO in yeast cultures containing 
exogenously added LCA, the bulk quantities of this bile acid (from 69.5% to 74.6% of the total 
pool of mitochondria-associated LCA) were confined to mitoplasts (Figures 2.3A and 2.3B). A 
smaller portion of LCA (from 20.7% to 26.6% of the total pool of mitochondrial LCA) was 
recovered in the OMM, and only minute quantities of it (from 1.4% to 8.3% of the total pool of 
mitochondria-associated LCA) were found in the IMS (Figures 2.3A and 2.3B). 
          I then quantitatively assessed the relative abundance of LCA in the membrane (i.e., the 
OMM and IMM) and soluble (i.e., the IMS and matrix) mitochondrial sub-compartments by 
subjecting purified mitochondria to fractionation using sonication and subsequent differential 
centrifugation. This fractionation approach results in a reconstruction of so-called 
submitochondrial particles (SMP). These vesicular particles (1) are depleted of protein and other 
components of the mitochondrial matrix and IMS; and (2) are surrounded by the IMM and OMM 
resealed in the inside-out orientation 
224
. High-speed centrifugation of sonicated mitochondria 
yields the pellet of SMP, whereas protein and other components of the mitochondrial matrix and 
IMS remain in the supernatant. I found that, in yeast cultured with LCA in the presence of 
DMSO or in its absence, this bile acid was confined mostly (from 92.8% to 98.5% of the total 
pool of mitochondrial LCA) to the pellet of SMP (Figures 2.3C and 2.3D). Minor quantities of 
LCA (from 1.5% to 7.2% of the total pool of mitochondria-associated LCA) were recovered in 




Figure 2.3. Mitochondria-associated LCA is confined mainly to the IMM, and also resides in the OMM.  
Cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose with exogenously added 50 
µM LCA in the presence of 1% DMSO (A and C) or in its absence (B and D). Purified mitochondria of cells that 
were taken at day 4 of cell culturing were subjected to fractionation using a swell-shrink procedure and subsequent 
equilibrium density gradient centrifugation (A and B) or to fractionation using sonication and subsequent differential 
centrifugation (C and D). (A and B) The percent recoveries of loaded protein and LCA in sucrose gradient fractions 
are presented. Equal volumes of gradient fractions were subjected to lipid extraction followed by mass spectrometric 
identification and quantitation of LCA in the extracts of lipids. Equal volumes of gradient fractions were also 
analyzed by immunoblotting with antibodies to Por1p (a protein marker of the OMM), Ccp1p (a protein marker of 
the IMS), Cox2p (a protein marker of the IMM) and Mge1p (a protein marker of the mitochondrial matrix). (C and 
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D) The percent recoveries of protein and LCA in the pellet of SMP (consisting of vesicular particles surrounded by 
the IMM and OMM resealed in the inside-out orientation) and the supernatant (containing protein and other 
components of the mitochondrial matrix and IMS); the pellet and supernatant fractions were recovered after high-
speed centrifugation of sonicated mitochondria. Data are presented as means ± SEM (n = 3; *p < 0.01). 
 
          Altogether, my quantitative analysis of LCA recovered in various mitochondrial sub-
compartments implies that, regardless of the presence of DMSO in yeast cultures containing 
exogenously added LCA, the mitochondria-associated pool of LCA resides mainly in the IMM. 
A smaller portion of this bile acid (from 20.7% to 26.6% of the total pool of mitochondrial LCA) 
associates with the OMM. 
 
2.3.4 Conclusion 
In sum, I used a combination of subcellular fractionation by differential centrifugation, 
organelle separation by equilibrium density gradient centrifugation, fractionation of purified 
mitochondria into various subcompartments and quantitative mass spectrometric analysis to 
make an initial step towards establishing a mechanism by which LCA extends longevity of 
chronologically aging yeast limited in calorie supply. My findings imply that exogenously added 
LCA enters yeast cells, is sorted only to mitochondria, resides mainly in the IMM, and also 


















3 A permanent exposure of yeast cells to LCA changes the age-related chronology of 
several longevity-defining processes taking place within mitochondria 
 
3.1 Introduction 
Dr. Vincent Richard, a former graduate student in the Titorenko laboratory, has used mass 
spectrometry to compare the membrane lipidomes of mitochondria purified from yeast cultured 
under caloric restriction (CR) conditions with or without LCA. He found that exogenously added 
LCA exhibits differential effects on the concentrations of different molecular forms of 
mitochondrial membrane phospholipids; moreover, these effects of LCA appeared to be age-
dependent 
193
. Specifically, he demonstrated that: (1) LCA causes a rise in the levels of 
mitochondrial phosphatidic acid (PA), phosphatidylglycerol (PG), phosphatidylserine (PS), 
phosphatidylcholine (PC) and phosphatidylinositol (PI); (2) the extent of such effect of LCA on 
PA, PG, PS, PC and PI levels increases with the chronological age of yeast cells; and (3) for the 
PG and PI classes of mitochondrial membrane glycerophospholipids, this effect of LCA can be 
seen only in cells recovered at post-diauxic (PD) or stationary (ST) growth phase on day 4 or 7 
(respectively) of cell culturing 
193
. Furthermore, mass spectrometric identification and 
quantitation of mitochondrial membrane phospholipids also revealed that (1) LCA elicits a 
decline in the levels of mitochondrial cardiolipin (CL), monolysocardiolipin (MLCL)  and 
phosphatidylethanolamine (PE); (2) the extent of such effect of LCA on CL, MLCL and PE 
levels decreases with the chronological age of yeast cells; and (3) for the MLCL species of 
mitochondrial membrane glycerophospholipids, this effect of LCA can be seen only in cells 
recovered at PD or ST growth phase on day 4 or 7 (respectively) of cell culturing 
193
. Taken 
together, these findings imply that the accumulation of LCA in the IMM and OMM causes 
significant changes in the phospholipid compositions of both mitochondrial membranes. 
          Two of the phospholipids whose levels were substantially reduced by LCA, namely PE 
and CL 
193
, have been shown to modulate protein complexes and supercomplexes that reside in 
the IMM and drive such longevity-defining processes as mitochondrial respiration, the 
maintenance of electrochemical membrane potential and preservation of ROS homeostasis 
227 - 
229
. I therefore hypothesized that the LCA-elicited changes in the membrane lipidome of 
mitochondria may impact these longevity-defining mitochondrial processes. Chapter 3 describes 
experiments that I conducted to test the validity of my hypothesis.   
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3.2  Materials and methods 
3.2.1 Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) was used in this study. The composition of YEPD (0.2% glucose) medium was as 
follows: 1% yeast extract, 2% peptone, 0.2% glucose. Cells were cultured at 30
o
C with rotational 
shaking at 200 rpm in Erlenmeyer flasks at a ″flask volume/medium volume″ ratio of 5:1.  
 
3.2.2 Pharmacological manipulation of chronological lifespan 
Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA) [#L6250] bile acid was from Sigma. The stock solution of LCA in DMSO was 
made on the day of adding this compound to cell cultures. LCA was added to growth medium at 
the final concentration of 50 µM immediately following cell inoculation into the medium. The 
final concentration of DMSO in yeast cultures supplemented with LCA (and in the 
corresponding control cultures supplemented with drug vehicle) was 1% (v/v). 
 
3.2.3 Monitoring the formation of ROS  
Wild-type and mutant cells grown in YEPD (0.2% glucose) were tested microscopically 
for the production of ROS by incubation with dihydrorhodamine 123 (DHR). In the cell, this 
nonfluorescent compound can be oxidized to the fluorescent chromophore rhodamine 123 by 
ROS. Cells were also probed with a fluorescent counterstain Calcofluor White M2R (CW), 
which stains the yeast cell walls fluorescent blue. CW was added to each sample in order to label 
all cells for their proper visualization. DHR was stored in the dark at –20oC as 50 l aliquots of a 
1 mg/ml solution in ethanol. CW was stored in the dark at –20oC as the 5 mM stock solution in 
anhydrous DMSO (dimethylsulfoxide).  
          The concurrent staining of cells with DHR and CW was carried out as follows. The 
required amounts of the 50 l DHR aliquots (1 mg/ml) and of the 5 mM stock solution of CW 
were taken out of the freezer and warmed to room temperature. The solutions of DHR and CW 
were then centrifuged at 21,000 x g for 5 min in order to clear them of any aggregates of 
fluorophores. For cell cultures with a titre of ~ 10
7
 cells/ml, 100 l was taken out of the culture 
to be treated. If the cell titre was lower, proportionally larger volumes were used. 6 l of the 1 
mg/ml DHR and 1 l of the 5 mM CW solutions were added to each 100 l aliquot of culture. 
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After a 2-h incubation in the dark at room temperature, the samples were centrifuged at 21,000 x 
g for 5 min. Pellets were resuspended in 10 l of PBS buffer (20 mM KH2PO4/KOH, pH 7.5, and 
150 mM NaCl). Each sample was then supplemented with 5 l of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides were 
prepared, they were visualized under the Zeiss Axioplan fluorescence microscope mounted with 
a SPOT Insight 2 megapixel color mosaic digital camera. Several pictures of the cells on each 
slide were taken, with two pictures taken of each frame. One of the two pictures was of the cells 
seen through a rhodamine filter in order to detect cells dyed with DHR. The second picture was 
of the cells seen through a DAPI filter in order to visualize CW, and therefore all the cells 
present in the frame. 
          For evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool (Version 
3.0) software was used to calculate both the total number of cells and the number of stained cells. 
Fluorescence of individual DHR-positive cells in arbitrary units was determined by using the 
UTHSCSA Image Tool software (Version 3.0). In each of 3-5 independent experiments, the 
value of median fluorescence was calculated by analyzing at least 800-1000 cells that were 
collected at each time point. The median fluorescence values were plotted as a function of the 
number of days cells were cultured.  
 
3.2.4 Monitoring the mitochondrial membrane potential () 
Rhodamine 123 (R123) (Invitrogen) staining for monitoring the mitochondrial membrane 
potential () was performed according to established procedure (Invitrogen manual for the 
Yeast Mitochondrial Stain Sampler Kit). Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic digital 
camera (Spot Diagnostic Instruments). For evaluating the percentage of R123-positive cells, the 
UTHSCSA Image Tool (Version 3.0) software was used to calculate both the total number of 
cells and the number of stained cells. Fluorescence of individual R123-positive cells in arbitrary 
units was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-6 
independent experiments, the value of median fluorescence was calculated by analyzing at least 
800-1000 cells that were collected at each time point. The median fluorescence values were 




3.2.5 Immunofluorescence microscopy 
Cell cultures were fixed in 3.7% formaldehyde for 45 min at room temperature. The cells 
were washed in solution B (100 mM KH2PO4/KOH pH 7.5, 1.2 M sorbitol), treated with 
Zymolyase 100T (MP Biomedicals, 1 μg Zymolyase 100T/1 mg cells) for 30 min at 30oC and 
then processed as previously described (Pringle et al., 1991). Monoclonal antibody raised against 
porin (Invitrogen, 0.25 μg/μl in TBSB buffer [20 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mg/ml 
BSA] was used as a primary antibody. Alexa Fluor 568 goat anti-mouse IgG (Invitrogen, 2 μg/μl 
in TBSB buffer) was used as a secondary antibody. The labeled samples were mounted in 
mounting solution (16.7 mM Tris/HCl pH 9.0, 1.7 mg/ml p-phenylenediamine, 83% glycerol). 
Images were collected with a Zeiss Axioplan fluorescence microscope (Zeiss) mounted with a 
SPOT Insight 2 megapixel color mosaic digital camera (Spot Diagnostic Instruments). 
 
3.2.6 Oxygen consumption assay 
The rate of oxygen consumption by yeast cells recovered at various time points was 
measured continuously in a 2-ml stirred chamber using a custom-designed biological oxygen 
monitor (Science Technical Center of Concordia University) equipped with a Clark-type oxygen 
electrode. 1 ml of YEPD medium supplemented with 0.2% glucose was added to the electrode 
for approximately 5 minutes to obtain a baseline. Cultured cells of a known titre were spun down 
at 3,000 x g for 5 minutes. The resulting pellet was resuspended in YEPD medium supplemented 
with 0.2% glucose and then added to the electrode with the medium that was used to obtain a 





 cells.  
 
3.2.7 Measurement of the frequency of mitochondrial mutations affecting mitochondrial 
components 









mutations in mtDNA affecting essential mitochondrial components was evaluated by measuring 
the fraction of respiratory-competent (rho
+
) yeast cells remaining in their aging population. rho
+
 
cells maintained intact their mtDNA and their nuclear genes encoding essential mitochondrial 
components. Therefore, rho
+
 cells were able to grow on glycerol, a non-fermentable carbon 
source. In contrast, mutant cells deficient in mitochondrial respiration were unable to grow on 
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mutations or large deletions rho
-
) or completely lacked this DNA (rho
o
 mutants). Serial dilutions 
of cell samples removed from different phases of growth were plated in triplicate onto YP plates 
containing either 2% glucose or 3% glycerol (#BP229-4; Fisher Scientific) as carbon source. 
Plates were incubated at 30
o
C. The number of CFU on YP plates containing 2% glucose was 
counted after 2 d of incubation, whereas the number of CFU on YP plates containing 3% 











) cells was calculated as follows: 100 – [(number of CFU 
per ml on YP plates containing 3% glycerol/number of CFU per ml on YP plates containing 2% 
glucose) × 100].  
          The frequency of spontaneous point mutations in the rib2 and rib3 loci of mtDNA was 
evaluated by measuring the frequency of mtDNA mutations that caused resistance to the 
antibiotic erythromycin. These mutations impair only mtDNA. A sample of cells was removed 
from each culture at various time-points. Cells were plated in triplicate onto YP plates containing 
3% glycerol and erythromycin (1 mg/ml) [#227330050; Acros Organics]. In addition, serial 
dilutions of each sample were plated in triplicate onto YP plates containing 3% glycerol as 
carbon source for measuring the number of respiratory-competent (rho
+
) cells. The number of 
CFU was counted after 6 d of incubation at 30
o
C. For each culture, the frequency of mutations 
that caused resistance to erythromycin was calculated as follows: number of CFU per ml on YP 
plates containing 3% glycerol and erythromycin/number of CFU per ml on YP plates containing 
3% glycerol. 
 
3.2.8 Immunodetection of carbonyl groups in oxidatively damaged cellular proteins  
Total cell lysates were made by vortexing the cells in ice-cold TCL buffer (25 mM 
MOPS/KOH, pH 7.2, 150 mM NaCl, 50 mM DTT, and 1% CHAPS) with glass beads three 
times for 1 min. Lysates were then centrifuged for 5 min at 21,000 × g at 4
o
C, and the 
supernatants of total cell lysates were collected. The carbonyl groups of proteins recovered in 
total cell lysates were derivatized to 2,4-dinitrophenylhydrazones using the OxyBlot
TM
 Protein 
Oxidation Detection Kit (Chemicon), according to the manufacturer’s instructions. Briefly, total 
cellular proteins were denatured by adding 12% SDS to an equal volume of the total cell lysate 
containing 10 μg of protein. Denatured proteins were incubated with 2,4-dinitrophenylhydrazine 
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for 15 min at room temperature. Proteins were separated by 12.5% SDS-PAGE. Immunoblotting 
using a Trans-Blot SD semi-dry electrophoretic transfer system (Bio-Rad) was performed as 
described 
230
. The derivatized carbonyl groups were detected with a 2,4-dinitrophenyl-specific 
antibody (Chemicon) and the Amersham ECL Western Blotting System (GE Healthcare).  
 
3.2.9 Isolation of crude mitochondrial fraction from yeast cells  
3.2.9.1 Reagents 
1. Dithiothreitol (DTT) buffer [100 mM Tris-H2SO4, 10 mM dithiothreitol] 
2. Zymolyase 100T from Arthrobacter luteus (MP Biomedicals) 
3. Zymolyase buffer [1.2 M sorbitol, 20 mM potassium phosphate] 
4. Homogenization buffer [0.6 M sorbitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.2% 
(w/v) BSA]  
5. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 
 
3.2.9.2 Procedure 
Cell cultures were combined in pre-weighed centrifuge bottles and cells were pelleted at 
3,000 × g for 5 min at room temperature using a Beckman JA-10 rotor. The cells were washed 
twice with distilled water, followed by the determination of their wet weight. The cell pellets 
were resuspended in 2 ml/g DTT buffer and incubated on a shaker at 80 rpm for 20 min at 30ºC. 
The cells were pelleted as per initial centrifugation, washed in 7 ml/g Zymolyase buffer without 
Zymolyase and pelleted once more. The cells were incubated on a shaker at 80 rpm for 45 min at 
30ºC with 1 mg/g (wet weight) of Zymolyase-100T in 7 ml/g Zymolyase buffer. Zymolyase was 
used because of its well-known strong lytic activity required to digest yeast cell wall. The 
spheroplasts obtained were then spun down at 2,200 × g for 8 min at 4ºC. All subsequent steps 
were carried out on ice or at 4°C with the use of cut pipette tips to avoid breaking organelles. The 
spheroplasts were resuspended in 6.5 ml/g ice-cold homogenization buffer and washed by 
centrifugation at 2,200 × g for 8 min at 4ºC. The spheroplasts were then mechanically 
homogenized with 15 strokes in 6.5 ml/g ice-cold homogenization buffer to disrupt yeast plasma 
membrane for releasing organelles and cytoplasm. Following the homogenization, the cell debris 
was pelleted by centrifuging at 1,500 × g for 5 min at 4ºC using a Beckman JA-17 rotor. The 
resulting lysate supernatant was subjected to centrifugation twice at 3000 × g for 5 min at 4ºC to 
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pellet the nuclei and 12,000 × g for 15 min at 4ºC. The newly obtained pellet contains mostly 
mitochondria, but also the endoplasmic reticulum (ER), Golgi, peroxisomes, lysosomes and 
vacuoles, whereas the supernatant contains the cytosol, microsomes from the ER and vacuoles. 
The pellet was resuspended in 6.5 ml/g in ice-cold homogenizing buffer, spun down for 5 min at 
3,000 × g at 4ºC to obtain a supernatant containing mitochondria, which was then subjected to a 
spin at 12, 000 × g for 15 min at 4ºC. The resulting pellet was resuspended in 3 ml of SEM to be 
overlaid onto a sucrose gradient. 
 
3.2.10 Purification of S. cerevisiae mitochondria devoid of microsomal and cytosolic 
contaminations 
3.2.10.1 Reagents 
1. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 
2. EM buffer [10 mM Mops (pH 7.2), 1 mM EDTA] 
 
3.2.10.2 Procedure 
In order to purify yeast mitochondria from the crude mitochondrial fraction, an 
equilibrium density-gradient centrifugation was performed. Yeast mitochondria have a density of 
1.18 g/cm
3
 whereas 10% and 50% sucrose respectively have a density of 1.10 g/cm
3
 and 1.30 
g/cm
3
. To prepare a sucrose density gradient for the purification of mitochondria, 1.5 ml of 60% 
sucrose in EM buffer was overlaid with 4 ml of 32%, 1.5 ml of 23% and 1.5 ml of 15% sucrose 
in EM buffer, followed by 3 ml of the crude mitochondrial suspension. The sucrose density 
gradient containing the mitochondrial suspension was subjected to centrifugation in a Beckman 
SW41 Ti swinging-bucket rotor at 134,000 × g for 60 min at 4ºC.  The mitochondrial band, 
which was easily distinguishable, appeared at the interface between 60% and 32% sucrose. 
Fractions of 1 ml were recovered using a cut pipette tip and placed in 1.5 ml Eppendorf tubes 
and frozen at -80ºC until use. In order to quickly freeze the mitochondrial fractions, the fractions 





3.2.11 Blue-native gel electrophoresis (BN-PAGE) 
3.2.11.1 Equipment 
1. Hoefer SE 400 vertical slab gel electrophoresis unit 
2. Bio Rad Power Pac 3000 Power supply  
 
3.2.11.2 Reagents 
1. 4% acrylamide running gel [1.5 ml AB (acrylamide/bis-acrylamide)-3 mix, 6 ml gel 
buffer 3×, 10.4 ml distilled water, 100 l APS, 10 l TEMED] 
2. 13% acrylamide running gel  
3. 3.5% acrylamide sample gel  
4. Solubilization buffer A [50 mM sodium chloride, 50 mM imidazole/HCl, 2 mM 6-
aminohexanoic acid, 1 mM EDTA, pH 7.0] 
5. Coomassie blue G-250 dye stock [5% wt/vol in 500 mM 6-aminohexanoic acid] 
6. Cathode buffer B [50 mM Tricine, 7.5 mM imidazole, 0.02% Coomassie blue G-250, pH 
7.0] 
7. Cathode buffer B/10 [50 mM Tricine, 7.5 mM imidazole, 0.002% Coomassie blue G-250, 
pH 7.0] 
8. Anode buffer [25 mM imidazole, pH 7.0] 
 
3.2.11.3 Procedure 
Mitochondria protein aliquots of 400 g were pelleted by centrifugation at 50,000 × g for 
30 min using a Beckman MLS-50 rotor. The mitochondria pellet was resuspended in 40 l of 
solubilization buffer A and the mitochondria membranes were homogenized by twirling a tiny 
spatula. The detergent digitonin at 20% (3.0 g/g; i.e., 6 l) was added to the homogenate, which 
was incubated for 10 min at room temperature. The sample was subsequently centrifuged at 
20,000 × g for 20 min at room temperature. To the resulting supernatant, 5 l of 5% Coomassie 
blue G-250 dye in 50% glycerol was added at an 8 g/g detergent/dye ratio (i.e., 3 l). The sample 
containing solubilized mitochondrial membrane was loaded to a 0.16 × 0.5 cm well of a gradient 
separation gel with dimensions 1.5 × 14 × 15 cm composed of 4% and 13% acrylamide mixture 
with a sample gel of 3.5% acrylamide. Urease at 1mg/ml was also loaded on an adjacent well 
and used as a molecular marker (10 l urease, 10 l buffer A, 2.4 l 50 % glycerol, 1.6 l 5% 
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Coomassie blue G-250). BN-PAGE was performed at 4°C under the following conditions: 300 
ml of Cathode buffer B in the upper chamber and 300 ml of Anode buffer in the lower chamber 
were used and the power supply set at constant 100 V, 15 mA, 400 W until the sample entered 
the gradient gel. Electrophoresis was then continued at 500 V and 15 mA until the blue running 
front moved about a third of the total running distance. At this point, Cathode Buffer B was 
replaced with 300 ml of Cathode buffer B/10 for better detection of faint protein bands and 
electrophoresis was continued for a total of 4 h or until the blue running front was 1 cm from the 
bottom of the gel. Once electrophoresis was completed the blue native gel stained with 
Coomassie blue G-250 was photographed, documented and stored at 4°C. 
 
3.2.12 Tricine-SDS-PAGE  
3.2.12.1 Equipment 
1. Hoefer SE 400 vertical slab gel electrophoresis unit 
2. Bio Rad Power Pac 3000 Power supply  
 
3.2.12.2 Reagents 
1. 10%T, 3%C Tricine-SDS running gel 
2. 10% acrylamide native stacking gel 
3. Anode buffer 10× [1.0 M Tris, 0.225 M HCl, pH 8.9] 
4. Cathode buffer 10× [1.0 M Tris, 1.0 M Tricine, 1% SDS, pH 8.25]  
5. Precision Plus Protein™ Unstained standards 10 - 250 kD (Bio-Rad) 
 
3.2.12.3 Procedure 
A 0.5-cm gel strip was cut from the 1
st
 dimension (1D) BN-PAGE gel and placed on a 
glass plate with the top of the strip to the left and the bottom of the strip to the right. The strip 
was soaked with 5 ml of a solution containing 1% SDS and 1% mercaptoethanol for 2 h at room 
temperature. Following the incubation, the strip was thoroughly rinsed with water and squeezed 
in between 1.5-mm spacers and 18 × 16 cm glass plates. A 30-ml separating gel mixture 
composed of 10%T, 3%C Tricine-SDS was poured in between the glass plates leaving a gap of 
0.5 cm from the native gel strip. After polymerization, a 0.5-cm spacer was inserted between the 
plates, and placed to the right of the gel to create a well to load protein markers. In order to fill 
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the 0.5-cm gap between the running gel and the native strip, as well as the space between the 
native gel and the spacers, 5 ml of a 10% acrylamide native gel mixture was used, and Unstained 
protein molecular markers (Bio-Rad) were loaded to the far right of the gel for reference. 
Electrophoresis was performed at constant 200 V, 50 mA, 400 W for 3 h at room temperature. 
 
3.2.13 Silver stain after 1D-BN-PAGE followed by 2D-Tricine-SDS-PAGE 




1. Fixative solution [200 ml methanol, 40 ml acetic acid, 40 ml Fixative Enhancer solution, 
120 ml distilled water] 
2. Staining solution [35 ml distilled water, 5 ml Silver complex solution, 5 ml Reduction 
Moderator solution, 5 ml Image Development solution, 50 ml Development Accelerator 
solution] 
3. Stop solution [5% acetic acid] 
 
3.2.13.2 Procedure 
Once electrophoresis was completed, the gel was incubated in 400 ml of 50% methanol 
on a shaker at 55 rpm for 2 h. The gel was then incubated in 200 ml of the Fixative solution for 
20 min and washed twice with 200 ml of distilled water for 10 min. The gel was then immersed 
in 100 ml of the Staining Solution composed of Silver complex, Reduction Moderator, Image 
Development and Development Accelerator solutions. Once the desired staining intensity was 
reached, development was immediately stopped by incubating the silver stained gel in 400 ml of 
5% acetic acid for 15 min, which was followed by a rinse with 400 ml of distilled water for 5 
min. The gel was then photographed, documented and stored at 4°C in 400 ml of distilled water. 
 
3.2.14 In-gel digestion of proteins separated by 2D-Tricine-SDS-PAGE 
3.2.14.1 Reagents 
1. 30 mM Potassium Ferricyanide  
2. 100 mM Sodium Thiosulfate  
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3. 100mM Ammonium Bicarbonate (ABC) 
4. 10 mM Dithiothreitol (DTT) [in 5ml of 100mM Ammonium Bicarbonate (ABC)] 
5. 55 mM Iodoacetamide (IAA) [in 5ml of 100mM Ammonium Bicarbonate (ABC)] 
6. Trypsin, Proteomics Grade (Sigma Aldrich) 
 
3.2.14.2 Procedure 
Once the individual mitochondrial proteins were separated, each band on the 1D BN-2D 
Tricine-SDS gel was cut out with a razor blade and the gel piece was placed in 0.5-ml siliconized 
Eppendorf tubes. The bands were washed with distilled water and destained with 50 l of a 1:1 
mixture of 20 mM potassium ferricyanide and 100 mM sodium thiosulfate for 20 min in the dark 
with occasional vortexing. The destaining solution was removed and the bands were washed 
twice with distilled water. The bands were then incubated in 50 l of acetonitrile (ACN) for 5 
min at 37°C, after which ACN was removed and the bands were dried at 37°C. Next, the 
destained bands were incubated in 50 l of 10 mM dithiothreitol for 30 min at 37°C to reduce 
thiol groups in peptides. DTT was discarded and the bands were incubated in 50 l of 55 mM 
iodoacetamide for 20 min at 37°C in the dark to remove the residual DTT. IAA was removed and 
the bands were incubated in 50 l of a 1:1 mixture of 100 mM ABC and 50% acetonitrile for 10 
min at 37°C. The mixture was discarded and the bands were incubated twice in 50 l of ACN 
under the same conditions and dried at 37°C. The trypsin and trypsin buffer were prepared as 
follows: (1) 1.6 ml of a 1:1 mixture of 100 mM ABC and 10mM CaCl2 were used to resuspend 
20 g of trypsin; and (2) for protein digest, 50 l of trypsin solution (1 mg/ml) was added to the 
bands, which were then incubated overnight at 37°C.  
 
3.2.15 Extracting peptides from yeast mitochondrial proteins digested with trypsin 
The following day, the samples were spun down and the supernatants containing peptides 
were transferred to new 0.5-ml siliconized Eppendorf tubes. To extract more peptides, the gel 
pieces were subjected to several washes and treatments at room temperature; the supernatants 
were conserved and combined with the first set to extracted peptides. For the first extraction, the 
bands were initially incubated in 50 l of 25 mM ABC for 10 min and then in 50 l of ACN for 
10 min. The samples were spun down and the supernatant were added to the first set of extracted 
peptides.  For the second extraction, the bands were incubated in 50 l of 5% formic acid for 10 
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min and then in 50 l of ACN for 10 min. The samples were spun down and the supernatant 
were combined with the first set of extracted peptides. The gel pieces were no longer used and 
discarded. To prevent possible oxidation during storage, 12.5 l of 100 mM DTT was added to 
each set of peptides. The peptides were completely dried in a Speed-Vac at medium temperature 
settings (37°C) for 2 h and stored at -20°C until MS analysis. 
 
3.2.16 Sample preparation for MS analysis 
Dried peptides were resuspended in 20 l of 5% ACN. For each recovered protein band, 
an aliquot of 10 l of dried peptides in 5% ACN was diluted 2-fold in Nano pure water for MS 
analysis. Samples can be stored at -20°C until being subjected to MS analysis. 
 
3.2.17 MS analysis 
Individual proteins composing each band were then identified by reverse phase high 
performance liquid chromatography coupled to mass spectrometry (RP-HPLC/MS) using an 
LTQ Orbitrap. 3-l aliquots of peptides were separated in ACN gradient using a 100-M 
capillary column packed with C18 mobile phase. 
 
3.2.18 Analysis using the Thermo Proteome Discoverer application and SEQUEST 
Once acquiring time was completed using the LTQ Orbitrap, the raw mass spectrometry 
data file obtained by Xcalibur were analyzed using the Thermo Scientific Xcalibur Proteome 
Discoverer application (version 1.3) hereafter referred to as the Proteome Discoverer. The 
Proteome Discoverer was used to identify individual protein components of the isolated 
mitochondrial respiratory complexes and supercomplexes by comparing the raw data of mass 
spectra of digested fragments to the mass spectra of peptides within the Uniprot FASTA 
database. The analysis by the Proteome Discoverer coupled to the FASTA database was enabled 
by using the peak-finding search engine SEQUEST. The SEQUEST engine processes MS data 
using a peak-finding algorithm to search the raw data for generating a peak probability list with 




3.2.18.1 SEQUEST search wizard within the Proteome Discoverer application 
3.2.18.1.1 Raw file and Scan Range Selection Parameters 
The raw file was selected and the Base peak ion chromatogram appeared to reveal: (1) 
the “Intensity (counts)” corresponding to the intensity of the largest peak in the spectrum; and (2) 
the “Time (min)” showing the retention time (RT). The following algorithm and settings were 
used: 
 
Lower RT Limit (min): The beginning of the RT of the scan range of interest: 10 min. 
Upper RT Limit (min): The end of the retention time of the scan range of interest: 18 min. 
Scan Extraction Parameters 
First mass: The mass of the first precursor ion in the range of ion fragments to search for in the 
database: 350 Daltons (Da). 
Last mass: The mass of the last precursor ion in the range of ion fragments to search for in the 
database: 5000 Daltons (Da). 
Activation type: The fragmentation method to use for activating the scan: Collision Induced 
Dissociation (CID). 
Unrecognized charge replacement: Specifies the charge number of the precursor ions: 
Automatic (Default), assigns a charge number of +2 and +3 to the spectrum. 
Intensity threshold: Specifies the intensity threshold below which ions are filtered out. The 
default value of 0.0 was used. 
Minimum ion count: The minimum ion count corresponds to the minimum number of ions that 
must be present in an MS/MS spectrum for it to be included in a search. The default value of 1 
was used. 
S/N threshold: The signal-to-noise threshold is the intensity of the signal to the intensity of the 
background noise. The use of this threshold filters out low-intensity ions that function as a noise. 
The value of 1.5 was used. 
Database: Uniprot_sprot FASTA 
Enzyme: Trypsin 
Missed Cleavages: The maximum number of internal cleavage sites per peptide fragment that is 
acceptable for an enzyme to miss during proteolytic digest. The default value of 2 was used. 
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Precursor mass tolerance: The precursor mass tolerance value used for finding peptide 
candidates. The possible range of values is 0.01 to 5000 ppm. The default value of 10 ppm was 
used. 
Fragment mass tolerance: The default mass tolerance value of 0.8 Da was used for matching 
fragment peaks. The possible range of values was 0.0001 to 2.0 Da. 
Ions series calculated: Specifies the ion factors for a, b, c, x, y, and z ions for the experiment 
type. The possible range is 0 through 1.0 for all ion factors. The ion factors used are b ions: 1 and 
y ions :1. 
Search against decoy database: Specifies if the application uses a decoy database in the search; 
the “yes” was used. 
Target FDR (strict): Specifies a strict target false discovery rate (FDR) for peptide matches with 
high confidence. The possible value range of 0.0 to 1.0 was used. The default value of 0.01 (1% 
FDR) was used. 
Target FDR (relaxed): Specifies a relaxed target false discovery rate (FDR) for peptide matches 
with moderate confidence. The possible value range from 0.0 to 1.0 was used. The default value 
of 0.05 (5% FDR) was used. 
 
3.2.18.1.2 Identification of yeast mitochondria complexes and supercomplexes using the 
Thermo Proteome Search Results Report 
Protein Results Parameters 
The protein page displays all the proteins and their corresponding peptides found in the sample 
during the database search. For each protein, the report shows the following results: 
Accession: The unique identifier was assigned to the protein by the Uniprot FASTA database. 
Description: The name and description of the protein of the identifier appeared in the 
corresponding Accession column.  
Score: The SEQUEST protein score is the sum of all peptide XCorr values above the specified 
score threshold. The score threshold was calculated as “0.8 + peptide charge * peptide relevance 
factor“, where peptide relevance factor has a default value of 0.4. For each spectrum, only the 
highest-scoring match was used. For each spectrum and sequence, the Proteome Discoverer 
application uses only the highest scored peptide.  
Coverage: Represents the percentage of the protein sequence covered by the identified peptides. 
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# Proteins: Represents the number of identified proteins in the protein group of a master protein. 
When the Protein Grouping setting is disabled, the #Proteins is always equal to 1.  
# Unique Peptides: Represents the number of peptide sequences unique to a protein. 
# Peptides: Represents the number of different peptide sequences identified in the protein.   
# PSMs: The peptide spectrum matches (PSMs) value corresponds to the total number of 
identified peptide sequences for the protein, including those that have been identified 
redundantly. 
# AAs: Represents the number of amino acid in the sequence length of the protein. 
MW 
kDa
: Represents the calculated molecular weight of the protein. 
Calc. pI: Represents the theoretically calculated isoelectric point, i.e. the pH value at which a 
particular molecule carries no net electrical charge. 
Peptides Results Parameters: For each identified peptide, the report shows the following results: 
Protein Descriptions: Identifies a protein associated with the peptides. This description is taken 
from the Uniprot FASTA file. 
# Proteins: Represents the total number of proteins in which this peptide can be found. 
Probability: Represents the probability score for the peptide. 
SpScore (search-dependent): Represents the raw value of the preliminary score of the 
SEQUEST algorithm. 
XCorr (search-dependent): Scores the number of fragment ions that are common to two 
different peptides with the same precursor mass; calculates the cross-correlation score for all 
candidate peptides queried from the database. 
Δ Score: A measure of the difference between the top two scores for the peptides identified by 
that spectrum; the Proteome Discoverer application calculates this score as follows: ΔScore = 
Score(Rank N Peptide) – Score(Rank 1 Peptide)/Score(Rank 1 Peptide). 
ΔCn: Represents the normalized score difference between the currently selected PSM and the 
highest-scoring PSM for that spectrum. 
# Missed Cleavages: Represents the number of cleavage sites in a peptide sequence that trypsin 
did not cleave, excluding the cases where the presence of proline prevents trypsin from cleaving 
the peptide bond. 
Peptides Matched: Represents the number of peptides included in the precursor mass tolerance 
window set for the search. 
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Charge: Represents the charge state of the peptide. 
Intensity: Represents the intensity of the precursor ion. 
MH+ 
Da
: Represents the protonated monoisotopic mass of the peptide, in Daltons. 
ΔM ppm: Represents the difference between the theoretical mass of the peptide and the 
experimental mass of the precursor ion. 
RT 
min
: Represents the retention time when the peptide was observed, in minutes. 
 
Xcalibur is a registered trademark of Thermo Fisher Scientific Inc. in the United States. 
SEQUEST is a registered trademark of the University of Washington in the United States. 
 
3.2.19 Miscellaneous procedures 
Total cell lysates were made by vortexing the cells in TCL buffer (25 mM Tris/HCl pH 
8.5, 150 mM NaCl, 1 mM EDTA, 0.1 mM DTT, 4% CHAPS, 1 mM PMSF, protease inhibitor 
cocktail [Sigma]) with glass beads three times for 1 min. Lysates were then centrifuged and 
supernatants collected. Protein concentration was determined with an RC DC protein assay kit 
(Bio-Rad) following the manufacturer's instructions. Enzymatic activities of cytochrome c 
oxidase 
231
 and aconitase 
232
 were determined by established methods. Preparation of cellular 





3.2.20 Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated using an unpaired 
two-tailed t test. 
 
3.3 Results and Discussion 
3.3.1 Treatment of yeast cells with LCA alters the age-related dynamics of changes in the 
rate of mitochondrial respiration, value of mitochondrial membrane potential and 
concentration of mitochondrial reactive oxygen species (ROS) 
I first examined how LCA influences the age-related chronology of changes in 
mitochondrial respiration. I found that in yeast cells grown under CR on 0.2% glucose in the 
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absence of LCA and recovered at different periods of chronological lifespan, the efficiency of 
mitochondrial respiration was (1) greatly amplified when yeast entered D growth phase on day 2 
of cell culturing; and (2) sharply declined through the subsequent PD and ST growth phases 
(Figure 3.1). In yeast cells cultured under CR on 0.2% glucose in the presence of exogenous 
LCA, the efficiency of mitochondrial respiration (1) increased to a much lesser extent during D 
phase than it increased in yeast cultured in the absence of LCA; and (2) reached a plateau in PD 
phase and declined slowly during the subsequent ST phase (Figure 3.1). It needs to be 
emphasized that, following entry of yeast cells into a quiescent state (i.e., during ST phase), the 
efficiency of mitochondrial respiration in yeast cultured in the presence of exogenous LCA 
significantly exceeded that in yeast cultured in its absence (Figure 3.1).  
 
 
Figure 3.1. LCA alters the age-related chronology of changes in mitochondrial respiration.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. The dynamics of age-related changes 
in the rate of oxygen consumption by cells was monitored as described in ʺMaterials and Methodsʺ. Data are 




          I then assessed how LCA affects the age-related dynamics of changes in (1) 
electrochemical potential across the IMM (ΔΨ); and (2) intracellular levels of hydrogen peroxide 
and superoxide radicals, the two major species of ROS known to be generated mainly as by-
products of mitochondrial respiration 
39
. I found that in yeast cells grown under CR on 0.2% 
glucose in the absence of LCA and recovered at different periods of chronological lifespan, the 
value of ΔΨ and the levels of both ROS species were (1) significantly magnified when yeast 
entered D growth phase on day 2 of cell culturing; and (2) abruptly reduced through the 
subsequent PD and ST growth phases (Figure 3.2). In yeast cells cultured under CR on 0.2% 
glucose in the presence of exogenous LCA, the value of ΔΨ and the levels of both ROS species 
were (1) elevated to a much lesser degree during D phase than they were elevated in yeast 
cultured in the absence of LCA; and (2) attained a plateau in PD phase and declined slowly (in 
case of ΔΨ), remained mainly unchanged (in case of hydrogen peroxide) or increased slightly 
and slowly (in case of superoxide radicals) during the subsequent ST phase (Figure 3.2). 
Importantly, in yeast cells that have entered a quiescent state (i.e., reach ST phase), the value of 
ΔΨ and the levels of both ROS species in yeast cultured in the presence of exogenous LCA 
substantially surpassed those in yeast cultured in its absence (Figure 3.2). 
 




Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. The dynamics of age-related changes 
in the value of ΔΨ and the levels of both ROS species (i.e., hydrogen peroxide H2O2 measured using DHR and 
superoxide radicals 
O2-
 measured using MitoSOX Red) were monitored as described in ʺMaterials and Methodsʺ. 
Data are presented as means ± SEM (n = 4-6). 
 
          Taken together, these findings validate my hypothesis that LCA can significantly alter the 
age-related chronology of the efficiency of mitochondrial respiration, the value of ΔΨ and the 
levels of both major ROS species (i.e., H2O2 and O2
-
) produced in mitochondria. It is conceivable 
that such effect of LCA is due to the LCA-elicited specific changes in the membrane lipidome of 
mitochondria; indeed, the lipid composition of the IMM is known to modulate protein complexes 
and supercomplexes that reside within this mitochondrial membrane and are involved in 
mitochondrial respiration, the maintenance of electrochemical membrane potential and 
preservation of ROS homeostasis 
193, 227 - 229
. 
   
3.3.2 LCA-driven decline of mitochondrially generated ROS in chronologically ʺyoungʺ 
yeast reduces the extent of oxidative damage to mitochondrial macromolecules, 
alters the abundance and composition of respiratory supercomplexes in the IMM, 
and elevates the levels of ATP produced in mitochondria  
Based on findings described in the previous section, I hypothesized that the LCA-driven 
decline of mitochondrially generated ROS seen in chronologically ʺyoungʺ yeast cells may 
reduce the extent of oxidative damage to mitochondrial macromolecules. In support of this 
hypothesis, I found that a permanent exposure of yeast cells to exogenous LCA (1) reduces the 
degree of oxidative damage to mitochondrial proteins and lipids through the entire lifespan 




) and point (i.e., rib2 
and rib3) mutations in mitochondrial DNA (mtDNA) following entry of yeast into a quiescent 
state, likely by protecting mtDNA from age-related oxidative damage (Figure 3.3); (3) enables to 
maintain enzymatic activities of cytochrome c oxidase and succinate dehydrogenase, two protein 
components of the mitochondrial electron transport chain (ETC) and the tricarboxylic acid 
(TCA) cycle (respectively), at the levels that through the entire ST phase considerably exceed 
those seen in mitochondria of yeast cultured in the absence of LCA (Figure 3.4); and (4) allows 
to sustain enzymatic activity of aconitase, a protein component of the mitochondrial TCA cycle, 
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at the level that through the entire ST phase is substantially higher than that observed in yeast 
grown without LCA - regardless whether or not the oxidation-dependent loss of one iron from 




 (Figure 3.5).     
 
 
Figure 3.3. Permanent exposure of yeast cells to exogenous LCA protects mitochondrial proteins and lipids 
from oxidative damage as well as reduces the frequencies of mutations in mitochondrial DNA (mtDNA), 
likely by protecting it from age-related oxidative damage.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. Mitochondria from cells recovered at 
different days of culturing were purified as described in ʺMaterials and Methodsʺ. The quantities of carbonylated 
(i.e., oxidatively damaged) proteins and oxidatively damaged membrane lipids in purified mitochondria were 
measured as described in ʺMaterials and Methodsʺ. The frequencies of deletion (i.e., rho- and rho0) and point (i.e., 
rib2 and rib3) mutations in mtDNA were monitored according to the procedures described in ʺMaterials and 





Figure 3.4. Permanent exposure of yeast cells to exogenous LCA enables to maintain enzymatic activities of 
cytochrome c oxidase and succinate dehydrogenase, two protein components of the mitochondrial electron 
transport chain and the tricarboxylic acid cycle (respectively), at the levels that through the entire ST phase 
considerably exceed those seen in mitochondria of yeast cultured in the absence of LCA.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. Mitochondria from cells recovered at 
different days of culturing were purified as described in ʺMaterials and Methodsʺ. Enzymatic activities of 
cytochrome c oxidase (CCO) and succinate dehydrogenase (SDH) in purified mitochondria were measured as 






Figure 3.5. Permanent exposure of yeast cells to exogenous LCA sustains enzymatic activity of aconitase, a 
protein component of the mitochondrial TCA cycle, at the level that through the entire ST phase is 
substantially higher than that observed in yeast grown without LCA.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. Enzymatic activities of aconitase 
(ACO) in total cell lysates were measured with or without the reactivation agents Fe
3+
 and Na2S, as described in 
ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 4-6).   
 
          I then hypothesized that the LCA-driven reduction of the extent of oxidative damage to 
mitochondrial macromolecules can alter the abundance and/or composition of respiratory protein 
supercomplexes in the IMM and, thus, can cause some changes to the level of intracellular ATP 
known to be produced mainly as a product of coupling between ADP phosphorylation and 
electron transport in mitochondria 
10, 132, 234
. A body of recent evidence supports the view that, 
instead of existing as separate units freely moving within the IMM, individual protein complexes 
of the mitochondrial ETC are assembled into supramolecular structures known as respiratory 
supercomplexes or respirasomes 
235, 236
; some changes in such supramolecular organization of 
respiratory protein complexes are known to cause detrimental alterations of the mitochondrial 
respiratory chain, thereby eliciting certain age-related pathologies 
237
. To validate this 
hypothesis, I purified mitochondria from wild-type cells cultured under CR on 0.2% glucose and 
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recovered on day 4 of culturing, used digitonin to solubilize protein complexes from the inner 
membrane of these mitochondria, and separated the solubilized protein complexes on a linear 4-
13% acrylamide gradient gel for first-dimension blue native PAGE (1-D BN-PAGE). This 
gradient gel is known to resolve protein complexes within the mass range of 100 kDa - 3 MDa 
238
. Such 1-D BN-PAGE analysis revealed that exposure of wild-type cells to LCA significantly 
increases the level of a respiratory supercomplex with the highest molecular weight (likely in a 
range of several MDa), which is marked by a red arrow in Figure 3.6. My mass spectrometry-
based analysis demonstrated that this respiratory supercomplex in the IMM of LCA-treated wild-
type cells consists of the complexes III and V of mitochondrial ETC as well as the ADP-ATP 
carrier protein AAC2 (Figure 3.7; respiratory supercomplex 1). My BN-PAGE analysis also 
revealed that exposure of wild-type cells to LCA increases the level of a respiratory 
supercomplex of a very high molecular weight (likely in an MDa range), which is marked by a 
yellow arrow in Figure 3.6. My mass spectrometry-based analysis showed that this respiratory 
supercomplex in the IMM of LCA-treated wild-type cells consists of (1) the ALD4 isoform of 
acetaldehyde dehydrogenase, an enzyme involved in the conversion of acetaldehyde to acetyl-
CoA in yeast mitochondria; (2) the IDH1 and IDH2 isoforms of isocitrate dehydrogenase, an 
enzyme involved in the TCA cycle; and (3) HSP60, a tetradecameric mitochondrial chaperonin 
that not only drives the ATP-dependent folding of precursor polypeptides and complex 
assembly, but also prevents aggregation and mediates protein refolding after heat shock (Figure 
3.7; respiratory supercomplex 6). 
          To define the composition of each of the protein supercomplexes recovered by 1-D BN-
PAGE (Figure 3.6), I resolved their individual protein components by second-dimension tricine-
SDS-PAGE (2-D SDS-PAGE), visualized these components by silver staining and identified 
them by mass spectrometry. I found that, in addition to one or more kinds of individual 
respiratory complexes, many protein supercomplexes in the IMM of wild-type cells exposed to 
exogenous LCA contain one or more proteins that have not been traditionally viewed as 
components associated (even transiently) with the mitochondrial respiratory chain. These novel 
protein components of respiratory protein supercomplexes in the IMM of wild-type cells treated 
with LCA include: (1) the ADP-ATP carrier protein Aac2p, a component of the supercomplexes 
1, 2 and 5; (2) the tetradecameric mitochondrial chaperonin HSP60, a component of the 
respiratory supercomplex 6; (3) the ALD4 isoform of acetaldehyde dehydrogenase, a component 
55 
 
of the supercomplexes 6, 8 and 9; (4) the IDH1 and IDH2 isoforms of isocitrate dehydrogenase, 
two components of the supercomplexes 6 and 8; (5) the HSP70 family ATPase SSC1, a 
component of the supercomplexes 9 and 10;  (6) the KGD1 subunit of the mitochondrial alpha-
ketoglutarate dehydrogenase complex involved in the TCA cycle, a component of the 
supercomplexes 9 and 10; (7) aconitase ACO1 involved in the TCA cycle, a component of the 
supercomplexes 9 and 10; and (8) the valyl-tRNA synthetase VAS1, a component of the 
supercomplex 10 (Figure 3.7). 
          These findings revealed several ways of rearranging respiratory supercomplexes in the 
IMM of yeast cells exhibiting an altered mitochondrial membrane lipidome in response to LCA 
treatment. First, LCA-driven changes in the mitochondrial membrane lipidome increase the 
abundance of the major respiratory supercomplexes (respirasomes) 1 and 6 (Figure 3.6). Second, 
LCA-driven changes in the mitochondrial membrane lipidome cause a recruitment of several 
new mitochondrial protein components, not previously known for being permanently associated 
with the ETC, into the remodeled respirasomes (Figures 3.7 and 3.8). It should be emphasized 
that all these protein components newly recruited into the remodeled respirasomes are known for 
their essential roles in mitochondria-confined processes that define longevity. Specifically, the 
observed recruitment of AAC2 to the remodeled respiratory supercomplexes suggests a 
mechanism in which the ability of AAC2 to sense the rates/efficacies with which electrons are 
transferred through the ETC (by the respiratory complex III) and ATP is synthesized (by the 
respiratory complex V) in mitochondria enables this transport protein to modulate accordingly 
the rate of ATP-ADP exchange between mitochondria and cytosol (Figure 3.8). The resulting 
increase of the efficiency of ATP synthesis in mitochondria of chronologically aging yeast is 
likely to extend their longevity. Furthermore, the observed recruitment of IDH1, IDH2, KGD1, 
ACO1, ALD4, HSP60 and SSC1 to the remodeled respiratory supercomplexes is expected to 
provide an efficient way of coordinating the rates of NADH synthesis (by IDH1, IDH2, KGD1 
and ACO1) and acetyl-CoA formation (by ALD4) with functional states of numerous proteins 
governed by the chaperone and protein import activities of HSP60 and SSC1 in mitochondria 
(Figure 3.8), thereby extending yeast longevity. Moreover, the observed recruitment of VAS1 (a 
valyl-tRNA synthetase for mitochondrial protein synthesis) to the remodeled respiratory 
supercomplexes is expected to provide an efficient way of coordinating the rate of mitochondrial 
NADH synthesis (by KGD1 and ACO1) with mitochondrial protein synthesis (by VAS1) and 
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mitochondrial protein import (by SSC1) (Figure 3.8); such remodeling of respiratory 
supercomplexes is likely to extend longevity of chronologically aging yeast.   
 
Figure 3.6. LCA (and genetic manipulations changing the makeup of mitochondrial membrane lipids) alter 
the abundance of respiratory supercomplexes in the inner mitochondrial membrane.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 50 µM) or without it. Mitochondria were purified from cells 
recovered on day 7 of culturing as described in ʺMaterials and Methodsʺ. Digitonin-solubilized protein complexes 
from the inner membrane of these mitochondria were separated on a linear 4-13% acrylamide gradient gel for first-
dimension blue native PAGE (1-D BN-PAGE) as described in ʺMaterials and Methodsʺ. Arrows mark the positions 
of protein supercomplexes whose levels were elevated in mitochondria of cells exposed to LCA. Although protein 
supercomplexes that were recovered in mitochondria purified from the mutant strains ups1 (MAT his31 leu20 
lys20 ura30 ups1::kanMX4), taz1 (MAT his31 leu20 lys20 ura30 taz1::kanMX4), gep4 (MAT 
his31 leu20 lys20 ura30 gep4::kanMX4), psd1 (MAT his31 leu20 lys20 ura30 psd1::kanMX4) and 
crd1 (MAT his31 leu20 lys20 ura30 crd1::kanMX4) are shown here, these unpublished data are not 






Figure 3.7. LCA alters the compositions of some of the respiratory supercomplexes residing in the inner 
mitochondrial membrane.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 50 µM) or without it. Mitochondria were purified from cells 
recovered on day 7 of culturing as described in ʺMaterials and Methodsʺ. Digitonin-solubilized protein complexes 
from the inner membrane of these mitochondria were first separated on a linear 4-13% acrylamide gradient gel for 
first-dimension blue native PAGE (1-D BN-PAGE) and then resolved by second-dimension tricine-SDS-PAGE (2-
D SDS-PAGE) as described in ʺMaterials and Methodsʺ. Following silver staining, the separated by 2-D SDS-




Figure 3.8. LCA causes a recruitment of certain mitochondrial protein components, not previously known for 
being permanently associated with the ETC, into the remodeled respirasomes within the inner mitochondrial 
membrane.  
All these protein components newly recruited into the remodeled respirasomes are known for their essential roles in 
mitochondria-confined processes that define longevity. There are several ways through which such recruitment may 
improve mitochondrial functionality and, thus, may extend yeast longevity. 
 
          Because a coupling between ADP phosphorylation and electron transport in mitochondria 
is known to produce the bulk of ATP in yeast 
10, 132, 234
 and LCA alters the abundance and 
composition of respiratory protein supercomplexes in the IMM (as described above), I then 
assessed how a permanent exposure of yeast cells to exogenous LCA influences the level of 
intracellular ATP. I found that in yeast grown under CR on 0.2% glucose and recovered at 
different periods of chronological lifespan, LCA alters the age-related dynamics of changes in 
the cellular level of ATP (Figure 3.9). Specifically, during ST growth phase the level of ATP in 
yeast cells cultured under CR conditions in the presence of exogenous LCA considerably 
exceeded that detected in yeast cultured in its absence (Figure 3.9). 
          Taken together, these findings validate my hypothesis that the LCA-driven reduction of 
the extent of oxidative damage to mitochondrial macromolecules alters the abundance and 
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composition of respiratory protein supercomplexes in the IMM. This, in turn, increases the level 
of ATP in chronologically active yeast cells that have entered a quiescent state.    
 
Figure 3.9. LCA alters the age-related dynamics of changes in the cellular level of ATP.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. Intracellular levels of ATP were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 3-5). 
 
3.4 Conclusions 
In sum, findings presented in Chapter 3 support the validity of my hypothesis that the 
LCA-elicited changes in the membrane lipidome of mitochondria alter the age-related dynamics 
of several longevity-defining mitochondrial processes. These processes include mitochondrial 
respiration, maintenance of mitochondrial membrane potential and ROS homeostasis, prevention 
of excessive oxidative damage to mitochondrial macromolecules, preservation of certain 









4 LCA extends yeast longevity by reducing the damaging effect of mitochondrially 
produced ROS on macromolecules outside mitochondria and by amplifying the 
ʺhormeticʺ effect of mitochondrially generated ROS on cell resistance to stresses  
 
4.1 Introduction 
I hypothesized that LCA may delay aging in yeast by influencing longevity-defining 
processes taking place not only in mitochondria but also in cellular locations outside these 
organelles. In particular, I thought that LCA may extend yeast longevity by (1) reducing the 
damaging effect of mitochondrially produced ROS on macromolecules (i.e. proteins, lipids 
and/or nucleic acids) outside mitochondria; and (2) amplifying the ʺhormeticʺ effect of 
mitochondrially generated ROS through an induction of the synthesis and/or post-translational 
activation of proteins that protect cells from oxidative and other forms of stress, protein 
aggregation and damage of nuclear DNA (Figure 4.1).  
 
 
Figure 4.1. LCA may extend yeast longevity by reducing the damaging effect of mitochondrially produced 
ROS on cellular macromolecules outside mitochondria and by amplifying the ʺhormeticʺ effect of 
mitochondrially generated ROS.  
See text for details.  
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4.2 Materials and methods 
4.2.1 Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) and mutant strains ndi1 (MAT his31 leu20 lys20 ura30 ndi1::kanMX4), 
gpx1 (MAT his31 leu20 lys20 ura30 gpx1::kanMX4), sod1 (MAT his31 leu20 
lys20 ura30 sod1::kanMX4), sod2 (MAT his31 leu20 lys20 ura30 
sod2::kanMX4), ctt1 (MAT his31 leu20 lys20 ura30 ctt1::kanMX4), cta1 (MAT 
his31 leu20 lys20 ura30 cta1::kanMX4), ccp1 (MAT his31 leu20 lys20 ura30 
ccp1::kanMX4), trx1 (MAT his31 leu20 lys20 ura30 trx1::kanMX4), trx2 (MAT 
his31 leu20 lys20 ura30 trx2::kanMX4), trx3 (MAT his31 leu20 lys20 ura30 
trx3::kanMX4), tsa1 (MAT his31 leu20 lys20 ura30 tsa1::kanMX4), tsa2 (MAT 
his31 leu20 lys20 ura30 tsa2::kanMX4), gpx1 (MAT his31 leu20 lys20 ura30 
gpx1::kanMX4), hyr1 (MAT his31 leu20 lys20 ura30 hyr1::kanMX4) were used in 
this study. The composition of YEPD (0.2% glucose) medium was as follows: 1% yeast extract, 
2% peptone, 0.2% glucose. Cells were cultured at 30
o
C with rotational shaking at 200 rpm in 
Erlenmeyer flasks at a ″flask volume/medium volume″ ratio of 5:1.  
 
4.2.2 A plating assay for the analysis of chronological lifespan 
 Cells were grown in YEPD (0.2% glucose) medium at 30
o
C with rotational shaking at 
200 rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. A sample of cells 
was removed from each culture at various time points. A fraction of the cell sample was diluted 
in order to determine the total number of cells per ml of culture using a hemacytometer. 10 l of 
serial dilutions (1:10 to 1:10
3
) of cells were applied to the hemacytometer, where each large 
square is calibrated to hold 0.1 l. The number of cells in 4 large squares was then counted and 
an average was taken in order to ensure greater accuracy. The concentration of cells was 
calculated as follows: number of cells per large square x dilution factor x 10 x 1,000 = total 





) of cells were plated onto YEPD (2% glucose) plates in triplicate in 
order to count the number of viable cells per ml of each culture. 100 l of diluted culture was 
plated onto each plate. After a 48-h incubation at 30
o
C, the number of colonies per plate was 
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counted. The number of colony forming units (CFU) equals to the number of viable cells in a 
sample. Therefore, the number of viable cells was calculated as follows: number of colonies x 
dilution factor x 10 = number of viable cells per ml. For each culture assayed, % viability of the 
cells was calculated as follows: number of viable cells per ml / total number of cells per ml x 
100%. The % viability of cells in mid-logarithmic phase was set at 100% viability for that 
particular culture. The life span curves for wild-type and some of the mutant strains were also 
validated using a LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's 
instructions for stationary-phase cultures.   
 
4.2.3 Pharmacological manipulation of chronological lifespan 
Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA) [#L6250] bile acid was from Sigma. The stock solution of LCA in DMSO was 
made on the day of adding this compound to cell cultures. LCA was added to growth medium at 
the final concentration of 50 µM immediately following cell inoculation. The final concentration 
of DMSO in yeast cultures supplemented with LCA (and in the corresponding control cultures 
supplemented with drug vehicle) was 1% (v/v). 
 
4.2.4 Plating assays for the analysis of resistance to various stresses 





type and mutant cells recovered from various phases of growth in YEPD (0.2% glucose) were 
spotted onto two sets of plates. One set of plates contained YEPD (2% glucose) medium alone, 
whereas the other set contained YEPD (2% glucose) medium supplemented with 5 mM 
hydrogen peroxide. Pictures were taken after a 3-day incubation at 30
o
C. 




) of wild-type and 
mutant cells recovered from various phases of growth in YEPD (0.2% glucose) were spotted 
onto two sets of YEPD (2% glucose) plates. One set of plates was incubated at 30
o
C. The other 
set of plates was initially incubated at 55
o
C for 30 min, and was then transferred to 30
o
C. 
Pictures were taken after a 3-day incubation at 30
o
C. 
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4.2.5 Monitoring the formation of ROS  
Wild-type and mutant cells grown in YEPD (0.2% glucose) were tested microscopically 
for the production of ROS by incubation with dihydrorhodamine 123 (DHR). In the cell, this 
nonfluorescent compound can be oxidized to the fluorescent chromophore rhodamine 123 by 
ROS. Cells were also probed with a fluorescent counterstain Calcofluor White M2R (CW), 
which stains the yeast cell walls fluorescent blue. CW was added to each sample in order to label 
all cells for their proper visualization. DHR was stored in the dark at –20oC as 50 l aliquots of a 
1 mg/ml solution in ethanol. CW was stored in the dark at –20oC as the 5 mM stock solution in 
anhydrous DMSO (dimethylsulfoxide).  
          The concurrent staining of cells with DHR and CW was carried out as follows. The 
required amounts of the 50 l DHR aliquots (1 mg/ml) and of the 5 mM stock solution of CW 
were taken out of the freezer and warmed to room temperature. The solutions of DHR and CW 
were then centrifuged at 21,000 x g for 5 min in order to clear them of any aggregates of 
fluorophores. For cell cultures with a titre of ~ 10
7
 cells/ml, 100 l was taken out of the culture 
to be treated. If the cell titre was lower, proportionally larger volumes were used. 6 l of the 1 
mg/ml DHR and 1 l of the 5 mM CW solutions were added to each 100 l aliquot of culture. 
After a 2-h incubation in the dark at room temperature, the samples were centrifuged at 21,000 x 
g for 5 min. Pellets were resuspended in 10 l of PBS buffer (20 mM KH2PO4/KOH, pH 7.5, and 
150 mM NaCl). Each sample was then supplemented with 5 l of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides were 
prepared, they were visualized under the Zeiss Axioplan fluorescence microscope mounted with 
a SPOT Insight 2 megapixel color mosaic digital camera. Several pictures of the cells on each 
slide were taken, with two pictures taken of each frame. One of the two pictures was of the cells 
seen through a rhodamine filter in order to detect cells dyed with DHR. The second picture was 
of the cells seen through a DAPI filter in order to visualize CW, and therefore all the cells 
present in the frame. 
          For evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool (Version 
3.0) software was used to calculate both the total number of cells and the number of stained cells. 
Fluorescence of individual DHR-positive cells in arbitrary units was determined by using the 
UTHSCSA Image Tool software (Version 3.0). In each of 3-5 independent experiments, the 
value of median fluorescence was calculated by analyzing at least 800-1000 cells that were 
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collected at each time point. The median fluorescence values were plotted as a function of the 
number of days cells were cultured.  
 
4.2.6 Immunofluorescence microscopy 
Cell cultures were fixed in 3.7% formaldehyde for 45 min at room temperature. The cells 
were washed in solution B (100 mM KH2PO4/KOH pH 7.5, 1.2 M sorbitol), treated with 
Zymolyase 100T (MP Biomedicals, 1 μg Zymolyase 100T/1 mg cells) for 30 min at 30oC and 
then processed as previously described (Pringle et al., 1991). Monoclonal antibody raised against 
porin (Invitrogen, 0.25 μg/μl in TBSB buffer [20 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mg/ml 
BSA]) was used as a primary antibody. Alexa Fluor 568 goat anti-mouse IgG (Invitrogen, 2 
μg/μl in TBSB buffer) was used as a secondary antibody. The labeled samples were mounted in 
mounting solution (16.7 mM Tris/HCl pH 9.0, 1.7 mg/ml p-phenylenediamine, 83% glycerol). 
Images were collected with a Zeiss Axioplan fluorescence microscope (Zeiss) mounted with a 
SPOT Insight 2 megapixel color mosaic digital camera (Spot Diagnostic Instruments). 
 
4.2.7 Measurement of the frequency of nuclear mutations  
The frequency of spontaneous point mutations in the CAN1 gene of nuclear DNA was 
evaluated by measuring the frequency of mutations that caused resistance to the antibiotic 
canavanine. A sample of cells was removed from each culture at various time-points. Cells were 
plated in triplicate onto YNB (0.67% Yeast Nitrogen Base without amino acids [#DF0919153; 
Fisher Scientific]) plates containing 2% glucose and supplemented with L-canavanine (50 mg/L), 
histidine, leucine, lysine and uracil (#C1625, #H8125, #L8912, #L5751 and #U0750, 
respectively; all from Sigma). In addition, serial dilutions of each sample were plated in triplicate 
onto YP plates containing 2% glucose for measuring the number of viable cells. The number of 
CFU was counted after 4 d of incubation at 30
o
C. For each culture, the frequency of mutations 
that caused resistance to canavanine was calculated as follows: number of CFU per ml on YNB 
plates containing 2% glucose, L-canavanine (50 mg/L), histidine, leucine, lysine and 




4.2.8 Immunodetection of carbonyl groups in oxidatively damaged cellular proteins  
Total cell lysates were made by vortexing the cells in ice-cold TCL buffer (25 mM 
MOPS/KOH, pH 7.2, 150 mM NaCl, 50 mM DTT, and 1% CHAPS) with glass beads three 
times for 1 min. Lysates were then centrifuged for 5 min at 21,000 × g at 4
o
C, and the 
supernatants of total cell lysates were collected. The carbonyl groups of proteins recovered in 
total cell lysates were derivatized to 2,4-dinitrophenylhydrazones using the OxyBlot
TM
 Protein 
Oxidation Detection Kit (Chemicon), according to the manufacturer’s instructions. Briefly, total 
cellular proteins were denatured by adding 12% SDS to an equal volume of the total cell lysate 
containing 10 μg of protein. Denatured proteins were incubated with 2,4-dinitrophenylhydrazine 
for 15 min at room temperature. Proteins were separated by 12.5% SDS-PAGE. Immunoblotting 
using a Trans-Blot SD semi-dry electrophoretic transfer system (Bio-Rad) was performed as 
described (Titorenko et al., 1998). The derivatized carbonyl groups were detected with a 2,4-
dinitrophenyl-specific antibody (Chemicon) and the Amersham ECL Western Blotting System 
(GE Healthcare).  
 
4.2.9 Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated using an unpaired 
two-tailed t test. 
 
4.3 Results and Discussion 
4.3.1 Treatment of yeast cells with LCA reduces the extent of oxidative damage to 
macromolecules outside mitochondria and protects cells from oxidative and thermal 
stresses 
In support of my hypothesis outlined in the ″Introduction″ section of this chapter, I found 
that a permanent exposure of yeast cells to exogenous LCA (1) considerably reduces the degree 
of oxidative damage to cellular proteins through the entire lifespan (Figures 4.2 and 4.3); (2) 
protects cellular lipids from oxidative damage through the entire lifespan (Figure 4.4); (3) 
decreases the frequencies of the can1 point mutations in the nuclear DNA following entry of 
yeast into a quiescent state, likely by protecting this DNA from age-related oxidative damage 
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(Figure 4.5); and (4) increases the resistance of chronologically aging yeast to chronic oxidative 
and thermal stresses (Figures 4.6 and 4.7). 
 
Figure 4.2. A permanent exposure of yeast cells to exogenous LCA considerably reduces the degree of 
oxidative damage to cellular proteins through the entire lifespan.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. The extent of oxidative damage to 
cellular proteins was monitored using the OxyBlot Protein Oxidation Detection Kit as described in ʺMaterials and 
Methodsʺ.  
 
Figure 4.3. A permanent exposure of yeast cells to exogenous LCA considerably reduces the degree of 
oxidative damage to cellular proteins through the entire lifespan.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. The extent of oxidative damage to 
cellular proteins was monitored using Protein Carbonyl Colorimetric Assay Kit as described in ʺMaterials and 





Figure 4.4. A permanent exposure of yeast cells to exogenous LCA protects cellular lipids from oxidative 
damage through the entire lifespan.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. The extent of oxidative damage to 
cellular lipids was monitored using the PeroXOquant Quantitative Peroxide Assay Kit as described in ʺMaterials and 
Methodsʺ. Data are presented as means ± SEM (n = 3-5). 
 
Figure 4.5. A permanent exposure of yeast cells to exogenous LCA decreases the frequencies of the can1 point 
mutations in the nuclear DNA following entry of yeast into a quiescent state, likely by protecting this DNA 
from age-related oxidative damage.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 25 µM or 50 µM) or without it. The frequencies of the can1 point 
mutations in the nuclear DNA were measured as described in ʺMaterials and Methodsʺ. Data are presented as means 





Figure 4.6. A permanent exposure of yeast cells to exogenous LCA increases the resistance of chronologically 
aging yeast to chronic oxidative stress.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 50 µM) or without it. Spot assays for monitoring oxidative stress 
resistance were performed as described in ʺMaterials and Methodsʺ. Serial ten-fold dilutions of cells were spotted on 
plates with solid YP medium containing 2% glucose as carbon source and 5 mM hydrogen peroxide. All pictures 





Figure 4.7. A permanent exposure of yeast cells to exogenous LCA increases the resistance of chronologically 
aging yeast to chronic thermal stress.  
Cells of the wild-type strain BY4742 were cultured in the nutrient-rich YP medium initially containing 0.2% glucose 
with LCA (added at the final concentration of 50 µM) or without it. Spot assays for monitoring oxidative stress 
resistance were performed as described in ʺMaterials and Methodsʺ. Serial ten-fold dilutions of cells were spotted on 
plates with solid YP medium containing 2% glucose as carbon source. Plates were initially incubated at 55
o
C for 30 
min, and were then transferred to 30
o






4.3.2 The ability of LCA to alter the age-related dynamics of mitochondrially produced 
ROS in chronologically ʺyoungʺ and ʺoldʺ yeast cells underlies its longevity-
extending effect  
I then used a complementary functional genetics approach for validating my hypothesis 
in which the longevity-extending potential of LCA is due to its ability to alter the age-related 
dynamics of mitochondrially produced ROS in both chronologically ʺyoungʺ and ʺoldʺ cells, thus 
reducing the damaging effect of these ROS in ʺyoungʺ cells and amplifying their ʺhormeticʺ 
effect in ʺoldʺ cells. It needs to be emphasized that mitochondrially generated ROS account for 
about 90% of all ROS in the cell, with the remainder being produced at various sites (Figure 4.8), 
including the cytosol, endoplasmic reticulum (ER), plasma membrane (PM) and peroxisome 
239 - 
242
. Within the cell, the actual steady-state level of ROS is dependent upon the balance between 
ROS formation and decomposition in various cellular locations (Figure 4.9) 
241, 242
. ROS 
decomposition is known to be accomplished through a network of antioxidant scavenger 
reactions; these reactions take place in mitochondria, the cytosol and peroxisomes (Figure 4.10). 
In the mitochondrion, superoxide radicals (O2
-
) are generated mainly from the incomplete 
metabolism of oxygen molecules in complex III of the ETC 
241
. Through the action of cytosolic 
(Sod1p) and mitochondrial (Sod2p) superoxide dismutase enzymes, harmful superoxide radicals 
are converted to the more stable and less toxic ROS, hydrogen peroxide (H2O2) 
241, 242
. Further 
detoxification of H2O2 is the result of other antioxidant scavenger enzymes (Figure 4.10), namely 
catalases, peroxiredoxins and glutathione peroxidases 
241, 242
. ROS-induced oxidative damage 
within the mitochondrion primarily targets mitochondrial proteins, DNA (mtDNA), and lipids, as 
summarized in Figure 4.11 
239 - 242
. Of note, in contrast to the oxidative damage of various 
cellular components caused by high intracellular concentrations of ROS, lower levels of harmful 
ROS are actually beneficial to the cell, upregulating mechanisms that serve to protect cellular 
constituents from oxidative stress and damage 
239, 242
. In their capacity as signaling molecules, 
ROS benefit cells on two fronts. First, ROS activate a group of proteins that function to prevent 
or delay apoptosis, thereby protecting the cells from ROS-induced programmed cell death 
(Figure 4.12) 
241, 242
. In their second protective capacity, ROS have specific sensors in the cytosol 
and mitochondrion that interact with certain shuttling proteins (cytosol-to-nucleus and 
mitochondrion-to-nucleus), which are then shuttled to the nucleus (Figure 4.12) 
240, 241
. Finally, 
these shuttling proteins activate transcriptional factors and cofactors in the nucleus, which serve 
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as activators of genes that encode both oxidative stress-response and anti-apoptotic proteins 
(Figure 4.12) 
241, 242
. An ʺoptimalʺ, pro-longevity level of ROS can be defined as one that is 
unable to cause sufficient oxidative damage to cellular constituents that would promote aging, 
while concurrently activating signaling networks that function to upregulate oxidative stress 
response and other anti-aging proteins 
241 – 243
. The latter role can be categorized as the 
ʺhormeticʺ effect of ROS, where hormesis is defined as a beneficial defence response of an 




Figure 4.8. Sites of ROS production.  
Superoxide radicals (O2
-
) are produced primarily in the mitochondrion, but also in the peroxisome. Hydrogen 
peroxide is formed from β-oxidation of fatty acids in the peroxisome as well as other cellular locations (the cytosol, 
plasma membrane 
PM






Figure 4.9. The steady-state level of ROS within a cell is dependent upon the balance between ROS formation 
and decomposition in various cellular locations, including the mitochondrion, cytosol, peroxisome and 




Figure 4.10. ROS decomposition is accomplished through a network of antioxidant scavenger reactions; these 
reactions take place in mitochondria, the cytosol and peroxisomes.  







Figure 4.11. ROS-induced oxidative damage within the mitochondrion primarily targets mitochondrial 
proteins, DNA (mtDNA) and lipids.  
ROS targets within the mitochondrion are highlighted in red. 
 
Figure 4.12. Low levels of harmful ROS can be beneficial to the cell, upregulating mechanisms that serve to 
protect cellular constituents from oxidative stress and damage.  
In their capacity as signaling molecules, ROS: 1) activate a group of proteins that function to prevent or delay 
apoptosis, thereby protecting the cells from ROS-induced programmed cell death; and 2) have specific sensors in the 
cytosol and mitochondrion that interact with certain shuttling proteins (cytosol-to-nucleus and mitochondrion-to-
nucleus), which are then shuttled to the nucleus. These shuttling proteins activate transcriptional factors and 
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cofactors in the nucleus, which serve as activators of genes that encode both oxidative stress-response and anti-
apoptotic proteins. 
 
          To use a functional genetics approach for validating my hypothesis on the ability of LCA 
to extend yeast longevity by altering the age-related dynamics of mitochondrially produced ROS 
in both chronologically ʺyoungʺ and ʺoldʺ cells, I sought to investigate how gene deletion 
mutations eliminating individual components of the mitochondrial ETC and cellular ROS 
scavenging network influence the ability of LCA to: (1) prolong yeast lifespan; and (2) alter the 
age-dependent dynamics of ROS production. Within such experimental framework, the 
functionalities of these components were placed into one of three categories: essential 
(activating) components, non-essential components or inhibitory components (Figure 4.13). 
These three categories were defined with respect to LCA’s ability to extend yeast longevity. As 
such, a component of the mitochondrial ETC or a ROS scavenger deemed essential is required 
for LCA to exert its ability to extend longevity; i.e. there would be a reduction in the mean 
lifespan 
MLS
 of the deletion mutant with LCA as compared to that of the wild type with LCA 
(Figure 4.13). In the case of a non-essential component, the values of MLS for the deletion 
mutant with LCA should be very similar to that for the wild type with LCA (Figure 4.13). 
Finally, the inhibitory component is such a component of the mitochondrial ETC or such a ROS 
scavenger that its absence in the deletion mutant significantly enhances the longevity-extending 
ability of LCA as compared to that for the wild type; i.e. the presence of such a component 
hinders the ability of LCA to extend yeast lifespan (Figure 4.13). 
 
Figure 4.13. Three categories of mitochondrial ETC components or ROS scavengers with respect to LCA’s 
ability to extend yeast longevity.  
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The functionalities of these components can be placed into one of three categories: essential (activating) 
components, non-essential components or inhibitory components. See text for details. 
 
          Within such experimental framework, if my hypothesis is valid, it is expected that: (1) any 
mutation that in the presence of LCA decreases the ʺearlyʺ spike in ROS in chronologically 
ʺyoungʺ cells may enhance the anti-aging effect of LCA; and (2) any mutation that in the 
presence of LCA increases the ʺearlyʺ spike in ROS in chronologically ʺyoungʺ cells may reduce 
or eliminate the anti-aging effect of LCA. In support of my hypothesis, I found that in yeast cells 
cultured in the presence of LCA, the ndi1Δ mutation (which eliminates complex I of the 
mitochondrial ETC) decreases the ʺearlyʺ spike in ROS in chronologically ʺyoungʺ cells and 
enhances the anti-aging effect of LCA (Figure 4.14). 
 
Figure 4.14. In yeast cells cultured in the presence of LCA, the ndi1Δ mutation (which eliminates complex I of 
the mitochondrial ETC) decreases the ʺearlyʺ spike in ROS in chronologically ʺyoungʺ cells and enhances 
the anti-aging effect of LCA.  
Wild-type and ndi1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with 50 µM LCA. The levels of intracellular ROS and chronological lifespans were measured as 





          Furthermore, if my hypothesis is valid, it is expected that: (1) any mutation that in the 
presence of LCA decreases the ʺlateʺ spike in ROS in chronologically ʺoldʺ cells may reduce or 
eliminate the anti-aging effect of LCA; and (2) any mutation that in the presence of LCA 
increases the ʺlateʺ spike in ROS in chronologically ʺoldʺ cells may enhance the anti-aging effect 
of LCA. In support of my hypothesis, I also found that in yeast cells cultured in the presence of 
LCA, the gpx1Δ mutation (which eliminates an isoform of the cytosolic phospholipid 
hydroperoxide glutathione peroxidase, one of the ROS scavengers; see Figure 4.10) increases the 
ʺlateʺ spike in ROS in chronologically ʺoldʺ cells and enhances the anti-aging effect of LCA 
(Figure 4.15).           
 
Figure 4.15 In yeast cells cultured in the presence of LCA, the gpx1Δ mutation (which eliminates an isoform 
of the cytosolic phospholipid hydroperoxide glutathione peroxidase, a ROS scavenger) increases the ʺlateʺ 
spike in ROS in chronologically ʺoldʺ cells and enhances the anti-aging effect of LCA.  
Wild-type and ndi1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with 50 µM LCA. The levels of intracellular ROS and chronological lifespans were measured as 
described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 3-5; *p < 0.01). 
 
          As a next step towards validating my hypothesis, I assessed how gene deletion mutations 
eliminating various ROS scavengers and eliciting variations of intracellular ROS within a wide 
range of concentrations impact longevity-extending efficacy of LCA. Twelve single-gene-
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deletions mutants were studied, each lacking one of the following ROS scavenging enzymes: 
cytosolic (Sod1p) and mitochondrial (Sod2p) superoxide dismutases; cytosolic (Ctt1p) and 
peroxisomal (Cta1p) catalases; mitochondrial cytochrome-c peroxidase (Ccp1p); cytosolic 
thioredoxin peroxidases isoforms 1 (Tsa1p) and 2 (Tsa2p); the cytosolic thioredoxin isoforms 1 
(Trx1p) and 2 (Trx2p) as well as the mitochondrial thioredoxin (Trx2p); cytosolic glutathione 
peroxidases (Gpx1p); and cytosolic thiol peroxidases (Hyr1p) (see Figure 4.10).  I found that: (1) 
LCA is unable to extend lifespan of the sod1Δ mutant strain and, thus, the cytosolic superoxide 
dismutase Sod1p is essential for the ability of LCA to extend yeast longevity (Figure 4.16); (2) 
LCA equally efficiently extends longevities of both the wild-type and mutant ctt1Δ strains and, 
thus, the cytosolic catalase Ctt1p is not essential for the ability of LCA to extend longevity 
(Figure 4.17); (3) LCA is unable to extend lifespan of the sod2Δ mutant strain and, thus, the 
mitochondrial superoxide dismutase Sod2p is essential for the ability of LCA to extend yeast 
longevity (Figure 4.18); (4) LCA equally efficiently extends longevities of both the wild-type 
and mutant cta1Δ strains and, thus, the peroxisomal catalase Cta1p is not essential for the ability 
of LCA to extend longevity (Figure 4.19). I concluded that both cytosolic and mitochondrial 
superoxide dismutases, but not cytosolic or peroxisomal catalase, are essential for lifespan 
extension by LCA (Figure 4.20). 
 
Figure 4.16. LCA is unable to extend lifespan of the sod1Δ mutant strain and, thus, the cytosolic superoxide 
dismutase Sod1p is essential for the ability of LCA to extend yeast longevity.  
Wild-type and sod1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 





Figure 4.17. LCA equally efficiently extends longevities of both the wild-type and mutant ctt1Δ strains and, 
thus, the cytosolic catalase Ctt1p is not essential for the ability of LCA to extend longevity.  
Wild-type and ctt1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 3-5). 
 
Figure 4.18. LCA is unable to extend lifespan of the sod2Δ mutant strain and, thus, the mitochondrial 
superoxide dismutase Sod2p is essential for the ability of LCA to extend yeast longevity.  
Wild-type and sod2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 





Figure 4.19. LCA equally efficiently extends longevities of both the wild-type and mutant cta1Δ strains and, 
thus, the peroxisomal catalase Cta1p is not essential for the ability of LCA to extend longevity.  
Wild-type and cta1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 4). 
 
Figure 4.20. Both cytosolic and mitochondrial superoxide dismutases, but not cytosolic or peroxisomal 
catalase, are essential for lifespan extension by LCA.  
Based on data presented in Figures 4.16 to 4.19. 
 
          Furthermore, I found that: (1) LCA is unable to extend lifespan of the ccp1Δ mutant strain 
lacking the mitochondrial cytochrome c peroxidase Ccp1p (Figure 4.21); and (2) LCA extends 
lifespan of the trx3Δ mutant strain (which lacks the mitochondrial thioredoxin Trx3p) to a 
significantly higher extent than that of the wild-type strain (Figure 4.22). I concluded that the 
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mitochondrial cytochrome c peroxidase Ccp1p is essential for the ability of LCA to extend yeast 
longevity, whereas the mitochondrial thioredoxin Trx3p weakens the longevity-extending effect 
of LCA in wild-type cells.  
 
Figure 4.21. LCA is unable to extend lifespan of the ccp1Δ mutant strain and, thus, the mitochondrial 
cytochrome c peroxidase Ccp1p is essential for the ability of LCA to extend yeast longevity.  
Wild-type and ccp1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 4; *p < 0.01). 
 
Figure 4.22. LCA extends lifespan of the trx3Δ mutant strain (which lacks the mitochondrial thioredoxin 
Trx3p) to a significantly higher extent than that of the wild-type strain and, thus, the mitochondrial 
thioredoxin Trx3p weakens the longevity-extending effect of LCA in wild-type cells.  
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Wild-type and trx3Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 4; *p < 0.01). 
 
 
Figure 4.23. The mitochondrial cytochrome c peroxidase Ccp1p is essential for the ability of LCA to extend 
yeast longevity, whereas the mitochondrial thioredoxin Trx3p weakens the longevity-extending effect of LCA 
in wild-type cells.  
Based on data presented in Figures 4.21 and 4.22. 
 
          Moreover, I revealed that: (1) LCA equally efficiently extends longevities of both the 
wild-type and mutant trx1Δ strains; this mutant stain lacks the Trx1p isoform of cytosolic 
thioredoxin (Figure 4.24); and (2) LCA extends lifespan of the trx2Δ mutant strain (which lacks 
the Trx2p isoform of cytosolic thioredoxin) to a significantly higher extent than that of the wild-
type strain (Figure 4.25). These findings imply that the Trx1p isoform of cytosolic thioredoxin is 
not essential for the ability of LCA to extend longevity, whereas its Trx2p isoform weakens the 
anti-aging effect of LCA (Figure 4.26). 
 
Figure 4.24. LCA equally efficiently extends longevities of both the wild-type and mutant trx1Δ strains and, 
thus, the Trx1p isoform of cytosolic thioredoxin is not essential for the ability of LCA to extend longevity.  
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Wild-type and trx1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 3-4). 
 
 
Figure 4.25. LCA extends lifespan of the trx2Δ mutant strain (which lacks the Trx2p isoform of cytosolic 
thioredoxin) to a significantly higher extent than that of the wild-type strain and, hence, the Trx2p isoform of 
cytosolic thioredoxin weakens the antiaging effect of LCA.  
Wild-type and trx2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 4; *p < 0.01). 
 
 
Figure 4.26. The Trx1p isoform of cytosolic thioredoxin is not essential for the ability of LCA to extend 
longevity, whereas its Trx2p isoform weakens the anti-aging effect of LCA.  
Based on data presented in Figures 4.24 and 4.25. 
 
          In addition, I found that: (1) LCA is unable to extend lifespan of the tsa1Δ mutant strain 
lacking the Tsa1p isoform of cytosolic thioredoxin peroxidase (Figure 4.27); and (2) LCA 
extends lifespan of the tsa2Δ mutant strain (which lacks the Tsa2p isoform of cytosolic 
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thioredoxin peroxidase) to a significantly higher extent than that of the wild-type strain (Figure 
4.28). Thus, the Tsa1p isoform of cytosolic thioredoxin peroxidase is essential for the ability of 
LCA to extend longevity, whereas its Tsa2p isoform weakens the anti-aging effect of LCA 
(Figure 4.29). 
 
Figure 4.27. LCA is unable to extend lifespan of the tsa1Δ mutant strain and, thus, the Tsa1p isoform of 
cytosolic thioredoxin peroxidase is essential for the ability of LCA to extend longevity.  
Wild-type and tsa1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 3-5; *p < 0.01). 
 
Figure 4.28. LCA extends lifespan of the tsa2Δ mutant strain to a significantly higher extent than that of the 
wild-type strain and, hence, the Tsa2p isoform of cytosolic thioredoxin peroxidase weakens the anti-aging 
effect of LCA.  
Wild-type and tsa2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 




Figure 4.29. The Tsa1p isoform of cytosolic thioredoxin peroxidase is essential for the ability of LCA to 
extend longevity, whereas its Tsa2p isoform weakens the anti-aging effect of LCA.  
Based on data presented in Figures 4.27 and 4.283. 
 
          I also found that: (1) LCA extends lifespan of the gpx1Δ mutant strain to a significantly 
higher extent than that of the wild-type strain and, hence, the Gpx1p isoform of cytosolic 
phospholipid hydroperoxide glutathione peroxidase weakens the anti-aging effect of LCA 
(Figure 4.30); and (2) LCA extends lifespan of the hyr1Δ mutant strain to a significantly higher 
extent than that of the wild-type strain and, hence, the cytosolic thiol peroxidase Hyr1p weakens 
the anti-aging effect of LCA (Figure 4.31). 
 
Figure 4.30. LCA extends lifespan of the gpx1Δ mutant strain to a significantly higher extent than that of the 
wild-type strain; thus, the Gpx1p isoform of cytosolic phospholipid hydroperoxide glutathione peroxidase 
weakens the anti-aging effect of LCA.  
Wild-type and gpx1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 




Figure 4.31. LCA extends lifespan of the hyr1Δ mutant strain to a significantly higher extent than that of the 
wild-type strain; hence, the cytosolic thiol peroxidase Hyr1p weakens the anti-aging effect of LCA.  
Wild-type and hyr1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 25 µM or 50 µM. The chronological lifespans were 
measured as described in ʺMaterials and Methodsʺ. Data are presented as means ± SEM (n = 4; *p < 0.01). 
 
          Altogether, the above findings revealed that out of twelve ROS scavenging enzymes: (1) 
four enzymes (i.e. Sod1p and Tsa1p in the cytosol as well as Sod2p and Ccp1p in mitochondria) 
are essential for the ability of LCA to delay aging; (2) five enzymes (i.e. Tsa2p, Trx2p, Gpx1p 
and Hyr1p in the cytosol as well as Trx3p in mitochondria) weaken the anti-aging effect of LCA; 
and (3) three enzymes (i.e. Trx1p and Ctt1p in the cytosol as well as Cta1p in the peroxisome) 







Figure 4.32. Some ROS scavenging enzymes are essential for the ability of LCA to delay aging, others weaken 
the anti-aging effect of LCA, whereas some of them are not essential for the ability of LCA to delay aging.  
Based on data presented in Figures 4.13-4.28. Data are presented as means ± SEM (n = 3-7; *p < 0.01).   
 
          To validate my hypothesis on the ability of LCA to extend yeast longevity by altering the 
age-related dynamics of mitochondrially produced ROS in both chronologically ʺyoungʺ and 
ʺoldʺ cells, I then assessed how the sod1Δ, sod2Δ, tsa1Δ and ccp1Δ mutations (all of which 
impair the ability of LCA to extend yeast longevity) influence such dynamics. I found that the 
sod1Δ, sod2Δ and tsa1Δ mutations: (1) in the L, D and PD growth phases, increase the level of 
intracellular ROS above its critically high level of 40 AU (for the definition of a level of ROS 
that is critically high for these growth phases, see discussion below); and (2) in the ST growth 
phase, sharply decrease intracellular ROS concentration to the level seen in wild-type cells 
(Figures 4.33, 4.34 and 4.35). I also found that the ccp1Δ mutation: (1) in the L, D and PD 
growth phases, does not alter the level of intracellular ROS; and (2) in the ST growth phase, 
initially elevates the level of intracellular ROS above its critically high level of 50 AU (for the 
definition of a level of ROS that is critically high for this growth phase, see discussion below) 
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and then sharply decrease intracellular ROS concentration to the level seen in wild-type cells 
(Figure 4.36). 
 
Figure 4.33. The sod1Δ mutation, which impairs the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and sod1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 





Figure 4.34. The sod2Δ mutation, which impairs the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and sod2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 





Figure 4.35. The tsa1Δ mutation, which impairs the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and tsa1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 
PD growth phases (days 1 to 7; 40 AU) or for the ST growth phase (Days 7 to 29; 50 AU). 
 
 
Figure 4.36. The ccp1Δ mutation, which impairs the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and ccp1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 
PD growth phases (days 1 to 7; 40 AU) or for the ST growth phase (Days 7 to 29; 50 AU). 
 
          As a further test of the validity of my hypothesis, I then examined how the tsa2Δ, trx2Δ, 
trx3Δ, gpx1Δ and hyr1Δ mutations (all of which enhance the ability of LCA to extend yeast 
longevity) influence the age-related dynamics of mitochondrially produced ROS in both 
chronologically ʺyoungʺ and ʺoldʺ cells. I found that the tsa2Δ mutation: (1) in the L, D and PD 
growth phases, does not alter the level of intracellular ROS; and (2) in the ST growth phase, 
increases the level of intracellular ROS but allows to maintain it below a critically high level of 
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50 AU (for the definition of a level of ROS that is critically high for this growth phase, see 
discussion below) (Figure 4.37). Furthermore, I revealed that the trx2Δ and trx3Δ mutations: (1) 
in the L, D and PD growth phases, elevate the level of intracellular ROS but permit to uphold it 
below a critically high level of 40 AU (I define this level as the highest level of ROS seen during 
the L, D and PD growth phases in cells that carry a mutation enhancing the ability of LCA to 
extend yeast longevity); and (2) in the ST growth phase, increase the level of intracellular ROS 
but allow to maintain it below a critically high level of 50 AU (I define this level as the highest 
level of ROS seen during the ST growth phase in cells that carry a mutation enhancing the ability 
of LCA to extend yeast longevity) most of the time (Figures 4.38 and 4.39). Moreover, I found 
that the gpx1Δ and hyr1Δ mutations: (1) in the L, D and PD growth phases, reduce the level of 
intracellular ROS; and (2) late in the ST growth phase, elevate the level of intracellular ROS but 
permit to sustain it below a critically high level of 50 AU (Figures 4.40 and 4.41).             
           
 
Figure 4.37. The tsa2Δ mutation, which enhances the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and tsa2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 






Figure 4.38. The trx2Δ mutation, which enhances the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and trx2Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 




Figure 4.39. The trx3Δ mutation, which enhances the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and trx3Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
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as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 
PD growth phases (days 1 to 7; 40 AU) or for the ST growth phase (Days 7 to 29; 50 AU). 
 
 
Figure 4.40. The gpx1Δ mutation, which enhances the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
Wild-type and gpx1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 
PD growth phases (days 1 to 7; 40 AU) or for the ST growth phase (Days 7 to 29; 50 AU). 
 
 
Figure 4.41. The hyr1Δ mutation, which enhances the ability of LCA to extend longevity, alters the age-
dependent dynamics of ROS production.  
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Wild-type and hyr1Δ cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose and 
supplemented with LCA added at the final concentration of 50 µM. The levels of intracellular ROS were measured 
as described in ʺMaterials and Methodsʺ. Red lines denote the levels of ROS that are critically high for the L, D and 
PD growth phases (days 1 to 7; 40 AU) or for the ST growth phase (Days 7 to 29; 50 AU). 
4.4 Conclusions 
In sum, findings described in this Chapter provide conclusive evidence in strong support of 
my hypothesis in which the longevity-extending potential of LCA is due in part to its ability to 
alter the age-related dynamics of mitochondrially produced ROS in both chronologically ʺyoungʺ 
and ʺoldʺ cells, thus reducing the damaging effect of these ROS in ʺyoungʺ cells and amplifying 


































5 LCA accumulated in yeast mitochondria orchestrates a development of an anti-aging 
cellular pattern by causing age-related changes in cellular proteome  
 
5.1 Introduction 
The composition, morphology and functional state of mitochondria have been implicated 
in cell growth, division, differentiation, homeostasis, metabolism, stress response, signaling, 
immune response, aging, survival and death in evolutionarily distant eukaryotes; these cellular 
organelles are therefore central to the physiology, health and disease of eukaryotic organisms 
across phyla 
3, 9, 10, 18, 19, 21, 23
. Mitochondria are indispensable for many vital cellular processes, 
including the following: (1) the synthesis of most cellular ATP via oxidative phosphorylation 
coupled to the electron transfer chain (ETC) in the inner mitochondrial membrane 
3, 10
; (2) the 
generation of the tricarboxylic acid (TCA) cycle intermediates, some of which are used for the 
synthesis of amino acids, lipids and heme in mitochondria 
3, 18, 19
; (3) the maintenance of a 
metabolic status-specific NAD
+
/NADH ratio, AMP/ATP ratio, level of acetyl-CoA and level of 
S-adenosylmethionine; these mitochondria-derived metabolites modulate activities of several 
protein sensors governing energy-producing cellular metabolism and are also used for 
acetylation and methylation of numerous non-mitochondrial proteins involved in many cellular 
processes 
3, 19, 23, 35
; (4) the synthesis and assembly of iron-sulfur clusters (ISC), inorganic 
cofactors of many mitochondrial, nuclear and cytosolic proteins playing essential roles in vital 
cellular processes 
57
; (5) the formation of reactive oxygen species (ROS); these by-products of 
mitochondrial respiration play critical roles in regulating cell proliferation, differentiation, 
metabolism, signaling, immune response, aging, survival and death 
18, 19, 41, 44, 47, 50, 53
; (6) the 
proteolytic degradation of unfolded proteins accumulated in mitochondria above a toxic 
threshold; the efflux of the resulting peptides from the mitochondria elicits a specific 
transcriptional response in the nucleus, thus reducing the number of unfolded proteins in 
mitochondria below the toxic threshold 
18, 53, 70, 71, 73
; (7) the efflux of cytochrome c and other 
pro-apoptotic proteins from mitochondria to initiate a programmed form of apoptotic cell death 
as well as to modulate various non-apoptotic cellular processes, including cell cycle progression, 
differentiation, metabolism, autophagy, inflammation, immunity and regulated necrotic death 
3, 9, 
10, 12, 13, 16, 23
; (8) the assembly and disassembly of various multi-protein complexes on the outer 
mitochondrial surface; these dynamic multi-protein complexes have been implicated in cell 
94 
 
differentiation, signaling, metabolism, immune response, hypoxic response and death, as well as 
in mitochondrial fusion, fission, motility, inheritance, DNA maintenance and autophagic 
degradation 
3, 9, 16, 21, 24, 93 - 97, 99
; (9) the establishment of zones of close apposition between the 
outer mitochondrial membrane and the mitochondria-associated membrane (MAM) domains of 
the endoplasmic reticulum (ER), plasma membrane, peroxisomes, vacuoles and 
autophagosomes; the MAM domains have been implicated in maintaining the homeostasis of 
intracellular Ca
2+
, sustaining membrane phospholipid homeostasis, controlling mitochondrial 
biogenesis and morphology, regulating mitochondrial division and movement, controlling ER 
stress, influencing ROS and ATP production, orchestrating autophagosome biogenesis during 
non-selective and mitochondria-selective forms of autophagy, impinging on immune signaling 
and inflammation, and defining cell susceptibility to a programmed form of apoptotic death 
3, 16, 
21, 24, 25, 27, 28, 106, 108, 109
; and (10) the communication of mitochondria with lysosomes and 
peroxisomes via small mitochondria-derived vesicles, which contribute to mitochondrial quality 
control and peroxisome biogenesis (respectively) 
120, 121
. 
          All these findings support the view that mitochondria operate as signaling organelles that 
are intimately integrated with other cellular compartments in orchestrating many vital processes 
within eukaryotic cells 
3, 16, 21, 24, 27, 28, 97, 99, 109
. A challenge is to uncover molecular mechanisms 
through which certain changes in the molecular composition of mitochondria influence their role 
as a signaling compartment that integrates cellular responses to various physiological conditions. 
A recent discovery by the Titorenko laboratory that exogenously added lithocholic bile acid 
(LCA) extends yeast chronological lifespan, accumulates in mitochondria and alters the 
mitochondrial membrane lipidome 
193
 provided an opportunity to explore how LCA-driven, 
longevity-extending changes in the composition of mitochondrial membrane phospholipids 
impact the ability of mitochondria to function as signaling organelles in aging. As a first step 
towards attaining our objective, in the studies described in this Chapter of my thesis I used 
quantitative mass spectrometry to investigate the effect of LCA on the age-related dynamics of 
alterations in levels of mitochondrial proteins and proteins in cellular locations outside of 




5.2 Materials and methods 
5.2.1 Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) was used in this study. The composition of YEPD (0.2% glucose) medium was as 
follows: 1% yeast extract, 2% peptone, 0.2% glucose. Cells were cultured at 30
o
C with rotational 
shaking at 200 rpm in Erlenmeyer flasks at a ″flask volume/medium volume″ ratio of 5:1.  
 
5.2.2 A plating assay for the analysis of chronological lifespan 
Cells were grown in YEPD (0.2% glucose) medium at 30
o
C with rotational shaking at 
200 rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. A sample of cells 
was removed from each culture at various time points. A fraction of the cell sample was diluted 
in order to determine the total number of cells per ml of culture using a hemacytometer. 10 l of 
serial dilutions (1:10 to 1:10
3
) of cells were applied to the hemacytometer, where each large 
square is calibrated to hold 0.1 l. The number of cells in 4 large squares was then counted and 
an average was taken in order to ensure greater accuracy. The concentration of cells was 
calculated as follows: number of cells per large square x dilution factor x 10 x 1,000 = total 





) of cells were plated onto YEPD (2% glucose) plates in triplicate in 
order to count the number of viable cells per ml of each culture. 100 l of diluted culture was 
plated onto each plate. After a 48-h incubation at 30
o
C, the number of colonies per plate was 
counted. The number of colony forming units (CFU) equals to the number of viable cells in a 
sample. Therefore, the number of viable cells was calculated as follows: number of colonies x 
dilution factor x 10 = number of viable cells per ml. For each culture assayed, % viability of the 
cells was calculated as follows: number of viable cells per ml / total number of cells per ml x 
100%. The % viability of cells in mid-logarithmic phase was set at 100% viability for that 
particular culture. The life span curves for wild-type and some of the mutant strains were also 
validated using a LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's 




5.2.3 Pharmacological manipulation of chronological lifespan 
Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA) [#L6250] bile acid was from Sigma. The stock solution of LCA in DMSO was 
made on the day of adding this compound to cell cultures. LCA was added to growth medium at 
the final concentration of 50 µM immediately following cell inoculation into the medium. The 
final concentration of DMSO in yeast cultures supplemented with LCA (and in the 
corresponding control cultures supplemented with drug vehicle) was 1% (v/v). 
 
5.2.4 Isolation of crude mitochondrial fraction from yeast cells  
5.2.4.1 Reagents 
1. Dithiothreitol (DTT) buffer [100 mM Tris-H2SO4, 10 mM dithiothreitol] 
2. Zymolyase 100T from Arthrobacter luteus (MP Biomedicals) 
3. Zymolyase buffer [1.2 M sorbitol, 20 mM potassium phosphate] 
4. Homogenization buffer [0.6 M sorbitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.2% 
(w/v) BSA]  
5. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 
 
5.2.4.2 Procedure 
Cell cultures were combined in pre-weighed centrifuge bottles and cells were pelleted at 
3,000 × g for 5 min at room temperature using a Beckman JA-10 rotor. The cells were washed 
twice with distilled water, followed by the determination of their wet weight. The cell pellets 
were resuspended in 2 ml/g DTT buffer and incubated on a shaker at 80 rpm for 20 min at 30ºC. 
The cells were pelleted as per initial centrifugation, washed in 7 ml/g Zymolyase buffer without 
Zymolyase and pelleted once more. The cells were incubated on a shaker at 80 rpm for 45 min at 
30ºC with 1 mg/g (wet weight) of Zymolyase-100T in 7 ml/g Zymolyase buffer. Zymolyase was 
used because of its well-known strong lytic activity required to digest yeast cell wall. The 
spheroplasts obtained were then spun down at 2,200 × g for 8 min at 4ºC. All subsequent steps 
were carried out on ice or at 4°C with the use of cut pipette tips to avoid breaking organelles. The 
spheroplasts were resuspended in 6.5 ml/g ice-cold homogenization buffer and washed by 
centrifugation at 2,200 × g for 8 min at 4ºC. The spheroplasts were then mechanically 
homogenized with 15 strokes in 6.5 ml/g ice-cold homogenization buffer to disrupt yeast plasma 
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membrane for releasing organelles and cytoplasm. Following the homogenization, the cell debris 
was pelleted by centrifuging at 1,500 × g for 5 min at 4ºC using a Beckman JA-17 rotor. The 
resulting lysate supernatant was subjected to centrifugation twice at 3000 × g for 5 min at 4ºC to 
pellet the nuclei and 12,000 × g for 15 min at 4ºC. The newly obtained pellet contains mostly 
mitochondria, but also the endoplasmic reticulum (ER), Golgi, peroxisomes, lysosomes and 
vacuoles, whereas the supernatant contains the cytosol, microsomes from the ER and vacuoles. 
The pellet was resuspended in 6.5 ml/g in ice-cold homogenizing buffer, spun down for 5 min at 
3,000 × g at 4ºC to obtain a supernatant containing mitochondria, which was then subjected to a 
spin at 12, 000 × g for 15 min at 4ºC. The resulting pellet was resuspended in 3 ml of SEM to be 
overlaid onto a sucrose gradient. 
 
5.2.5 Purification of S. cerevisiae mitochondria devoid of microsomal and cytosolic 
contaminations 
5.2.5.1 Reagents 
1. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 
2. EM buffer [10 mM Mops (pH 7.2), 1 mM EDTA] 
  
5.2.5.2 Procedure 
In order to purify yeast mitochondria from the crude mitochondrial fraction, an 
equilibrium density-gradient centrifugation was performed. Yeast mitochondria have a density of 
1.18 g/cm
3
 whereas 10% and 50% sucrose respectively have a density of 1.10 g/cm
3
 and 1.30 
g/cm
3
. To prepare a sucrose density gradient for the purification of mitochondria, 1.5 ml of 60% 
sucrose in EM buffer was overlaid with 4 ml of 32%, 1.5 ml of 23% and 1.5 ml of 15% sucrose 
in EM buffer, followed by 3 ml of the crude mitochondrial suspension. The sucrose density 
gradient containing the mitochondrial suspension was subjected to centrifugation in a Beckman 
SW41 Ti swinging-bucket rotor at 134,000 × g for 60 min at 4ºC.  The mitochondrial band, 
which was easily distinguishable, appeared at the interface between 60% and 32% sucrose. 
Fractions of 1 ml were recovered using a cut pipette tip and placed in 1.5 ml Eppendorf tubes 
and frozen at -80ºC until use. In order to quickly freeze the mitochondrial fractions, the fractions 




5.2.6 Analysis of proteins by mass spectrometry 
Proteins were resolved by SDS-PAGE and visualized by silver staining 
245
. Protein bands 
were excised from the gel, reduced, alkylated and in-gel digested with trypsin 
245
. The proteins 
were identified by matrix-assisted laser desorption/ionization mass spectrometric (MALDI MS) 
peptide mapping 
246
, using a Micromass M@LDI time-of-flight (TOF) mass spectrometer 
(Waters). Database searching using peptide masses was performed with the Mascot web-based 
search engine. For evaluating relative levels of individual proteins recovered in total cell lysates 
or purified mitochondria, a selected protein band was excised from the silver-stained gel and 
placed into an Eppendorf tube. A band of BSA containing 2 μg of this protein, which was also 
excised from the silver-stained gel, was added to each of the protein bands to be analyzed. 
Protein bands were reduced, alkylated and in-gel digested with trypsin 
245
. The desalted peptide 
mixture was added to the surface of a MALDI target plate and allowed to air dry. The sample 
spot was then overlaid with MALDI matrix solution containing the Angiotensin I peptide 
standard (1:1 ratio). The presence of Angiotensin I in the sample carrying the analyzed mixture 
of peptides provided an additional estimate of the mass measurement accuracy after calibration, 
giving an opportunity to calculate the value of peptide mass tolerance for each individual mass 
spectrum. After the desalted peptide mixture was analyzed by MALDI-TOF, the monoisotopic 
masses of recovered BSA peptides and the intensities of their monoisotopic peaks were grouped 
separately from the masses and intensities of peptides originated from the protein of interest. 
These data provided an additional estimate of the mass measurement accuracy and were used for 
the quantitation of relative levels of the same protein recovered in different samples. For 
evaluating relative levels of the protein of interest found in the samples to be compared, a ratio 
“the intensity of the monoisotopic peak of a peptide originated from the protein of interest/the 
intensity of the monoisotopic peak of a BSA peptide with the monoisotopic mass closest to the 
mass of the peptide of interest” was calculated for each peptide originated from the protein of 
interest. Based on these data, the average value for relative levels of the protein of interest found 
in the two compared samples was calculated. The method for evaluating relative levels of the 
protein of interest recovered in different samples was validated by calculating relative levels of 
several standard proteins in the samples supplemented with different quantities of each of these 
proteins. Relative levels of proteins in cells or mitochondria of cells cultured in the presence of 
LCA (fold difference relative to those in the absence of LCA) are represented in the figures. 
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5.2.7 Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated using an unpaired 
two-tailed t test. 
 
5.3 Results 
5.3.1 LCA elicits age-related changes in mitochondrial proteome 
I hypothesized that LCA accumulated in mitochondria of chronologically aging yeast 
may alter not only the membrane lipidome of these organelles 
193
 but also their proteome. To test 
this hypothesis, I used quantitative mass spectrometry to compare proteins that were recovered in 
mitochondria purified from wild-type (WT) cells cultured in the presence of LCA or in its 
absence. I found that LCA alters the age-related dynamics of changes in levels of numerous 
mitochondrial proteins implicated in many essential mitochondrial functions (Figure 5.1 and 
Appendix 1), including the following: (1) various enzymes of the TCA cycle (The 
Saccharomyces Genome Database (SGD): http://www.yeastgenome.org/); (2) Icl1p and Mls1p, 
enzymes of the glyoxylate cycle in mitochondria 
157, 158
; (3) various protein components of the 
ETC 
247
; (4) Aat1p, Gdh3p, Ilv5p, Ilv6p and Lys12p, enzymes involved in the biosynthesis of 
several amino acids, including aspartate, asparagine, threonine, glycine, isoleucine, glutamate, 
leucine, valine and lysine 
248, 249
; (5) the Cox10p, Cyc3p and Hem14p proteins implicated in 
heme synthesis and attachment 
250, 251
; (6) the Grx5p protein involved in the synthesis and 
assembly of ISCs, indispensable inorganic cofactors of various mitochondrial, nuclear and 
cytosolic proteins 
57, 252
; (7) Pos5p, an enzyme catalyzing the synthesis of NADPH from NADH 
253, 254
; (8) key protein components of reactive oxygen species (ROS) detoxification in 
mitochondria 
247
; (9) stress response proteins that have been implicated in mitochondrial protein 
import, folding and stress protection 
247
; (10) the Mia40p and Tim23p components of a 
machinery involved in protein import into the inner membrane, intermembrane space and matrix 
of mitochondria 
250, 255, 256
; (11) the Caf4p and Mdv1p protein components of mitochondrial 
fission machinery 
9
; (12) proteins that are essential for the synthesis, processing and translation 
of various mitochondrial RNA species 
247
; and (13) various mtDNA-binding proteins with 







Figure 5.1. LCA alters the age-related dynamics of changes in levels of numerous mitochondrial proteins 
implicated in many essential mitochondrial functions.  
Wild-type cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose, with 50 µM LCA or 
without it. Mitochondria were purified from cells recovered on days 2, 5 and 9 of culturing (D, PD and ST growth 
phases, respectively) as described in ʺMaterials and Methodsʺ. Mass spectrometry-based identification and 
quantitation of proteins recovered in purified mitochondria were performed as described in ʺMaterials and Methodsʺ. 
Relative levels of proteins in mitochondria of cells cultured in the presence of LCA (fold difference relative to those 
in the absence of LCA) are shown. Abbreviations: D, diauxic growth phase; ETC, the mitochondrial electron 
transport chain; mtDNA, mitochondrial DNA; PD, post-diauxic growth phase; ROS, reactive oxygen species; ST, 
stationary growth phase; TCA, the tricarboxylic acid cycle in mitochondria. 
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          With the help of the SPELL online search engine 
257
, I used each of these mitochondrial 
proteins as a query for analyzing extensive datasets of gene expression profiles in yeast mutants 
that lack (1) various transcription factors; (2) protein components of several signaling pathways 
known to be modulated by mitochondria; or (3) mitochondrial proteins shown to be essential for 
modulating these signaling pathways. Such bioinformatic analysis revealed that the 
mitochondrial proteins whose levels were altered in an age-related fashion in yeast cells cultured 
with LCA can be divided into two regulons, each modulated by a different kind of mitochondrial 
dysfunction. I call these two regulons a partial mitochondrial dysfunction (PMD) regulon and an 
oxidative stress (OS) regulon (Figure 5.2). Based on expression profiles of the genes encoding 
mitochondrial proteins composing the PMD regulon and taking into consideration published data 
on regulation of such proteins in response to certain mitochondrial dysfunctions, it can be 
divided into six ʺclustersʺ (Figure 5.2). Each of these clusters denotes a distinct type of partial 
mitochondrial dysfunction that elicits a different signaling pathway governed by a distinct set of 
transcription factors. The PMD regulon includes the following clusters: (1) rho
0
 cluster (which is 
governed by Rtg2p, a sensor of an age-related reduction of mitochondrial membrane potential) 
18, 
158, 258 - 262
; (2) S1 cluster 
18, 258, 260, 261
; (3) general TCA cycle dysfunction cluster 
18, 258 - 261
; (4) 
kgd1Δ, kgd2Δ or lpd1Δ cluster 18, 259 - 261; (5) yme1Δ mdl1Δ cluster 18, 261; and (6) afo1Δ cluster 
(which is governed by Sfp1p, a transcription activator of genes encoding cytoplasmic ribosomal 
proteins) 
18, 172
. The OS regulon includes the following clusters: (1) a cluster governed by the 
transcription factor Yap1p, a primary determinant in the antioxidant response of yeast cells 
263 - 
269
; (2) a cluster governed by the transcription factors Msn2p/Msn4p, which are required for 
expression of numerous genes in response to thermal, oxidative and other types of stress 
262, 267 - 
270
; (3) a cluster governed by the transcription factor Skn7p, which is involved in the osmotic and 
oxidative stress responses 
263 - 269
; and (4) a cluster governed by Hog1p, a mitogen-activated 







Figure 5.2. The mitochondrial proteins whose levels are altered in an age-related fashion in yeast cells 
cultured with LCA can be divided into two regulons called a partial mitochondrial dysfunction (PMD) 
regulon and an oxidative stress (OS) regulon. 
Each regulon is modulated by a different kind of mitochondrial dysfunction. Based on expression profiles of the 
genes encoding mitochondrial proteins composing the PMD and OS regulons and considering published data on 
regulation of such proteins in response to certain mitochondrial dysfunctions, each regulon can be divided into 
several ʺclustersʺ. Each cluster denotes a distinct type of partial mitochondrial dysfunction that elicits a different 
signaling pathway mediated by a distinct set of transcription factors. Because mitochondrial proteins constituting the 
PMD and OS regulons exhibit three different patterns of the age-related dynamics of changes in their cellular levels, 
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each of these regulons is separated into regulons ʺtype 1ʺ, ʺtype 2ʺ and ʺtype 3ʺ. The names of proteins that belong 
to more than one PMD or OS regulon are italicized; the names of proteins that are members of both a PMD regulon 
and an OS regulon are underlined. Abbreviations: D, diauxic growth phase; PD, post-diauxic growth phase; ST, 
stationary growth phase. 
 
          It needs to be emphasized that mitochondrial proteins constituting the PMD and OS 
regulons exhibit three different patterns of the age-related dynamics of changes in their cellular 
levels; to underscore the existence of such differences in expression, we separated each of the 
PMD and OS regulons into regulons ʺtype 1ʺ, ʺtype 2ʺ and ʺtype 3ʺ (Figure 5.2 and Appendix 1). 
The cellular levels of mitochondrial proteins comprising the PMD and OS regulons type 1 
remained nearly unchanged during diauxic (D) and post-diauxic (PD) growth phases but 
underwent a 2-3 fold increase or decrease during the subsequent stationary (ST) growth phase 
(Figure 5.2; PMD regulon 1 and OS regulon 1). Furthermore, the cellular levels of mitochondrial 
proteins comprising the PMD and OS regulons type 2 elevated by 2-3 folds during D and PD 
growth phases but remained almost unaltered during the following ST growth phase (Figure 5.2; 
PMD regulon 2 and OS regulon 2). Moreover, the cellular levels of mitochondrial proteins 
comprising the PMD and OS regulons type 3 remained nearly the same during the most of D and 
PD growth phases but underwent a 3-4 fold reduction during the subsequent ST growth phase 
(Figure 5.2; PMD regulon 3 and OS regulon 3). Noteworthy, the expression of genes encoding 
mitochondrial proteins that belong to the PMD regulons type 1, 2 and 3 is known to be regulated 
by the transcription factors Rtg1p/Rtg2p/Rtg3p, Sfp1p and Aft1p 
18, 172, 262
. The expression of 
genes coding for mitochondrial proteins that belong to the OS regulons type 1, 2 and 3 has been 
shown to be under the control of the transcription factors Yap1p, Msn2p/Msn4p, Skn7p and 
Hog1p 
263 - 268, 270, 271
. 
 
5.3.2 LCA causes age-related changes in cellular proteome 
Age-related alterations in the rates and efficiencies of several processes within 
mitochondria are known to modulate the capacity of these organelles to make and release certain 
molecular signals; outside mitochondria, such signals have been shown to cause changes in the 
rates and efficiencies of longevity-defining processes in other cellular locations 




Of note, I found that a treatment of yeast cells with LCA alters the age-related 
104 
 
chronology of these mitochondrial processes 
19, 139, 155, 184, 193, 218
. I therefore hypothesized that 
LCA may impact not only the levels of numerous mitochondrial proteins but also the levels of 
proteins in cellular locations outside mitochondria. To validate this hypothesis, I used 
quantitative mass spectrometry to compare proteins that were recovered in total lysates of WT 
cells cultured in the presence of LCA or in its absence. This quantitative analysis of cellular 
proteins confirmed the data of such analysis for proteins recovered in purified mitochondria; 
indeed, I found that LCA alters the age-related dynamics of changes in levels of many 
mitochondrial proteins known for their essential roles in vital mitochondrial functions and aging 
in yeast (compare Figures 5.1 and 5.3, as well as Appendices 1 and 2). Moreover, I found that 
LCA causes age-related changes in levels of numerous proteins known to be located outside of 
mitochondria and shown to be involved in various cellular processes (Figure 5.3 and Appendix 
2). These cellular processes include the following: (1) glycogen degradation; (2) the glycolytic 
pathway; (3) the pentose phosphate pathway; (4) pyruvate conversion to acetyl-CoA; (5) the 
maintenance of redox balance between NAD and NADH with the help of carnitine and glycerol-
3-phosphate shuttles; (6) ROS detoxification; (7) stress response; (8) glutathione synthesis; (9) 
gluconeogenesis; (10) ethanol formation; (11) the synthesis and hydrolytic degradation of 
triacylglycerols (TAG) and ergosteryl esters (EE), the two major neutral lipids; (12) the synthesis 
of various amino acids; (13) nucleotide synthesis; (14) the assembly of the 40S and 60S 
ribosomal subunits from numerous protein components whose levels were altered by LCA; and 
(15) proteasomal and vacuolar protein degradation 
18, 19, 145, 155, 158, 214, 247
. 
          I then subjected cellular proteins whose levels were changed in yeast grown in a medium 
supplemented with LCA to bioinformatic analysis with the help of the SPELL online search 
engine 
257
, as described above for mitochondrial proteins. Just as my bioinformatic analysis of 
mitochondrial proteins revealed (see above), I found that each of the cellular proteins whose 
level was altered in yeast cultured with LCA belongs to the following two multi-clustered 
regulons: (1) the PMD regulon, which consisted of the rho
0
 (Rtg2p governed) cluster, S1 cluster, 
general TCA cycle dysfunction cluster, kgd1Δ, kgd2Δ or lpd1Δ cluster, yme1Δ mdl1Δ cluster, 
and afo1Δ (Sfp1p governed) cluster 18, 19, 158, 172, 258 - 262; and (2) the OS regulon, which included 





Figure 5.3. LCA alters the age-related dynamics of changes in levels of many mitochondrial proteins and 
numerous proteins located outside of mitochondria; these mitochondrial and non-mitochondrial proteins 
have been implicated in various cellular processes.  
Wild-type cells were cultured in the nutrient-rich YP medium initially containing 0.2% glucose, with 50 µM LCA or 
without it. Cells were recovered on days 2, 5 and 9 of culturing (D, PD and ST growth phases, respectively). Mass 
spectrometry-based identification and quantitation of proteins recovered in total lysates of yeast cells were 
performed as described in ʺMaterials and Methodsʺ. Relative levels of proteins in cells cultured in the presence of 
LCA (fold difference relative to those in the absence of LCA) are shown. Abbreviations: C, cytosol; D, diauxic 
growth phase; EE, ergosteryl esters; ETC, the mitochondrial electron transport chain; M, mitochondria; mtDNA, 
mitochondrial DNA; PD, post-diauxic growth phase; ROS, reactive oxygen species; ST, stationary growth phase; 





Figure 5.4. Each of the cellular proteins whose level is changed in yeast cultured with LCA belongs to the 
following two multi-clustered regulons, each modulated by a different kind of mitochondrial dysfunction. 
(1) the partial mitochondrial dysfunction (PMD) regulon, which consisted of the rho
0
 (Rtg2p governed) cluster, S1 
cluster, general TCA cycle dysfunction cluster, kgd1Δ, kgd2Δ or lpd1Δ cluster, yme1Δ mdl1Δ cluster, and afo1Δ 
(Sfp1p governed) cluster; and 2) the oxidative stress (OS) regulon, which included the Yap1p governed cluster, 
Msn2p/Msn4p governed cluster, Skn7p governed cluster and Hog1p governed cluster. Each cluster denotes a 
distinct type of partial mitochondrial dysfunction that elicits a different signaling pathway governed by a distinct set 
of transcription factors. Because cellular proteins that belong to the PMD and OS regulons display three different 
patterns of age-related changes in their levels, each of these regulons is separated into regulons ʺtype 1ʺ, ʺtype 2ʺ 
and ʺtype 3ʺ. The names of cellular proteins that belong to more than one PMD or OS regulon are italicized; the 
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names of cellular proteins that are members of both a PMD regulon and an OS regulon are underlined. 
Abbreviations: D, diauxic growth phase; PD, post-diauxic growth phase; ST, stationary growth phase. 
 
and Hog1p governed cluster (Figure 5.4) 
18, 19, 262 - 268, 270 - 272
. I also found that, akin to 
mitochondrial proteins constituting the PMD and OS regulons, cellular proteins that belong to 
each of them displays either of the following three patterns of age-related changes in their levels: 
(1) the levels of cellular proteins that belong to the PMD and OS regulons type 1 remained 
nearly unchanged during D and PD growth phases but underwent a 3-4 fold rise or reduction 
during the subsequent ST growth phase (Figure 5.4; PMD regulon 1 and OS regulon 1); (2) the 
levels of cellular proteins that belong to the PMD and OS regulons type 2 increased by 3-4 folds 
during D and PD growth phases but remained almost unaltered during the following ST growth 
phase (Figure 5.4; PMD regulon 2 and OS regulon 2); and (3) the levels of cellular proteins that 
belong to the PMD and OS regulons type 3 remained practically the same during the most of D 
and PD growth phases but underwent a 2-4 fold reduction or rise during the subsequent ST 
growth phase (Figure 5.4; PMD regulon 3 and OS regulon 3). Moreover, I noted that: (1) similar 
to mitochondrial proteins constituting the three different PMD regulons, the expression of genes 
for cellular proteins that belong to the PMD regulons type 1, 2 and 3 has been shown to be 
governed by the transcription factors Rtg1p/Rtg2p/Rtg3p, Sfp1p and Aft1p 
18, 172, 262
; and (2) akin 
to mitochondrial proteins constituting the three different OS regulons, the expression of genes for 
cellular proteins that belong to the OS regulons type 1, 2 and 3 is known to be controlled by the 
transcription factors Yap1p, Msn2p/Msn4p, Skn7p and Hog1p 
263 - 268, 270 - 272
.  
 
5.3.3 Longevity extension by LCA requires a distinct set of transcription factors  
I found that gene-deletion mutations eliminating either the Rtg1p, Rtg2p, Rtg3p, Sfp1p, 
Yap1p, Msn2p/Msn4p, Skn7p or Hog1p transcription factor(s) significantly reduce the extent to 
which LCA extends yeast longevity (Figures 5.5 and 5.6); all these factors are known to cause a 
development of an anti-aging cellular pattern by activating specific transcriptional programs in 
the nucleus 
18, 19, 172, 261 - 268, 270 - 272
. In contrast, a single-gene-deletion mutation eliminating the 
transcription factor Aft1p increased the longevity-extending efficiency of LCA (Figures 5.5 and 
5.6); this factor has been shown to respond to reduced levels of cellular ISCs by eliciting a pro-
aging transcriptional program in the nucleus 
18, 19, 56, 60
. In sum, these findings suggest that, by 
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establishing a specific pattern of an age-related expression of numerous nuclear genes encoding 
mitochondrial and non-mitochondrial proteins that belong to the PMD or OS regulons of type 1, 
2 or 3, each of these transcription factors plays an essential role in longevity extension by LCA. 
 
Figure 5.5. Gene-deletion mutations eliminating the Rtg1p, Rtg2p, Rtg3p, Sfp1p, Aft1p, Yap1p, 
Msn2p/Msn4p, Skn7p or Hog1p transcription factor significantly alter the extent to which LCA extends yeast 
longevity.  
Wild-type and mutant cells lacking one (or two, as in case of msn2/4Δ mutant cells) of the above transcription 
factors were cultured in the nutrient-rich YP medium initially containing 0.2% glucose, with 50 µM LCA or without 
it. The chronological lifespans were measured as described in ʺMaterials and Methodsʺ. Data are presented as means 




Figure 5.6. Gene-deletion mutations eliminating the Rtg1p, Rtg2p, Rtg3p, Sfp1p, Aft1p, Yap1p, 
Msn2p/Msn4p, Skn7p or Hog1p transcription factor significantly alter the extent to which LCA extends yeast 
longevity.  
Wild-type and mutant cells lacking one (or two, as in case of msn2/4Δ mutant cells) of these transcription factors 
were cultured in the nutrient-rich YP medium initially containing 0.2% glucose, with 50 µM LCA or without it. The 
chronological lifespans were measured as described in ʺMaterials and Methodsʺ. Survival curves of chronologically 





This study and my recent published data 
193
 suggest that LCA-driven changes in 
mitochondrial lipidome alter mitochondrial proteome and functionality, thereby enabling 
mitochondria to function as signaling organelles that orchestrate an establishment of an anti-
aging transcriptional program for many longevity-defining nuclear genes (Figure 5.7). It is 
conceivable that the reduced mitochondrial membrane potential seen in chronologically ʺyoungʺ 
yeast cells cultured with LCA 
193
 triggers the mitochondrial retrograde (RTG) signaling pathway 
of cellular aging regulation (Figure 5.7); the Rtg2p protein component of this pathway is known 
to respond to a decline in mitochondrial membrane potential by stimulating nuclear import of the 
Rtg1p-Rtg3p heterodimeric transcription factor, which in the nucleus triggers an anti-aging 
transcriptional program 
18, 19, 262
. Furthermore, the observed in chronologically ʺoldʺ yeast cells 
cultured with LCA reduction in the levels of several protein components of the large and small 
subunits of mitochondrial ribosome (Figures 5.1 and 5.2) is likely to activate the so-called back-
signaling pathway (Figure 5.7); in response to reduced levels of mitochondrial ribosomal 
proteins this pathway is known to trigger an anti-aging transcriptional program which in the 
nucleus is activated by the transcription factor Sfp1p 
18, 19, 172
. Moreover, it is plausible that the 
observed in chronologically ʺoldʺ yeast cells cultured with LCA rise in the levels of proteins 
involved in the synthesis and assembly of ISCs in mitochondria (Figures 5.1 and 5.2) may 
diminish activity and/or nuclear import of Aft1p (Figure 5.7), a transcription factor known to 
respond to reduced levels of cellular ISCs by driving a pro-aging transcriptional program in the 
nucleus 
18, 19, 56, 60
. It is also conceivable that the observed in chronologically ʺyoungʺ and ʺoldʺ 
yeast cells cultured with LCA significant changes in the levels of numerous mitochondrial and 
non-mitochondrial proteins comprising the yme1Δ mdl1Δ cluster of the PMD regulon (Figures 
5.1 to 5.4) activate a distinct retrograde response signaling pathway that triggers an anti-aging 
transcriptional program in the nucleus (Figure 5.7); this pathway is known to be elicited in 
response to a simultaneous lack of the mitochondrial i-AAA protease Yme1p and the 
mitochondrial ABC-transporter Mdl1p involved in peptide export from mitochondria 
18, 19, 261
. 
Finally, the observed ability of LCA to amplify the ʺhormeticʺ, anti-aging effect of 
mitochondrially generated ROS by enabling to maintain their levels in chronologically ʺoldʺ 
yeast cells relatively high but below a cytotoxic threshold 
19, 193
 is likely to delay aging by 
activating Yap1p, Msn2p/Msn4p, Skn7p or Hog1p (Figure 5.7); these transcription factors are 
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known to respond to ʺhormeticʺ levels of ROS by triggering an anti-aging transcriptional 
program in the nucleus 
18, 19, 263 - 268, 270 - 272
. 
 
Figure 5.7. A model for how LCA-driven changes in mitochondrial lipidome alter mitochondrial proteome 
and functionality, thereby enabling mitochondria to function as signaling organelles modulating transcription 
of many longevity-defining nuclear genes.  
See text for details. Abbreviations: Ac-CoA, acetyl-CoA; ETC, the mitochondrial electron transport chain; mtDNA, 
mitochondrial DNA; ROS, reactive oxygen species; ST, stationary growth phase; TCA, the tricarboxylic acid cycle 
in mitochondria. 
 
          Moreover, this study and published data from the Titorenko laboratory 
19, 20, 139, 155, 159, 184, 
193, 214, 218
 suggest the following model for how LCA-driven changes in mitochondrial proteome 
and functionality early and late in life of chronologically aging yeast cause a stepwise 




          Early in life of a chronologically aging yeast cell, during the D phase of growth, LCA 
within the inner and outer membranes of mitochondria reduces the capacities of coupled 
mitochondrial respiration, mitochondrial membrane potential and mitochondrial ROS production 
(Figure 5.8) - likely by decreasing the levels of the ʺupstreamʺ protein components (i.e. Ndi1p, 
Nde1p, Nde2p and Sdh1p-Sdh4p) of the mitochondrial ETC and increasing the levels of its 
ʺdownstreamʺ protein components (i.e. cytochrome c as well as respiratory complexes III, IV and 
V) (Figures 5.1 to 5.4). By differentially altering the levels of proteins involved in the 
mitochondrial TCA cycle (Figures 5.1 to 5.4), LCA increases the efficiencies with which some 
of the intermediates of this cycle are converted into amino acids, NADPH and heme within 
mitochondria (Figure 5.8); the rates of such conversion during D growth phase are further 
elevated by the LCA-elicited rise in the levels of mitochondrial enzymes catalyzing the key 
reactions of the conversion (Figures 5.1 to 5.4). The rise in the levels of proteins known to be 
essential for the synthesis, processing and translation of various mitochondrial RNA species, 
which is observed in mitochondria of cultured with LCA cells during D growth phase (Figures 
5.1 to 5.4), improves mitochondrial functionality by stimulating these processes within 
mitochondria (Figure 5.8). Furthermore, the elevated levels of mitochondrial components 
involved in protein import into the inner membrane, intermembrane space and matrix of 
mitochondria (Figures 5.1 to 5.4) accelerate these processes during D growth phase, thus further 
improving mitochondrial functionality (Figure 5.8). Additionally, by increasing the levels of 
mtDNA-binding proteins during D growth phase (Figures 5.1 to 5.4), LCA stabilizes the 
mitochondrial nucleoid and protects it from oxidative and other forms of age-related damage 
(Figure 5.8). During the D phase of growth, LCA within the inner and outer mitochondrial 
membranes also elevates the levels of mitochondrial membrane proteins required for acetyl-CoA 
uptake by mitochondria (Figures 5.1 to 5.4); moreover, the altered functionality of these 
mitochondria triggers several mitochondria-to-nucleus signaling pathways that differentially 
affect cellular levels of non-mitochondrial proteins involved in various metabolic pathways for 
carbohydrates and lipids (Figures 5.1 to 5.4). The resulting remodeling of these pathways in 
yeast cells cultured in the presence of LCA (1) stimulates glycogen degradation, glycolysis, 
acetyl-CoA formation in the cytosol and neutral lipids synthesis in the ER – thus increasing the 
levels of NADH, ATP and neutral lipids; and (2) inhibits ethanol formation from acetaldehyde, 
acyl-CoA conversion to acetate, gluconeogenetic metabolism of pyruvate and the lipolytic 
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conversion of neutral lipids into fatty acids – thereby further stimulating acetyl-CoA formation in 
the cytosol, from which it is then transported with the increased efficiency into mitochondria to 
improve their functionality (Figure 5.8) 
18,19
. 
          During the subsequent PD phase of growth, LCA within the inner and outer mitochondrial 
membranes not only maintains its ability to decrease the levels of the ʺupstreamʺ protein 
components of the mitochondrial ETC and to increase the levels of its ʺdownstreamʺ protein 
components but also elevates the level of the mitochondrial cytochrome-c peroxidase Ccp1p 
(Figures 5.1 to 5.4) – thus enabling to sustain reduced capacities of coupled mitochondrial 
respiration, mitochondrial membrane potential and mitochondrial ROS production (Figure 5.8). 
By increasing the levels of stress response proteins implicated in mitochondrial protein import, 
folding, stress protection and membrane proteins biogenesis (Figures 5.1 to 5.4), LCA stimulates 
all these longevity-defining processes in mitochondria of yeast cells that have entered the PD 
phase of growth (Figure 5.8). Furthermore, a sustained ability of LCA to increase the levels of 
mtDNA-binding proteins during PD growth phase (Figures 5.1 to 5.4) enables it to support 
mitochondrial nucleoid stability and protection from age-related damage (Figure 5.8). Moreover, 
by increasing the levels of numerous mitochondrial proteins integrated into a network of 
antioxidant scavenger reactions for ROS decomposition (Figures 5.1 to 5.4), LCA attenuates 
oxidative damage to mitochondrial proteins, lipids and nucleic acids (Figure 5.8). In addition, the 
altered functionality of mitochondria in cells cultured with LCA triggers mitochondria-to-
nucleus signaling that during PD growth phase increases the levels of non-mitochondrial proteins 
involved in the pentose phosphate pathway (Figures 5.1 to 5.4); this pathway is known to 
generate NADPH, the primary source of cellular reducing equivalents required for the reductive 
synthesis of fatty acids, sterols and some amino acids as well as for the protection of numerous 




          During ST phase, LCA within mitochondria maintains its ability to elevate the levels of 
many mitochondrial proteins involved in antioxidant scavenger reactions for ROS decomposition 
(Figures 5.1 to 5.4), thus reducing the extent of oxidative damage to mitochondrial proteins, 
lipids and nucleic acids (Figure 5.8). In addition, LCA attenuates mitochondrial fragmentation 
during ST phase by reducing the levels of the Caf4p and Mdv1p protein components of 
mitochondrial fission machinery (Figures 5.1 to 5.4) - thus delaying an age-related form of 
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programmed apoptotic cell death (Figure 5.8). During ST phase, the altered functionality of 
mitochondria in yeast cultured in the presence of LCA also stimulates several mitochondria-to-
nucleus signaling pathways that differentially affect cellular levels of many non-mitochondrial 
proteins involved in various longevity-defining processes (Figures 5.1 to 5.4). The resulting 
remodeling of these processes outside mitochondria (1) reduces the extent of oxidative damage 
to cytosolic proteins; (2) stimulates protein folding, unfolding and refolding in the cytosol; (3) 
promotes vacuolar and proteasomal protein degradation; (4) slows down amino acid and 
nucleotide synthesis in the cytosol; and (5) decelerates protein synthesis in the cytosol by 
attenuating the assembly of the 40S and 60S ribosomal subunits (Figure 5.8). 
          In the future, it would be important to further explore the following key aspects of the 
mechanism we proposed here, through which yeast mitochondria function as signaling organelles 
orchestrating a stepwise development of a longevity-defining cellular pattern. First, it would be 
intriguing to investigate how several genetic interventions known to cause various changes in the 
mitochondrial membrane lipidome 
273 - 276
 might influence the ability of LCA (1) to extend 
longevity of chronologically aging yeast; (2) to elicit a characteristic set of age-related changes 
in mitochondrial proteome and functionality; and (3) to cause a distinct kind of age-related 
alterations in the levels of proteins outside mitochondria. Second, it would be interesting to 
elucidate how genetic interventions known to alter mitochondrial membrane potential, 
mitochondrial ribosomal proteins, mitochondrial synthesis and assembly of ISCs, mitochondrial 
protein degradation and peptide efflux, or mitochondrial ROS 
18, 19
, would impact the capability 
of LCA to trigger a characteristic pattern of age-related changes in the concentrations of proteins 
located outside of mitochondria. Third, it would be important to use quantitative mass 
spectrometry-based metabolomics to investigate the characteristic anti-aging ʺmetabolic 




Figure 5.8. A model for how LCA-driven changes in mitochondrial proteome and functionality early and late 
in life of chronologically aging yeast orchestrate a stepwise development of an anti-aging cellular pattern and 
its maintenance throughout lifespan.  
From the data of proteomic analysis (Figures 5.1-5.4) and based on the data of biochemical and cell biological 
analyses 
19, 20, 139, 155, 159, 184, 193, 210, 211, 214, 218
, I inferred an outline of metabolic pathways and processes that were 
activated (red arrows) or inhibited (green arrows) in cells cultured with exogenous LCA. Arrows next to the names 
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of metabolites, proteins or processes denote those of them whose concentrations or efficiencies were elevated (red 
arrows) or reduced (green arrows) in cells cultured with exogenous LCA. Abbreviations: Ac-CoA, acetyl-CoA; D, 
diauxic growth phase; EE, ethyl esters; ER, endoplasmic reticulum; EtOH, ethanol; ETC, the mitochondrial electron 
transport chain; FFA, free fatty acids; IMM, inner mitochondrial membrane; LD, lipid droplets; mtDNA, 
mitochondrial DNA; OMM, outer mitochondrial membrane; PD, post-diauxic growth phase; ST, stationary growth 
phase; TAG, triacylglycerols; TCA, the tricarboxylic acid cycle in mitochondria. See text for details. 
 
5.5 Conclusions 
Using quantitative mass spectrometry in the studies described in this Chapter of my thesis, I 
demonstrated that LCA alters the age-related dynamics of changes in levels of many 
mitochondrial proteins, as well as numerous proteins in cellular locations outside of 
mitochondria. These proteins belong to two regulons, each modulated by a different 
mitochondrial dysfunction; I call them a partial mitochondrial dysfunction regulon and an 
oxidative stress regulon. I found that proteins constituting these regulons (1) can be divided into 
several ʺclustersʺ, each of which denotes a distinct type of partial mitochondrial dysfunction that 
elicits a different signaling pathway mediated by a discrete set of transcription factors; (2) exhibit 
three different patterns of the age-related dynamics of changes in their cellular levels; and (3) are 
encoded by genes whose expression is regulated by the transcription factors Rtg1p/Rtg2p/Rtg3p, 
Sfp1p, Aft1p, Yap1p, Msn2p/Msn4p, Skn7p and Hog1p, each of which is essential for longevity 
extension by LCA. My findings suggest that LCA-driven changes in the mitochondrial lipidome 
alter the mitochondrial proteome and functionality, thereby enabling mitochondria to operate as 
signaling organelles that orchestrate the establishment of an anti-aging transcriptional program 
for many longevity-defining nuclear genes. Based on these findings, I proposed a model for how 
such LCA-driven changes early and late in life of chronologically aging yeast cause a stepwise 









6 Mitophagy delays yeast chronological aging because it maintains a healthy population 
of functional mitochondria  
 
6.1 Introduction 
Mitophagy is a key mechanism of mitochondrial quality and quantity control responsible 
for the autophagic degradation of aged, dysfunctional, damaged or excessive mitochondria 
277, 
278
. Mitophagy in mammalian cells is known to be indispensable for several vital biological 
processes underlying organismal aging, development and differentiation, including (1) selective 
degradation of depolarized mitochondria in dopaminergic neurons in the substantia nigra, a 
PINK1/Parkin-dependent process impaired in autosomal recessive forms of Parkinson’s disease; 
(2) massive elimination of mitochondria driven by Nix, a protein in the outer mitochondrial 
membrane, during reticulocyte-to-erythrocyte maturation; and (3) selective clearance of surplus 
mitochondria during white adipose tissue differentiation in an Atg5/Atg7-dependent manner 
278 – 
281
. In contrast, the physiological roles of mitophagy in yeast remain unknown. To examine the 
importance of mitophagy in yeast chronological aging, I investigated how the single-gene-
deletion mutation atg32Δ, eliminating a mitochondrial receptor for selective autophagic removal 
of mitochondria 
213, 278
 impacts the chronological lifespan of yeast cultured under CR conditions. 
I also evaluated how the atg32Δ-dependent mutational block of mitophagy influences the 
efficiency with which LCA extends longevity of chronologically aging yeast. In addition, I 
examined how the atg32Δ mutation influences mitochondrial morphology and function in yeast 
cells cultured with or without LCA.  
 
6.2 Materials and methods 
6.2.1 Strains and media 
The wild-type strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 lys20 
ura30) and mutant strains atg32 (MAT his31 leu20 lys20 ura30 atg32::kanMX4) and 
atg36 (MAT his31 leu20 lys20 ura30 atg36::kanMX4) were used in this study. The 
composition of YEPD (0.2% glucose) medium was as follows: 1% yeast extract, 2% peptone, 
0.2% glucose. Cells were cultured at 30
o
C with rotational shaking at 200 rpm in Erlenmeyer 




6.2.2 A plating assay for the analysis of chronological lifespan 
Cells were grown in YEPD (0.2% glucose) medium at 30
o
C with rotational shaking at 
200 rpm in Erlenmeyer flasks at a flask volume/medium volume ratio of 5:1. A sample of cells 
was removed from each culture at various time points. A fraction of the cell sample was diluted 
in order to determine the total number of cells per ml of culture using a hemacytometer. 10 l of 
serial dilutions (1:10 to 1:10
3
) of cells were applied to the hemacytometer, where each large 
square is calibrated to hold 0.1 l. The number of cells in 4 large squares was then counted and 
an average was taken in order to ensure greater accuracy. The concentration of cells was 
calculated as follows: number of cells per large square x dilution factor x 10 x 1,000 = total 





) of cells were plated onto YEPD (2% glucose) plates in triplicate in 
order to count the number of viable cells per ml of each culture. 100 l of diluted culture was 
plated onto each plate. After a 48-h incubation at 30
o
C, the number of colonies per plate was 
counted. The number of colony forming units (CFU) equals to the number of viable cells in a 
sample. Therefore, the number of viable cells was calculated as follows: number of colonies x 
dilution factor x 10 = number of viable cells per ml. For each culture assayed, % viability of the 
cells was calculated as follows: number of viable cells per ml / total number of cells per ml x 
100%. The % viability of cells in mid-logarithmic phase was set at 100% viability for that 
particular culture. The life span curves for wild-type and some of the mutant strains were also 
validated using a LIVE/DEAD yeast viability kit (Invitrogen) following the manufacturer's 
instructions for stationary-phase cultures.  
 
6.2.3 Pharmacological manipulation of chronological lifespan 
Chronological lifespan analysis was performed as described above in this section. The 
lithocholic (LCA) [#L6250] bile acid was from Sigma. The stock solution of LCA in DMSO was 
made on the day of adding this compound to cell cultures. LCA was added to growth medium at 
the final concentration of 50 µM immediately following cell inoculation into the medium. The 
final concentration of DMSO in yeast cultures supplemented with LCA (and in the 




6.2.4 Monitoring the formation of ROS  
Wild-type and mutant cells grown in YEPD (0.2% glucose) were tested microscopically 
for the production of ROS by incubation with dihydrorhodamine 123 (DHR). In the cell, this 
nonfluorescent compound can be oxidized to the fluorescent chromophore rhodamine 123 by 
ROS. Cells were also probed with a fluorescent counterstain Calcofluor White M2R (CW), 
which stains the yeast cell walls fluorescent blue. CW was added to each sample in order to label 
all cells for their proper visualization. DHR was stored in the dark at –20oC as 50 l aliquots of a 
1 mg/ml solution in ethanol. CW was stored in the dark at –20oC as the 5 mM stock solution in 
anhydrous DMSO (dimethylsulfoxide).  
          The concurrent staining of cells with DHR and CW was carried out as follows. The 
required amounts of the 50 l DHR aliquots (1 mg/ml) and of the 5 mM stock solution of CW 
were taken out of the freezer and warmed to room temperature. The solutions of DHR and CW 
were then centrifuged at 21,000 x g for 5 min in order to clear them of any aggregates of 
fluorophores. For cell cultures with a titre of ~ 10
7
 cells/ml, 100 l was taken out of the culture 
to be treated. If the cell titre was lower, proportionally larger volumes were used. 6 l of the 1 
mg/ml DHR and 1 l of the 5 mM CW solutions were added to each 100 l aliquot of culture. 
After a 2-h incubation in the dark at room temperature, the samples were centrifuged at 21,000 x 
g for 5 min. Pellets were resuspended in 10 l of PBS buffer (20 mM KH2PO4/KOH, pH 7.5, and 
150 mM NaCl). Each sample was then supplemented with 5 l of mounting medium, added to a 
microscope slide, covered with a coverslip, and sealed using nail polish. Once the slides were 
prepared, they were visualized under the Zeiss Axioplan fluorescence microscope mounted with 
a SPOT Insight 2 megapixel color mosaic digital camera. Several pictures of the cells on each 
slide were taken, with two pictures taken of each frame. One of the two pictures was of the cells 
seen through a rhodamine filter in order to detect cells dyed with DHR. The second picture was 
of the cells seen through a DAPI filter in order to visualize CW, and therefore all the cells 
present in the frame. 
          For evaluating the percentage of DHR-positive cells, the UTHSCSA Image Tool (Version 
3.0) software was used to calculate both the total number of cells and the number of stained cells. 
Fluorescence of individual DHR-positive cells in arbitrary units was determined by using the 
UTHSCSA Image Tool software (Version 3.0). In each of 3-5 independent experiments, the 
value of median fluorescence was calculated by analyzing at least 800-1000 cells that were 
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collected at each time point. The median fluorescence values were plotted as a function of the 
number of days cells were cultured.  
 
6.2.5 Monitoring the mitochondrial membrane potential () 
Rhodamine 123 (R123) (Invitrogen) staining for monitoring the mitochondrial membrane 
potential () was performed according to established procedure (Invitrogen manual for the 
Yeast Mitochondrial Stain Sampler Kit). Images were collected with a Zeiss Axioplan 
fluorescence microscope (Zeiss) mounted with a SPOT Insight 2 megapixel color mosaic digital 
camera (Spot Diagnostic Instruments). For evaluating the percentage of R123-positive cells, the 
UTHSCSA Image Tool (Version 3.0) software was used to calculate both the total number of 
cells and the number of stained cells. Fluorescence of individual R123-positive cells in arbitrary 
units was determined by using the UTHSCSA Image Tool software (Version 3.0). In each of 3-6 
independent experiments, the value of median fluorescence was calculated by analyzing at least 
800-1000 cells that were collected at each time point. The median fluorescence values were 
plotted as a function of the number of days cells were cultured.  
 
6.2.6 Immunofluorescence microscopy 
Cell cultures were fixed in 3.7% formaldehyde for 45 min at room temperature. The cells 
were washed in solution B (100 mM KH2PO4/KOH pH 7.5, 1.2 M sorbitol), treated with 
Zymolyase 100T (MP Biomedicals, 1 μg Zymolyase 100T/1 mg cells) for 30 min at 30oC and 
then processed as previously described (Pringle et al., 1991). Monoclonal antibody raised against 
porin (Invitrogen, 0.25 μg/μl in TBSB buffer [20 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mg/ml 
BSA]) was used as a primary antibody. Alexa Fluor 568 goat anti-mouse IgG (Invitrogen, 2 
μg/μl in TBSB buffer) was used as a secondary antibody. The labeled samples were mounted in 
mounting solution (16.7 mM Tris/HCl pH 9.0, 1.7 mg/ml p-phenylenediamine, 83% glycerol). 
Images were collected with a Zeiss Axioplan fluorescence microscope (Zeiss) mounted with a 
SPOT Insight 2 megapixel color mosaic digital camera (Spot Diagnostic Instruments). 
 
6.2.7 Oxygen consumption assay 
The rate of oxygen consumption by yeast cells recovered at various time points was 
measured continuously in a 2-ml stirred chamber using a custom-designed biological oxygen 
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monitor (Science Technical Center of Concordia University) equipped with a Clark-type oxygen 
electrode. 1 ml of YEPD medium supplemented with 0.2% glucose was added to the electrode 
for approximately 5 minutes to obtain a baseline. Cultured cells of a known titre were spun down 
at 3,000 x g for 5 minutes. The resulting pellet was resuspended in YEPD medium supplemented 
with 0.2% glucose and then added to the electrode with the medium that was used to obtain a 





 cells.  
 
6.2.8 Measurement of the frequency of nuclear mutations  
The frequency of spontaneous point mutations in the CAN1 gene of nuclear DNA was 
evaluated by measuring the frequency of mutations that caused resistance to the antibiotic 
canavanine. A sample of cells was removed from each culture at various time-points. Cells were 
plated in triplicate onto YNB (0.67% Yeast Nitrogen Base without amino acids [#DF0919153; 
Fisher Scientific]) plates containing 2% glucose and supplemented with L-canavanine (50 mg/L), 
histidine, leucine, lysine and uracil (#C1625, #H8125, #L8912, #L5751 and #U0750, 
respectively; all from Sigma). In addition, serial dilutions of each sample were plated in triplicate 
onto YP plates containing 2% glucose for measuring the number of viable cells. The number of 
CFU was counted after 4 d of incubation at 30
o
C. For each culture, the frequency of mutations 
that caused resistance to canavanine was calculated as follows: number of CFU per ml on YNB 
plates containing 2% glucose, L-canavanine (50 mg/L), histidine, leucine, lysine and 
uracil/number of CFU per ml on YP plates containing 2% glucose. 
 
6.2.9 Measurement of the frequency of mitochondrial mutations affecting mitochondrial 
components 









mutations in mtDNA affecting essential mitochondrial components was evaluated by measuring 
the fraction of respiratory-competent (rho
+
) yeast cells remaining in their aging population. rho
+
 
cells maintained intact their mtDNA and their nuclear genes encoding essential mitochondrial 
components. Therefore, rho
+
 cells were able to grow on glycerol, a non-fermentable carbon 
source. In contrast, mutant cells deficient in mitochondrial respiration were unable to grow on 







mutations or large deletions rho
-
) or completely lacked this DNA (rho
o
 mutants). Serial dilutions 
of cell samples removed from different phases of growth were plated in triplicate onto YP plates 
containing either 2% glucose or 3% glycerol (#BP229-4; Fisher Scientific) as carbon source. 
Plates were incubated at 30
o
C. The number of CFU on YP plates containing 2% glucose was 
counted after 2 d of incubation, whereas the number of CFU on YP plates containing 3% 











) cells was calculated as follows: 100 – [(number of CFU 
per ml on YP plates containing 3% glycerol/number of CFU per ml on YP plates containing 2% 
glucose)] × 100.  
          The frequency of spontaneous point mutations in the rib2 and rib3 loci of mtDNA was 
evaluated by measuring the frequency of mtDNA mutations that caused resistance to the 
antibiotic erythromycin. These mutations impair only mtDNA. A sample of cells was removed 
from each culture at various time-points. Cells were plated in triplicate onto YP plates containing 
3% glycerol and erythromycin (1 mg/ml) [#227330050; Acros Organics]. In addition, serial 
dilutions of each sample were plated in triplicate onto YP plates containing 3% glycerol as 
carbon source for measuring the number of respiratory-competent (rho
+
) cells. The number of 
CFU was counted after 6 d of incubation at 30
o
C. For each culture, the frequency of mutations 
that caused resistance to erythromycin was calculated as follows: number of CFU per ml on YP 
plates containing 3% glycerol and erythromycin/number of CFU per ml on YP plates containing 
3% glycerol. 
 
6.2.10 Isolation of crude mitochondrial fraction from yeast cells  
6.2.10.1 Reagents 
1. Dithiothreitol (DTT) buffer [100 mM Tris-H2SO4, 10 mM dithiothreitol] 
2. Zymolyase 100T from Arthrobacter luteus (MP Biomedicals) 
3. Zymolyase buffer [1.2 M sorbitol, 20 mM potassium phosphate] 
4. Homogenization buffer [0.6 M sorbitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.2% 
(w/v) BSA]  





Cell cultures were combined in pre-weighed centrifuge bottles and cells were pelleted at 
3,000 × g for 5 min at room temperature using a Beckman JA-10 rotor. The cells were washed 
twice with distilled water, followed by the determination of their wet weight. The cell pellets 
were resuspended in 2 ml/g DTT buffer and incubated on a shaker at 80 rpm for 20 min at 30ºC. 
The cells were pelleted as per initial centrifugation, washed in 7 ml/g Zymolyase buffer without 
Zymolyase and pelleted once more. The cells were incubated on a shaker at 80 rpm for 45 min at 
30ºC with 1 mg/g (wet weight) of Zymolyase-100T in 7 ml/g Zymolyase buffer. Zymolyase was 
used because of its well-known strong lytic activity required to digest yeast cell wall. The 
spheroplasts obtained were then spun down at 2,200 × g for 8 min at 4ºC. All subsequent steps 
were carried out on ice or at 4°C with the use of cut pipette tips to avoid breaking organelles. The 
spheroplasts were resuspended in 6.5 ml/g ice-cold homogenization buffer and washed by 
centrifugation at 2,200 × g for 8 min at 4ºC. The spheroplasts were then mechanically 
homogenized with 15 strokes in 6.5 ml/g ice-cold homogenization buffer to disrupt yeast plasma 
membrane for releasing organelles and cytoplasm. Following the homogenization, the cell debris 
was pelleted by centrifuging at 1,500 × g for 5 min at 4ºC using a Beckman JA-17 rotor. The 
resulting lysate supernatant was subjected to centrifugation twice at 3000 × g for 5 min at 4ºC to 
pellet the nuclei and 12,000 × g for 15 min at 4ºC. The newly obtained pellet contains mostly 
mitochondria, but also the endoplasmic reticulum (ER), Golgi, peroxisomes, lysosomes and 
vacuoles, whereas the supernatant contains the cytosol, microsomes from the ER and vacuoles. 
The pellet was resuspended in 6.5 ml/g in ice-cold homogenizing buffer, spun down for 5 min at 
3,000 × g at 4ºC to obtain a supernatant containing mitochondria, which was then subjected to a 
spin at 12, 000 × g for 15 min at 4ºC. The resulting pellet was resuspended in 3 ml of SEM to be 
overlaid onto a sucrose gradient. 
 
6.2.11 Purification of S. cerevisiae mitochondria devoid of microsomal and cytosolic 
contaminations 
6.2.11.1 Reagents 
1. SEM buffer [250 mM sucrose, 1 mM EDTA, 10 mM Mops (pH 7.2)] 





In order to purify yeast mitochondria from the crude mitochondrial fraction, an 
equilibrium density-gradient centrifugation was performed. Yeast mitochondria have a density of 
1.18 g/cm
3
 whereas 10% and 50% sucrose respectively have a density of 1.10 g/cm
3
 and 1.30 
g/cm
3
. To prepare a sucrose density gradient for the purification of mitochondria, 1.5 ml of 60% 
sucrose in EM buffer was overlaid with 4 ml of 32%, 1.5 ml of 23% and 1.5 ml of 15% sucrose 
in EM buffer, followed by 3 ml of the crude mitochondrial suspension. The sucrose density 
gradient containing the mitochondrial suspension was subjected to centrifugation in a Beckman 
SW41 Ti swinging-bucket rotor at 134,000 × g for 60 min at 4ºC.  The mitochondrial band, 
which was easily distinguishable, appeared at the interface between 60% and 32% sucrose. 
Fractions of 1 ml were recovered using a cut pipette tip and placed in 1.5 ml Eppendorf tubes 
and frozen at -80ºC until use. In order to quickly freeze the mitochondrial fractions, the fractions 
were immersed, with the aid of long tweezers, in a beaker of isopropyl alcohol kept in the -80ºC 
freezer. 
 
6.2.12 Blue-native gel electrophoresis (BN-PAGE) 
6.2.12.1 Equipment 
1. Hoefer SE 400 vertical slab gel electrophoresis unit 
2. Bio Rad Power Pac 3000 Power supply  
 
6.2.12.2 Reagents 
1. 4% acrylamide running gel [1.5 ml AB (acrylamide/bis-acrylamide)-3 mix, 6 ml gel 
buffer 3×, 10.4 ml distilled water, 100 l APS, 10 l TEMED] 
2. 13% acrylamide running gel  
3. 3.5% acrylamide sample gel  
4. Solubilization buffer A [50 mM sodium chloride, 50 mM imidazole/HCl, 2 mM 6-
aminohexanoic acid, 1 mM EDTA, pH 7.0] 
5. Coomassie blue G-250 dye stock [5% wt/vol in 500 mM 6-aminohexanoic acid] 




7. Cathode buffer B/10 [50 mM Tricine, 7.5 mM imidazole, 0.002% Coomassie blue G-250, 
pH 7.0] 
8. Anode buffer [25 mM imidazole, pH 7.0] 
 
6.2.12.3 Procedure 
Mitochondria protein aliquots of 400 g were pelleted by centrifugation at 50,000 × g for 
30 min using a Beckman MLS-50 rotor. The mitochondria pellet was resuspended in 40 l of 
solubilization buffer A and the mitochondria membranes were homogenized by twirling a tiny 
spatula. The detergent digitonin at 20% (3.0 g/g; i.e., 6 l) was added to the homogenate, which 
was incubated for 10 min at room temperature. The sample was subsequently centrifuged at 
20,000 × g for 20 min at room temperature. To the resulting supernatant, 5 l of 5% Coomassie 
blue G-250 dye in 50% glycerol was added at an 8 g/g detergent/dye ratio (i.e., 3 l). The sample 
containing solubilized mitochondrial membrane was loaded to a 0.16 × 0.5 cm well of a gradient 
separation gel with dimensions 1.5 × 14 × 15 cm composed of 4% and 13% acrylamide mixture 
with a sample gel of 3.5% acrylamide. Urease at 1mg/ml was also loaded on an adjacent well 
and used as a molecular marker (10 l urease, 10 l buffer A, 2.4 l 50 % glycerol, 1.6 l 5% 
Coomassie blue G-250). BN-PAGE was performed at 4°C under the following conditions: 300 
ml of Cathode buffer B in the upper chamber and 300 ml of Anode buffer in the lower chamber 
were used and the power supply set at constant 100 V, 15 mA, 400 W until the sample entered 
the gradient gel. Electrophoresis was then continued at 500 V and 15 mA until the blue running 
front moved about a third of the total running distance. At this point, Cathode Buffer B was 
replaced with 300 ml of Cathode buffer B/10 for better detection of faint protein bands and 
electrophoresis was continued for a total of 4 h or until the blue running front was 1 cm from the 
bottom of the gel. Once electrophoresis was completed the blue native gel stained with 
Coomassie blue G-250 was photographed, documented and stored at 4°C. 
 
6.2.13 Tricine-SDS-PAGE  
6.2.13.1 Equipment 
1. Hoefer SE 400 vertical slab gel electrophoresis unit 





1. 10%T, 3%C Tricine-SDS running gel 
2. 10% acrylamide native stacking gel 
3. Anode buffer 10× [1.0 M Tris, 0.225 M HCl, pH 8.9] 
4. Cathode buffer 10× [1.0 M Tris, 1.0 M Tricine, 1% SDS, pH 8.25]  
5. Precision Plus Protein™ Unstained standards 10 - 250 kD (Bio-Rad) 
 
6.2.13.3 Procedure 
A 0.5-cm gel strip was cut from the 1
st
 dimension (1D) BN-PAGE gel and placed on a 
glass plate with the top of the strip to the left and the bottom of the strip to the right. The strip 
was soaked with 5 ml of a solution containing 1% SDS and 1% mercaptoethanol for 2 h at room 
temperature. Following the incubation, the strip was thoroughly rinsed with water and squeezed 
in between 1.5-mm spacers and 18 × 16 cm glass plates. A 30-ml separating gel mixture 
composed of 10%T, 3%C Tricine-SDS was poured in between the glass plates leaving a gap of 
0.5 cm from the native gel strip. After polymerization, a 0.5-cm spacer was inserted between the 
plates, and placed to the right of the gel to create a well to load protein markers. In order to fill 
the 0.5-cm gap between the running gel and the native strip, as well as the space between the 
native gel and the spacers, 5 ml of a 10% acrylamide native gel mixture was used, and Unstained 
protein molecular markers (Bio-Rad) were loaded to the far right of the gel for reference. 
Electrophoresis was performed at constant 200 V, 50 mA, 400 W for 3 h at room temperature. 
 
6.2.14 Silver stain after 1D-BN-PAGE followed by 2D-Tricine-SDS-PAGE 




1. Fixative solution [200 ml methanol, 40 ml acetic acid, 40 ml Fixative Enhancer solution, 
120 ml distilled water] 
2. Staining solution [35 ml distilled water, 5 ml Silver complex solution, 5 ml Reduction 




3. Stop solution [5% acetic acid] 
 
6.2.14.2 Procedure 
Once electrophoresis was completed, the gel was incubated in 400 ml of 50% methanol 
on a shaker at 55 rpm for 2 h. The gel was then incubated in 200 ml of the Fixative solution for 
20 min and washed twice with 200 ml of distilled water for 10 min. The gel was then immersed 
in 100 ml of the Staining Solution composed of Silver complex, Reduction Moderator, Image 
Development and Development Accelerator solutions. Once the desired staining intensity was 
reached, development was immediately stopped by incubating the silver stained gel in 400 ml of 
5% acetic acid for 15 min, which was followed by a rinse with 400 ml of distilled water for 5 
min. The gel was then photographed, documented and stored at 4°C in 400 ml of distilled water. 
 
6.2.15 In-gel digestion of proteins separated by 2D-Tricine-SDS-PAGE 
6.2.15.1 Reagents 
1. 30 mM Potassium Ferricyanide  
2. 100 mM Sodium Thiosulfate  
3. 100mM Ammonium Bicarbonate (ABC) 
4. 10 mM Dithiothreitol (DTT) [in 5ml of 100mM Ammonium Bicarbonate (ABC)] 
5. 55 mM Iodoacetamide (IAA) [in 5ml of 100mM Ammonium Bicarbonate (ABC)] 
6. Trypsin, Proteomics Grade (Sigma Aldrich) 
 
6.2.15.2 Procedure 
Once the individual mitochondrial proteins were separated, each band on the 1D BN-2D 
Tricine-SDS gel was cut out with a razor blade and the gel piece was placed in 0.5-ml siliconized 
Eppendorf tubes. The bands were washed with distilled water and destained with 50 l of a 1:1 
mixture of 20 mM potassium ferricyanide and 100 mM sodium thiosulfate for 20 min in the dark 
with occasional vortexing. The destaining solution was removed and the bands were washed 
twice with distilled water. The bands were then incubated in 50 l of acetonitrile (ACN) for 5 
min at 37°C, after which ACN was removed and the bands were dried at 37°C. Next, the 
destained bands were incubated in 50 l of 10 mM dithiothreitol for 30 min at 37°C to reduce 
thiol groups in peptides. DTT was discarded and the bands were incubated in 50 l of 55 mM 
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iodoacetamide for 20 min at 37°C in the dark to remove the residual DTT. IAA was removed and 
the bands were incubated in 50 l of a 1:1 mixture of 100 mM ABC and 50% acetonitrile for 10 
min at 37°C. The mixture was discarded and the bands were incubated twice in 50 l of CAN 
under the same conditions and dried at 37°C. The trypsin and trypsin buffer were prepared as 
follows: (1) 1.6 ml of a 1:1 mixture of 100 mM ABC and 10mM CaCl2 were used to resuspend 
20 g of trypsin; and (2) for protein digest, 50 l of trypsin solution (1 mg/ml) was added to the 
bands, which were then incubated overnight at 37°C.  
 
6.2.16 Extracting peptides from yeast mitochondrial proteins digested with trypsin 
The following day, the samples were spun down and the supernatants containing peptides 
were transferred to new 0.5-ml siliconized Eppendorf tubes. To extract more peptides, the gel 
pieces were subjected to several washes and treatments at room temperature; the supernatants 
were conserved and combined with the first set to extracted peptides. For the first extraction, the 
bands were initially incubated in 50 l of 25 mM ABC for 10 min and then in 50 l of ACN for 
10 min. The samples were spun down and the supernatant were added to the first set of extracted 
peptides.  For the second extraction, the bands were incubated in 50 l of 5% formic acid for 10 
min and then in 50 l of ACN for 10 min. The samples were spun down and the supernatant 
were combined with the first set of extracted peptides. The gel pieces were no longer used and 
discarded. To prevent possible oxidation during storage, 12.5 l of 100 mM DTT was added to 
each set of peptides. The peptides were completely dried in a Speed-Vac at medium temperature 
settings (37°C) for 2 h and stored at -20°C until MS analysis. 
 
6.2.17 Sample preparation for MS analysis 
Dried peptides were resuspended in 20 l of 5% ACN. For each recovered protein band, 
an aliquot of 10 l of dried peptides in 5% ACN was diluted 2-fold in Nano pure water for MS 
analysis. Samples can be stored at -20°C until being subjected to MS analysis. 
 
6.2.18 MS analysis 
Individual proteins composing each band were then identified by reverse phase high 
performance liquid chromatography coupled to mass spectrometry (RP-HPLC/MS) using an 
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LTQ Orbitrap. 3-l aliquots of peptides were separated in ACN gradient using a 100-M 
capillary column packed with C18 mobile phase. 
 
6.2.19 Analysis using the Thermo Proteome Discoverer application and SEQUEST 
Once acquiring time was completed using the LTQ Orbitrap, the raw mass spectrometry 
data file obtained by Xcalibur were analyzed using the Thermo Scientific Xcalibur Proteome 
Discoverer application (version 1.3) hereafter referred to as the Proteome Discoverer. The 
Proteome Discoverer was used to identify individual protein components of the isolated 
mitochondrial respiratory complexes and supercomplexes by comparing the raw data of mass 
spectra of digested fragments to the mass spectra of peptides within the Uniprot FASTA 
database. The analysis by the Proteome Discoverer coupled to the FASTA database was enabled 
by using the peak-finding search engine SEQUEST. The SEQUEST engine processes MS data 
using a peak-finding algorithm to search the raw data for generating a peak probability list with 
relative protein abundances.   
 
6.2.19.1 SEQUEST search wizard within the Proteome Discoverer application 
6.2.19.1.1 Raw file and Scan Range Selection Parameters 
The raw file was selected and the Base peak ion chromatogram appeared to reveal: (1) 
the “Intensity (counts)” corresponding to the intensity of the largest peak in the spectrum; and (2) 
the “Time (min)” showing the retention time (RT). The following algorithm and settings were 
used: 
 
Lower RT Limit (min): The beginning of the RT of the scan range of interest: 10 min. 
Upper RT Limit (min): The end of the retention time of the scan range of interest: 18 min. 
Scan Extraction Parameters 
First mass: The mass of the first precursor ion in the range of ion fragments to search for in the 
database: 350 Daltons (Da). 
Last mass: The mass of the last precursor ion in the range of ion fragments to search for in the 
database: 5000 Daltons (Da). 




Unrecognized charge replacement: Specifies the charge number of the precursor ions: 
Automatic (Default), assigns a charge number of +2 and +3 to the spectrum. 
Intensity threshold: Specifies the intensity threshold below which ions are filtered out. The 
default value of 0.0 was used. 
Minimum ion count: The minimum ion count corresponds to the minimum number of ions that 
must be present in an MS/MS spectrum for it to be included in a search. The default value of 1 
was used. 
S/N threshold: The signal-to-noise threshold is the intensity of the signal to the intensity of the 
background noise. The use of this threshold filters out low-intensity ions that function as a noise. 
The value of 1.5 was used. 
Database: Uniprot_sprot FASTA 
Enzyme: Trypsin 
Missed Cleavages: The maximum number of internal cleavage sites per peptide fragment that is 
acceptable for an enzyme to miss during proteolytic digest. The default value of 2 was used. 
Precursor mass tolerance: The precursor mass tolerance value used for finding peptide 
candidates. The possible range of values is 0.01 to 5000 ppm. The default value of 10 ppm was 
used. 
Fragment mass tolerance: The default mass tolerance value of 0.8 Da was used for matching 
fragment peaks. The possible range of values was 0.0001 to 2.0 Da. 
Ions series calculated: Specifies the ion factors for a, b, c, x, y, and z ions for the experiment 
type. The possible range is 0 through 1.0 for all ion factors. The ion factors used are b ions: 1 and 
y ions :1. 
Search against decoy database: Specifies if the application uses a decoy database in the search; 
the “yes” was used. 
Target FDR (strict): Specifies a strict target false discovery rate (FDR) for peptide matches with 
high confidence. The possible value range of 0.0 to 1.0 was used. The default value of 0.01 (1% 
FDR) was used. 
Target FDR (relaxed): Specifies a relaxed target false discovery rate (FDR) for peptide matches 
with moderate confidence. The possible value range from 0.0 to 1.0 was used. The default value 




6.2.19.1.2 Identification of yeast mitochondria complexes and supercomplexes using the 
Thermo Proteome Search Results Report 
Protein Results Parameters 
The protein page displays all the proteins and their corresponding peptides found in the sample 
during the database search. For each protein, the report shows the following results: 
Accession: The unique identifier was assigned to the protein by the Uniprot FASTA database. 
Description: The name and description of the protein of the identifier appeared in the 
corresponding Accession column.  
Score: The SEQUEST protein score is the sum of all peptide XCorr values above the specified 
score threshold. The score threshold was calculated as “0.8 + peptide charge * peptide relevance 
factor“, where peptide relevance factor has a default value of 0.4. For each spectrum, only the 
highest-scoring match was used. For each spectrum and sequence, the Proteome Discoverer 
application uses only the highest scored peptide.  
Coverage: Represents the percentage of the protein sequence covered by the identified peptides. 
# Proteins: Represents the number of identified proteins in the protein group of a master protein. 
When the Protein Grouping setting is disabled, the #Proteins is always equal to 1.  
# Unique Peptides: Represents the number of peptide sequences unique to a protein. 
# Peptides: Represents the number of different peptide sequences identified in the protein.   
# PSMs: The peptide spectrum matches (PSMs) value corresponds to the total number of 
identified peptide sequences for the protein, including those that have been identified 
redundantly. 
# AAs: Represents the number of amino acid in the sequence length of the protein. 
MW 
kDa
: Represents the calculated molecular weight of the protein. 
Calc. pI: Represents the theoretically calculated isoelectric point, i.e. the pH value at which a 
particular molecule carries no net electrical charge. 
Peptides Results Parameters: For each identified peptide, the report shows the following results: 
Protein Descriptions: Identifies a protein associated with the peptides. This description is taken 
from the Uniprot FASTA file. 
# Proteins: Represents the total number of proteins in which this peptide can be found. 
Probability: Represents the probability score for the peptide. 
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SpScore (search-dependent): Represents the raw value of the preliminary score of the 
SEQUEST algorithm. 
XCorr (search-dependent): Scores the number of fragment ions that are common to two 
different peptides with the same precursor mass; calculates the cross-correlation score for all 
candidate peptides queried from the database. 
Δ Score: A measure of the difference between the top two scores for the peptides identified by 
that spectrum; the Proteome Discoverer application calculates this score as follows: ΔScore = 
Score(Rank N Peptide) – Score(Rank 1 Peptide)/Score(Rank 1 Peptide). 
ΔCn: Represents the normalized score difference between the currently selected PSM and the 
highest-scoring PSM for that spectrum. 
# Missed Cleavages: Represents the number of cleavage sites in a peptide sequence that trypsin 
did not cleave, excluding the cases where the presence of proline prevents trypsin from cleaving 
the peptide bond. 
Peptides Matched: Represents the number of peptides included in the precursor mass tolerance 
window set for the search. 
Charge: Represents the charge state of the peptide. 
Intensity: Represents the intensity of the precursor ion. 
MH+ 
Da
: Represents the protonated monoisotopic mass of the peptide, in Daltons. 
ΔM ppm: Represents the difference between the theoretical mass of the peptide and the 
experimental mass of the precursor ion. 
RT 
min
: Represents the retention time when the peptide was observed, in minutes. 
 
Xcalibur is a registered trademark of Thermo Fisher Scientific Inc. in the United States. 
SEQUEST is a registered trademark of the University of Washington in the United States. 
 
6.2.20 Immunodetection of carbonyl groups in oxidatively damaged cellular proteins  
Total cell lysates were made by vortexing the cells in ice-cold TCL buffer (25 mM 
MOPS/KOH, pH 7.2, 150 mM NaCl, 50 mM DTT, and 1% CHAPS) with glass beads three 
times for 1 min. Lysates were then centrifuged for 5 min at 21,000 × g at 4
o
C, and the 
supernatants of total cell lysates were collected. The carbonyl groups of proteins recovered in 





Oxidation Detection Kit (Chemicon), according to the manufacturer’s instructions. Briefly, total 
cellular proteins were denatured by adding 12% SDS to an equal volume of the total cell lysate 
containing 10 μg of protein. Denatured proteins were incubated with 2,4-dinitrophenylhydrazine 
for 15 min at room temperature. Proteins were separated by 12.5% SDS-PAGE. Immunoblotting 
using a Trans-Blot SD semi-dry electrophoretic transfer system (Bio-Rad) was performed as 
described 
230
. The derivatized carbonyl groups were detected with a 2,4-dinitrophenyl-specific 
antibody (Chemicon) and the Amersham ECL Western Blotting System (GE Healthcare).  
 
6.2.21 Miscellaneous procedures 
Protein concentration in samples of purified mitochondria was determined with an RC 
DC protein assay kit (#500-0122; Bio-Rad) following the manufacturer's instructions.  
          SDS-PAGE and immunoblotting using a Trans-Blot SD semi-dry electrophoretic transfer 
system (#170-3940; Bio-Rad) were performed as previously described 
230
. Blots were decorated 
with monoclonal antibodies raised against porin (#459500; Invitrogen) or polyclonal antisera 
raised against cytochrome c (kind gift of Dr. Roland Lill, Philipps Universität Marburg), 
cytochrome c1, subunit II of cytochrome c oxidase or alpha and beta subunits of the 
mitochondrial F1ATPase (all three antisera were kind gifts of Dr. Carla Koehler, University of 
California, Los Angeles). Antigen-antibody complexes were detected by enhanced 
chemiluminescence using an Amersham ECL Plus Western Blotting Detection Reagents 
(#RPN2132; GE Healthcare).  
          State III and IV respiratory rates measurement using NADH as a respiratory substrate of 
external NADH:quinone oxidoreductase or succinate as a respiratory substrate of complex II, as 
well as uncoupled respiratory rates (UC) measurement in the presence of the uncoupler CCCP 
and a respiratory substrate (NADH or succinate) were performed by polarography of purified 
mitochondria according to established procedures 
282
. The ratios of state III rate/state IV rate 
(i.e., RCR), state III rate/UC rate and ADP/O (i.e., the stoichiometry of coupled oxidation and 
phosphorylation) were calculated as previously described 
283
. Enzymatic activities of 
NADH:decylubiquinone oxidoreductase (NQR; an impaired in proton pumping across the IMM 
analog of the respiratory complex I in higher eukaryotes) 
284
, succinate:decylubiquinone-2,6-
dichlorophenolindophenol oxidoreductase (the respiratory complex II) 
285
, ubiquinol:cytochrome 
c oxidoreductase (the respiratory complex III) 
286





 and F1F0-ATP synthase (the respiratory complex V) 
288
 were determined by established 
methods. 
          Electron microscopy followed by morphometric analyses of the resulting images 
289
 were 
performed according to established procedures. Preparation of cellular extracts and microanalytic 




6.2.22 Statistical analysis 
Statistical analysis was performed using Microsoft Excel’s (2010) Analysis ToolPack-
VBA. All data are presented as mean ± SEM. The p values were calculated using an unpaired 
two-tailed t test. 
 
6.3 Results 
6.3.1 Mitophagy is a longevity assurance process 
As a first step towards addressing a role of selective autophagic mitochondrial removal in 
sustaining essential biological processes in yeast, I evaluated the importance of mitophagy in 
longevity assurance. I compared the chronological lifespan (CLS) of wild-type (WT) strain to 
that of the single-gene-deletion mutant strain atg32Δ, which is impaired only in the mitophagic 
pathway of selective autophagy but not in other pathways of selective or non-selective autophagy 
213, 278
. Both yeast strains were cultured in the nutrient-rich YP (1% yeast extract and 2% 
peptone) medium initially containing low (0.2%) concentration of glucose, a fermentable carbon 
source. Importantly, yeast cells grown under these longevity-extending caloric restriction (CR) 
conditions are not starving 
145
. I found that the atg32Δ mutation substantially shortens both the 
mean and maximum CLS of yeast limited in calorie supply (Figure 6.1). Thus, mitophagy is an 
essential longevity assurance process in chronologically aging yeast grown under CR.  
          The essential role of mitophagy in regulating yeast longevity under CR conditions is 
limited to this form of selective autophagy. Indeed, I found that the single-gene-deletion 
mutation atg36Δ, known to impair only the pexophagic pathway of selective autophagy but not 
mitophagic or any other pathways of selective or non-selective autophagy 
290
, did not influence 




6.3.2 Mitophagy is required for longevity extension by LCA 
We revealed that LCA extends the CLS of yeast grown under CR on 0.2% glucose 
155
. To 
assess a role of selective autophagic mitochondrial removal in longevity extension by LCA, I 
tested if this bile acid added to growth medium at the time of cell inoculation is able to extend 
longevity of the mitophagy-deficient atg32Δ mutant. As I found, the atg32Δ mutation abolishes 
the ability of LCA to increase both the mean and maximum CLS of yeast limited in calorie 
supply (Figure 6.1). Hence, mitophagy is required for longevity extension by LCA in 
chronologically aging yeast grown under CR on 0.2% glucose. Unlike mitophagy, the 
pexophagic form of selective autophagy is not obligatory for the ability of LCA to extend 
longevity of chronologically aging yeast under CR conditions. In fact, the exclusive impairment 
of pexophagy by the single-gene-deletion mutation atg36Δ did not compromise the longevity-




Figure 6.1. Under CR conditions, the atg32Δ-dependent mutational block of mitophagy substantially shortens 
yeast CLS and abolishes the longevity-extending effect of LCA.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose in the 
presence or absence of 50 µM LCA. Effect of the atg32Δ mutation and LCA on survival (A) and on the mean (B) 
and maximum (C) lifespans of chronologically aging yeast grown under CR conditions on 0.2% glucose. Data are 
presented as means ± SEM (n = 6-8; *p < 0.01). Abbreviations: Diauxic (D), logarithmic (L), post-diauxic (PD) or 




Figure 6.2. Under CR conditions, the atg36Δ-dependent mutational block of pexophagy does not alter yeast 
CLS and does not compromise the longevity-extending efficacy of LCA.  
WT and atg36Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose in the 
presence or absence of 50 µM LCA. Effect of the atg36Δ mutation and LCA on survival (A) and on the mean (B) 
and maximum (C) lifespans of chronologically aging yeast grown under CR conditions on 0.2% glucose. Data are 
presented as means ± SEM (n = 5-6; *p < 0.01; ns, not significant). Abbreviations: Diauxic (D), logarithmic (L), 




6.3.3 Macromitophagy defines the size and number of mitochondria, their shape and 
morphology, and their ability to exist as a network  
To provide a mechanistic insight into the demonstrated essential role of mitophagy in 
defining longevity of chronologically aging yeast under CR conditions, I used electron 
microscopy (EM) to compare the age-related dynamics of changes in the size, number and 
morphology of mitochondria in WT cells to that in mitophagy-deficient atg32Δ cells. I found that 
in cells grown under CR on 0.2% glucose and recovered at different periods of CLS, the atg32Δ 
mutation (1) results in accumulation of greatly enlarged mitochondria (Figures 6.3A and 6.3B); 
(2) substantially increases the number of mitochondria (Figures 6.3A and 6.3C); (3) alters 
mitochondrial morphology by elevating the proportion of round-shaped mitochondria, especially 
in cells entered PD growth phase and recovered on day 4 of cell culturing (Figure 6.3A); and (4) 
reduces the length of mitochondrial cristae and alters their morphological appearance (Figure 
6.3A). Furthermore, my indirect immunofluorescence microscopy analysis of cells grown under 
CR on 0.2% glucose and recovered at different periods of CLS revealed that the atg32Δ mutation 
also causes massive fragmentation of the elaborate mitochondrial network seen in WT cells 
(Figures 6.3B and 6.3E). 
          In sum, my microscopical analyses suggest that under CR conditions mitophagy is 
required to maintain a network of mitochondria, perhaps by selectively eliminating individual 
mitochondria segregated from this network due to certain changes in the morphology of their 
cristae. One could envisage that the inability of mitophagy-deficient atg32Δ cells to eliminate 
these morphologically distinct (and possibly dysfunctional) mitochondria following their 
segregation from the mitochondrial network may result in their progressive accumulation with 
age, thereby leading to the establishment of a pro-aging cellular pattern and ultimately shortening 





Figure 6.3. Under CR conditions, the atg32Δ-dependent mutational block of mitophagy alters the age-related 
dynamics of changes in mitochondrial size, number, shape, morphology and network appearance.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose. (A) 
Transmission electron micrographs of WT and atg32Δ cells recovered on day 1, 2 or 4 of cell culturing. M, 
mitochondrion. Bar, 1 μm. (B) Percentage of mitochondria in WT and atg32Δ cells having the indicated relative area 
of mitochondrion section. The relative area of mitochondrion section was calculated as (area of mitochondrion 
section/area of cell section) × 100. Data are presented as means ± SEM (at least 100 cells of each strain were used 
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for morphometric analysis at each time-point). (C) Numbers of mitochondria in WT and atg32Δ cells. The data of 
morphometric analysis are expressed as the number of mitochondria per μm3 of cell section ± SEM (at least 100 
cells of each strain were used for morphometric analysis at each time-point). (D) Morphology of mitochondria in 
WT and atg32Δ cells recovered on day 1, 2 or 4 of cell culturing. Mitochondria were visualized by indirect 
immunofluorescence microscopy using monoclonal anti-porin primary antibodies and Alexa Fluor 568-conjugated 
goat anti-mouse IgG secondary antibodies. (E) The percentage of cells exhibiting fragmented mitochondria was 
calculated. At least 800 cells of each strain were used for quantitation at each time-point. Data are presented as mean 
± SEM (n = 3). 
 
6.3.4 Macromitophagy sustains a healthy population of functional mitochondria 
Based on my finding that mitophagy plays an essential role in preserving the 
mitochondrial network in CR yeast, I hypothesized that this form of selective autophagy is 
required for sustaining a healthy population of functional mitochondria in chronologically aging 
cells. To test the validity of my hypothesis, I assessed the age-related dynamics of changes in 
several vital mitochondrial functions during chronological aging of WT and atg32Δ yeast cells. I 
found that in cells cultured under CR on 0.2% glucose and recovered at different periods of CLS, 
the atg32Δ mutation (1) leads to accumulation of dysfunctional mitochondria exhibiting reduced 
respiration (Figure 6.4A); (2) causes a build-up of dysfunctional mitochondria having a reduced 
electrochemical potential across the inner mitochondrial membrane (IMM) (Figure 6.4B); (3) 
triggers a release of cytochrome c from the intermediate space of mitochondria into the cytosol 
(Figure 6.4C), known to be a hallmark event of mitochondrial outer membrane permeabilization 
(MOMP) 
10
; and (4) reduces the cellular level of ATP (Figure 6.4D), which under CR conditions 
is produced mainly in mitochondria 
189
. All these changes in vital mitochondrial functions were 
observed in mitophagy-deficient atg32Δ cells as early as after 2 days of culturing (Figure 6.4).  
          These findings suggest that under CR conditions mitophagy is required to sustain a healthy 
network of functional mitochondria that actively respire, exhibit high electrochemical potential 
across the IMM, maintain outer mitochondrial membrane impermeability to proteins and 
efficiently synthesize ATP. Thus, it is conceivable that in chronologically aging yeast limited in 
calorie supply mitophagy selectively eliminates dysfunctional mitochondria impaired in vital 





Figure 6.4. Under CR conditions, the atg32Δ-dependent mutational block of mitophagy alters the age-related 
chronology of changes in vital mitochondrial functions.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose. Effect of the 
atg36Δ mutation on the rate of oxygen consumption by cells (A), electrochemical potential across the IMM (ΔΨ) 
(B), level of cytochrome c in purified mitochondria (marked as ″M″) and the cytosolic fraction (marked as ″C″) (C), 
and cellular level of ATP (D). Data in A, B and D are presented as means ± SEM (n = 6-9). 
 
6.3.5 Mitophagy maintains a population of mitochondria whose inner membrane exhibits 
abundant respiratory and non-respiratory protein supercomplexes of distinct 
compositions 
A body of recent evidence supports the view that, instead of existing as separate units 
freely moving within the IMM, individual respiratory protein complexes are assembled into 
supramolecular structures known as respiratory supercomplexes or respirasomes 
235, 236
. Some 
changes in such supramolecular organization of respiratory protein complexes may cause 
detrimental alterations of the mitochondrial respiratory chain, thereby eliciting certain age-
related pathologies 
237
. I therefore hypothesized that the observed inability of prematurely aging 
under CR conditions atg32Δ cells to sustain a healthy population of functional mitochondria 
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(Figure 6.4) may be caused in part by some changes in the abundance and/or composition of 
certain respiratory protein supercomplexes. To validate this hypothesis, I purified mitochondria 
from WT and atg32Δ cells, used digitonin to solubilize protein complexes from the inner 
membrane of these mitochondria, and separated the solubilized protein complexes on a linear 4-
13% acrylamide gradient gel for first-dimension blue native PAGE (1-D BN-PAGE). This 
gradient gel is known to resolve protein complexes within the mass range of 100 kDa - 3 MDa 
238
. My 1-D BN-PAGE analysis revealed that in cells cultured under CR on 0.2% glucose and 
recovered on day 4 of culturing, the atg32Δ mutation reduces the levels of several protein 
complexes in the IMM, including complexes 2, 3, 4 and 5 (Figure 6.5A). Because the molecular 
masses of all these and other protein complexes resolved by 1-D BN-PAGE exceeded 545 kDa, a 
molecular mass of the largest commercially available urease tetramer marker protein (Figure 
6.5A), they represent very large protein supercomplexes assembled from several protein 
complexes 
284
. Noteworthy, my separation of denatured monomeric membrane proteins from 
purified mitochondria by SDS-PAGE and their subsequent quantitative analysis by 
immunoblotting revealed that the atg32Δ mutation does not cause significant changes to the total 
levels of the respiratory complexes III, IV or V (Figures 6.5B and 6.5C). Hence, the observed 
reduction of the levels of protein supercomplexes 2, 3, 4 and 5 in the IMM of atg32Δ cells 
(Figure 6.5A) was not due to a decrease in the total amounts of the respiratory complexes III, IV 
or V. It is conceivable therefore that in the IMM of atg32Δ cells a significant portion of these 
protein supercomplexes undergo a remodeling caused by their complete or partial dissociation 
into individual proteins or small protein subcomplexes.                     
          To define the composition of each of the protein supercomplexes recovered by 1-D BN-
PAGE (Figure 6.5A), I resolved their individual protein components by second-dimension 
tricine-SDS-PAGE (2-D SDS-PAGE), visualized these components by silver staining and 
identified them by mass spectrometry. I found that, in addition to one or more kinds of individual 
respiratory complexes, many protein supercomplexes in the IMM of WT cells contain one or 
more proteins that have not been traditionally viewed as components associated (even 
transiently) with the mitochondrial respiratory chain. These novel protein components of 
respiratory protein supercomplexes in the IMM of WT cells include: (1) the ADP-ATP carrier 
protein Aac2p, a component of supercomplexes 1, 2, 4 and 6; (2) the mitochondrial porin Por1p, 
a component of supercomplexes 1, 2 and 8; (3) the Pda1p, Pdb1p, Lat1p and Lpd1p subunits of 
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the mitochondrial pyruvate dehydrogenase complex, components of the supercomplex 1; (4) the 
mitochondrial external NADH dehydrogenase Nde1p, a component of the supercomplex 1; (5) 
the Kgd1p subunit of the mitochondrial alpha-ketoglutarate dehydrogenase complex, a 
component of the supercomplex 2; (6) the Ald4p isoform of acetaldehyde dehydrogenase, a 
component of the supercomplex 8; and (7) the Idh1p and Idh2p isoforms of isocitrate 
dehydrogenase, a component of the supercomplex 8 (Figure 6.6A; Appendix 3). Moreover, the 
protein supercomplex 5 in the IMM of WT cells is a non-respiratory supercomplex composed of 
many molecules of Yme2p (Figure 6.6A; Appendix 3), an integral IMM protein with a role in 
maintaining mitochondrial nucleoid structure and number. It should be stressed that the atg32Δ 
mutation not only eliminates this non-respiratory supercomplex 5 but also causes a dissociation 
of several proteins or protein complexes from supercomplexes 1, 2, 3, 4, 6, 7 and 8. Some of 
these dissociated in atg32Δ cells proteins or protein complexes are known as components of the 
mitochondrial respiratory chain, including (1) Ndi1p, a dissociated from the supercomplex 1 
oxidoreductase that (akin to the mitochondrial respiratory complex I in higher eukaryotes) 
transfers electrons from NADH to ubiquinone in the respiratory chain but (unlike respiratory 
complex I in higher eukaryotes) does not pump protons; (2) the respiratory complex III, which 
dissociates from supercomplexes 3, 7 and 8; (3) the respiratory complex IV, which dissociates 
from the supercomplex 7; and (4) the respiratory complex V, which dissociates from 
supercomplexes 4, 6 and 8 (Figures 6.6A and 6.6B; Appendix 3). Other of the dissociated in 
atg32Δ cells proteins or protein complexes have not been traditionally viewed as components 
associated (even transiently) with the mitochondrial respiratory chain; they include (1) 
dissociated from the supercomplex 1 subunits Pda1p, Pdb1p, Lat1p and Lpd1p of the 
mitochondrial pyruvate dehydrogenase complex; (2) a dissociated from the supercomplex 1 
mitochondrial external NADH dehydrogenase Nde1p; and (3) a dissociated from the 
supercomplex 2 subunit Kgd1p of the mitochondrial alpha-ketoglutarate dehydrogenase complex 
(Figures 6.6A and 6.6B; Appendix 3).        
          In sum, these data suggest that under CR conditions mitophagy is required to sustain a 
population of mitochondria whose inner membrane exhibits abundant protein supercomplexes, 
each composed of a distinct set of respiratory and non-respiratory protein complexes. Thus, in 
chronologically aging yeast limited in calorie supply mitophagy selectively eliminates 
mitochondria whose inner membrane (1) has reduced levels of respiratory and non-respiratory 
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protein supercomplexes 2, 3, 4 and 5 due to their complete dissociation into individual proteins 
or small protein subcomplexes; (2) accumulates respiratory and non-respiratory protein 
supercomplexes 1, 3, 4, 6, 7 and 8 that lack one or more respiratory complexes; (3) amasses 
respiratory and non-respiratory protein supercomplexes 1, 2 and 8 that lack proteins not 
traditionally viewed as components associated with the mitochondrial respiratory chain; and/or 
(4) has diminished level of the non-respiratory protein supercomplex 5 composed of many 
molecules of Yme2p, an integral IMM protein involved in maintaining mitochondrial nucleoid 
structure and number. 
 
Figure 6.5. Under CR conditions, the atg32Δ mutation reduces the levels of several large protein 
supercomplexes in the IMM, likely due to their dissociation into individual proteins or small protein 
subcomplexes.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose. 
Mitochondria were purified from WT and atg32Δ cells recovered on day 4 of culturing. (A) Digitonin-solubilized 
protein complexes from the inner membrane of these mitochondria were separated on a linear 4-13% acrylamide 
gradient gel for first-dimension blue native PAGE (1-D BN-PAGE). Arrows mark the positions of protein 
supercomplexes 2, 3, 4 and 5 whose levels were reduced in the IMM of atg32Δ cells. (B and C) Equal quantities (10 
μg) of protein from these mitochondria were subjected to first-dimension SDS-PAGE (1-D SDS-PAGE) and 
analyzed by quantitative immunoblotting with antibodies to porin (loading control), Cyt1p (cytochrome c1, a 
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component of the respiratory complex III), Cox2p (subunit II of cytochrome c oxidase, a component of the 
respiratory complex IV) or F1α/β (alpha and beta subunits of the mitochondrial F1ATPase, the respiratory complex 
V). Data in C are presented as means ± SEM (n = 3-4; ns, not significant). 
 
 
Figure 6.6. Under CR conditions, the atg32Δ mutation eliminates the non-respiratory protein supercomplex 5 
in the IMM and alters compositions of other protein supercomplexes recovered by 1-D BN-PAGE.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose. 
Mitochondria were purified from WT and atg32Δ cells recovered on day 4 of culturing. Digitonin-solubilized 
protein supercomplexes from the inner membrane of mitochondria purified from WT (A) or atg32Δ (B) cells were 
separated by first-dimension blue native PAGE (1-D BN-PAGE) and then resolved by second-dimension tricine-
SDS-PAGE (2-D SDS-PAGE). Following silver staining, the separated by 2-D SDS-PAGE proteins were identified 
by mass spectrometry. Arrows in A mark the non-respiratory protein supercomplex 5 lacking in the IMM of atg32Δ 
cells as well as individual proteins or respiratory protein complexes dissociated from other protein supercomplexes 




6.3.6 Mitophagy preserves a population of mitochondria that efficiently couple electron 
transport to ATP synthesis and exhibit high and balanced activities of all five 
oxidative phosphorylation (OXPHOS) complexes 
I sought to investigate whether the mitophagy-deficient atg32Δ cells in which we 
observed reduced abundance and altered composition of the major respiratory and non-
respiratory protein supercomplexes (Figures 6.5 and 6.6) have an impact on the functional state 
of the electron transport and OXPHOS system in the IMM of these prematurely aging mutant 
cells.    
          To attain this objective, I used polarography of mitochondria purified from WT and 
atg32Δ cells for measuring the following three kinds of respiratory rate: (1) the rate of state III 
(also called ADP-stimulated state) respiration 
282, 283
, which was assessed immediately following 
addition of 50 µM ADP to mitochondria supplemented with a respiratory substrate; (2) the rate 
of state IV (also known as resting, basal or ADP-independent state) respiration 
283, 287
, which was 
monitored after the exogenously added ADP was entirely converted to ATP; and (3) the rate of 
uncoupled (UC) respiration 
283, 288
, which was determined after addition of the uncoupler 
carbonyl cyanide m-chlorophenylhydrazone (CCCP) to mitochondria incubated with a 
respiratory substrate in the absence of exogenous ADP. In these polarographic assays, the rates 
of state III, state IV and UC respiration were measured using NADH as a respiratory substrate of 
external NADH:quinone oxidoreductase or succinate as a respiratory substrate of complex II.        
          I found that the atg32Δ mutation significantly reduces the rates of state IV (Figures 6.7D 
and 6.7E) and UC (Figures 6.7G and 6.7H) respiration in the presence of NADH or succinate as 
a respiratory substrate. Both these respiratory rates are known to reflect the capacity of the 
electron transport chain (ETC) in the IMM 
282, 283
. Thus, in cells grown under CR conditions on 
0.2% glucose mitophagy is required to preserve a population of mitochondria that exhibit high 
capacity of electron transport along the respiratory chain.      
          I also found that the atg32Δ mutation considerably decreases (1) the rate of state III 
respiration (Figures 6.7A and 6.7B); (2) the state III rate/state IV rate ratio (known as the 
respiratory control ratio, RCR) (Figures 6.7J and 6.7K); (3) the state III rate/UC rate ratio 
(Figures 6.7M and 6.7N); and (4) the ADP/O ratio (i.e., the number ATP molecules synthesized 
per oxygen atom reduced) (Figures 6.7P and 6.7Q). All these parameters are known to reflect the 
extent of the functional and physical integrity of the IMM; the ADP/O ratio is also a direct 
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measure of the efficacy of coupling between ADP phosphorylation and electron transport along 
the respiratory chain 
282, 283, 288
. I therefore concluded that in yeast cells limited in calorie supply 
macromitophagy is obligatory for sustaining a population of mitochondria that (1) preserve the 
functional and physical integrity of the IMM; and (2) efficiently couple electron transport to ATP 
synthesis. 
          To get insight into the effect of the observed in mitophagy-deficient atg32Δ cells reduced 
abundance and altered composition of the major respiratory and non-respiratory protein 
supercomplexes on the functional state of each of the five OXPHOS protein complexes, I 
measured their enzymatic activities in mitochondria purified from WT and atg32Δ cells grown 
under CR conditions on 0.2% glucose. As I found, the atg32Δ mutation causes a significant 
reduction in enzymatic activities of NADH:decylubiquinone oxidoreductase (NQR; an analog of 
the respiratory complex I in higher eukaryotes that is impaired in proton pumping across the 
IMM), succinate:decylubiquinone-2,6-dichlorophenolindophenol oxidoreductase (the respiratory 
complex II), ubiquinol:cytochrome c oxidoreductase (the respiratory complex III), cytochrome c 
oxidase (the respiratory complex IV) and F1F0-ATP synthase (the respiratory complex V) 
(Figures 6.7C, 6.7F, 6.7I, 6.7L and 6.7O). Noteworthy, the extent of such reduction for the 
respiratory complexes IV and V substantially exceeded that for NQR as well as for the 
respiratory complexes II and III (Figure 6.7R). Hence, in yeast cells limited in calorie supply 
mitophagy is needed for maintaining a population of mitochondria that display high and 
balanced activities of all five OXPHOS complexes. 
          Altogether, my polarographic and enzymatic assays in mitochondria purified from WT and 
atg32Δ cells suggest that in chronologically aging yeast under CR conditions, mitophagy may 
selectively eliminate mitochondria whose inner membrane exhibits (1) a compromised functional 
and physical integrity of the IMM; (2) disproportionally reduced activities of the five OXPHOS 
complexes; (3) a low capacity of electron transport along the respiratory chain; and (4) a reduced 





Figure 6.7. Under CR conditions, the atg32Δ mutation reduces capacity of the mitochondrial ETC, lowers the 
efficacy of coupling between ADP phosphorylation and electron transport, compromises the integrity of the 
IMM, and disproportionally decreases activities of all OXPHOS enzymes.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose. 
Mitochondria were purified from WT and atg32Δ cells recovered on day 4 of culturing. The rates of state III (A and 
B), state IV (D and E) and UC (G and H) respiration were measured using NADH (A, D and G) or succinate (B, E 
and H) as a respiratory substrate. The ratios of state III rate/state IV rate (RCR; J and K), state III rate/UC rate (M 
and N) and ADP/O (P and Q) were determined using NADH (J, M and P) or succinate (K, N and Q) as a respiratory 
substrate. Enzymatic activities of the OXPHOS enzymes NADH:decylubiquinone oxidoreductase (NQR; C), 
succinate:decylubiquinone-2,6-dichlorophenolindophenol oxidoreductase (complex II) (F), ubiquinol:cytochrome c 
oxidoreductase (complex III) (I), cytochrome c oxidase (complex IV) (L) and F1F0-ATP synthase (complex V) (O) 
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were assessed. For each of these OXPHOS enzymes, the ratio “activity in mitochondria of atg32Δ strain/activity in 
mitochondria of WT strain” was calculated (R). 
 
6.3.7 Mitophagy sustains a population of mitochondria that generate low levels of ROS 
and exhibit only a minor oxidative damage to mitochondrial macromolecules 
The available literature supports the view that the multifactorial functional state of the 
mitochondrial ETC and OXPHOS system in the inner membrane of yeast mitochondria (rather 
than just the total number of electrons transported along the respiratory chain) determines the 
rate of mitochondrial ROS production, thereby modulating the extent of oxidative cellular 
damage and other vital processes defining yeast longevity 
185, 186, 291 – 293
. It is well established 
that the functional state of the mitochondrial ETC and coupled OXPHOS system in yeast is 
influenced in part by the rate of mitochondrial respiration, capacity of electron flow through the 
respiratory chain, number and activity of individual OXPHOS enzymes, and relative levels of the 
five OXPHOS complexes 
185, 186, 188, 291, 292
. I demonstrated that in yeast limited in calorie supply, 
the atg32Δ-dependent mutational block of mitophagy reduces mitochondrial respiration, 
decreases capacity of the mitochondrial ETC, lowers the efficacy of coupling between ADP 
phosphorylation and electron transport, and disproportionally lessens activities of all OXPHOS 
enzymes (Figures 6.4A and 6.7). This observation prompted me to investigate if the longevity-
shortening atg32Δ mutation alters the age-related dynamics of changes in mitochondrially 
generated ROS and/or impacts the extent of oxidative damage to mitochondrial macromolecules. 
I found that in chronologically aging yeast cultured under CR on 0.2% glucose and recovered at 
different periods of CLS, the atg32Δ mutation elevates the level of mitochondrially produced 
ROS (Figure 6.8A). Furthermore, my comparative analysis of mitochondria purified from WT 
and atg32Δ mutant cells limited in calorie supply revealed that this mutation increases the extent 
of oxidative carbonylation of mitochondrial proteins (Figures 6.8B and 6.9) and elevates the 
levels of oxidatively damaged mitochondrial membrane lipids (Figure 6.8C). I also observed that 
atg32Δ mutant cells grown under CR on 0.2% glucose exhibited augmented, as compared to WT 




) and point (rib2 and rib3) mutations in mitochondrial 
DNA (mtDNA) (Figures 6.8D and 6.8E) - likely due to an elevated extent of oxidative damage to 




Figure 6.8. Under CR conditions, the atg32Δ mutation increases the level of mitochondrially produced ROS, 
elevates the extent of oxidative damage to mitochondrial proteins and membrane lipids, and rises the 
frequencies of mutations in mtDNA.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose. (A) The 
dynamics of age-dependent changes in the intracellular levels of ROS during chronological aging of yeast. ROS 
were visualized using dihydrorhodamine 123 (DHR). At least 1,000 cells were used for quantitation of DHR 
staining for each of 4 independent experiments. Data are presented as mean  SEM. (B and C) Carbonylated 
proteins (B) and oxidatively damaged membrane lipids (C) in purified mitochondria were determined as described in 
ʺMaterials and Methodsʺ. Data are presented as mean  SEM (n = 2-3). (D) The percentage of respiratory-deficient 
cells unable to grow in medium containing 3% glycerol because they carried large mtDNA deletions (rho
-
) or lacked 
mtDNA (rho
o
). Data are presented as mean  SEM (n = 5). (E) The frequencies of rib2 and rib3 point mutations in 




Figure 6.9. Under CR conditions, the atg32Δ mutation elevates the extent of oxidative damage to 
mitochondrial proteins.  
WT and atg32Δ strains were cultured in the nutrient-rich YP medium initially containing 0.2% glucose. 
Immunodetection of carbonyl groups in oxidatively damaged proteins of purified mitochondria was performed as 
described in ʺMaterials and Methodsʺ. 
 
          Taken together, these findings suggest that under CR conditions mitophagy is required to 
sustain a population of mitochondria that generate low levels of ROS and exhibit only minor 
oxidative damage to mitochondrial proteins, membrane lipids and DNA. Thus, it is conceivable 
that in chronologically aging yeast limited in calorie supply, mitophagy selectively eliminates 
mitochondria producing excessively high concentrations of ROS and accumulating elevated 
levels of macromolecules oxidatively damaged due to their exposure to mitochondrial ROS. One 
could predict that the inability of mitophagy-deficient atg32Δ cells to eliminate these oxidatively 
impaired (and therefore dysfunctional) mitochondria may result in their progressive 




6.4 Discussion and Conclusions 
CR is a diet in which only calorie availability is limited but the supply of amino acids, 
nucleotides, vitamins and other nutrients is not compromised 
294
. This dietary intervention is 
known for its robust longevity-extending and health-improving effects across species 
294 – 298
, 
although recent findings in mice and primates initiated an intense debate over some of the 
beneficial effects attributed to CR 
299, 300
. In this Chapter of my thesis, I provide the first evidence 
that selective autophagic mitochondrial removal plays a pivotal role in longevity extension by a 
CR diet in chronologically aging yeast; such a diet was implemented by culturing yeast cells in a 
nutrient-rich medium initially containing low (0.2%) concentration of glucose, a fermentable 
carbon source. It should be emphasized that under these longevity-extending CR conditions yeast 
cells are not starving but undergo an extensive remodeling of their metabolism in order to match 
the level of ATP produced under longevity-shortening non-CR conditions 
145, 214
. Moreover, the 
findings presented in this Chapter of my thesis also revealed that in chronologically aging yeast 
limited in calorie supply, mitophagy is essential for longevity extension by LCA. This bile acid 
is a potent anti-aging intervention previously shown to act in synergy with CR to enable a 
significant further extension of yeast lifespan under CR conditions by modulating so-called 
“housekeeping” longevity pathways 155, 184. In sum, these findings imply that mitophagy is a 
longevity assurance process that in chronologically aging yeast underlies the synergistic 
beneficial effects of anti-aging dietary and pharmacological interventions (i.e., CR and LCA) on 
lifespan.    
          The data presented in this Chapter of my thesis suggest that mitophagy can maintain 
survival of chronologically aging yeast limited in calorie supply by controlling a compendium of 
vital cellular processes known for their essential roles in defining longevity, as outlined below.  
          First, in short-lived atg32Δ cells we observed significant reduction in the level of ATP, 
which implies that mitophagy can selectively eliminate mitochondria incapable of producing this 
universal energy source in quantities sufficient to drive pro-longevity cellular processes. The 
diminished mitochondrial ATP production we see in mitophagy-deficient atg32Δ cells is likely 
due to their demonstrated inability to sustain a population of functional mitochondria whose 
inner membranes exhibit abundant protein supercomplexes, each composed of a distinct set of 
respiratory and non-respiratory protein complexes. It is conceivable that these atg32Δ cells 
accumulate mitochondria that exhibit (1) a decreased respiration rate; (2) a reduced 
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electrochemical potential across the IMM; (3) an impaired functional and physical integrity of 
the IMM; (4) disproportionally lowered activities of all five OXPHOS complexes; (5) a reduced 
capacity of electron transport along the respiratory chain; and (6) a low efficacy of coupling 
between ADP phosphorylation and electron transport. Within these prematurely aging atg32Δ 
cells, the build-up of these dysfunctional mitochondria can be progressively accelerated by the 
age-related accumulation of mitochondria that (1) generate high levels of ROS; (2) display a 
major oxidative damage to mitochondrial proteins and lipids; and (3) exhibit increased 
frequencies of mtDNA mutations likely caused by excessive levels of mitochondrial ROS. 
          Second, in prematurely aging atg32Δ cells, the substantial rise of ROS in mitochondria, 
the major cellular site of ROS formation as by-products of respiration 
39, 243, 301
, implies that 
mitophagy can selectively eliminate mitochondria incapable of maintaining intracellular ROS 
concentration below a toxic threshold. Because both mitochondrial membranes are permeable to 
the hydrogen peroxide form of ROS 
39, 243, 301
, the elevated ROS production by mitochondria 
accumulating in mitophagy-deficient atg32Δ cells is likely to accelerate yeast aging by causing 
an excessive oxidative damage to extramitochondrial cellular macromolecules. To test the 
validity of this hypothesis, I am currently investigating an impact of the atg32Δ mutation on the 
levels of oxidatively damaged proteins, lipids and nucleic acids that reside outside mitochondria.      
          Third, in short-lived atg32Δ cells, we observed massive fragmentation of the elaborate 
mitochondrial network, reduction of the electrochemical potential across the IMM, release of 
cytochrome c from the intermediate space of mitochondria into the cytosol and an elevated level 
of ROS, implying that mitophagy can selectively eliminate mitochondria that exhibit MOMP and 
the so-called mitochondrial permeability transition (MPT). MOMP is known to trigger apoptotic 
cell death, whereas MPT promotes necrotic cell death 
10, 302
. One could anticipate that the early 
loss of viability by prematurely aging atg32Δ cells demonstrated in this chapter may be due to 
their accelerated apoptotic or necrotic death controlled by mitochondria. It should be emphasized 
that both these cell death modalities have been shown to define yeast longevity 
145, 155, 184, 209, 303
. 
It is conceivable, therefore, that mitophagy can maintain survival of chronologically aging yeast 
limited in calorie supply by eliminating only mitochondria capable of triggering an age-related 
form of apoptotic or necrotic cell death initiated by MOMP and/or MPT. A challenge for the 
future will be to use chronologically aging yeast under CR conditions as a valuable model for 
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elucidating the impact of the atg32Δ mutation on the spatiotemporal dynamics of various 
hallmark events characteristic of apoptotic and necrotic modes of cell death.  
          Fourth, in atg32Δ cells grown under CR conditions, we observed substantial reduction of 
both mitochondrial respiration and the electrochemical potential across the IMM, which has been 
shown to stimulate activity of the cAMP-dependent protein kinase A (PKA) in WT yeast cells 
cultured under conditions of amino acid starvation 
304
. PKA is known to govern several 
longevity-defining processes in chronologically aging yeast 
137
. If activated, this nutrient-sensory 
protein kinase (1) inhibits a housekeeping, anti-aging process of non-selective macroautophagy 
304 – 306
; (2) activates a pro-aging process of protein synthesis in the cytosol (Smets et al., 2010); 
and (3) inhibits nuclear import of Msn2p and Msn4p, thus turning off an anti-aging 
transcriptional program driven by these two stress response transcriptional activators 
307, 308
. One 
could predict that mitophagy can maintain survival of chronologically aging yeast limited in 
calorie supply by eliminating mitochondria exhibiting a decreased respiration rate and a reduced 
electrochemical potential across the IMM, thereby attenuating PKA signalling to establish a pro-
longevity cellular pattern. It would be important to test the validity of this hypothesis in the near 
future by assessing the effects of the atg32Δ mutation on non-selective autophagy, protein 
synthesis in the cytosol, nuclear import of Msn2p and Msn4p, and transcriptional pattern in yeast 
cultured under CR conditions. 
          Another challenge for the future will be to establish which of the numerous morphological 
and physiological features (exhibited by dysfunctional mitochondria that amass in atg32Δ cells) 
direct only a population of dysfunctional mitochondria for selective mitophagic destruction in 
WT cells limited in calorie supply. It would be also important to investigate if in WT cells grown 
under CR, only a pool of Atg32p confined to dysfunctional mitochondria is subjected to 
phosphorylation, as it has been seen in yeast undergoing mitophagy triggered in response to 
nitrogen starvation 
309, 310
. Moreover, it remains to be seen which of the mitophagy-linked 
proteins other than Atg32p (a number of such proteins have been identified in the genome-wide 
screens as products of genes essential for mitophagy 
212, 213
) are involved in macromitophagy in 







7 Integration of peroxisomes into an endomembrane system that governs cellular aging   
 
7.1 Introduction 
A growing body of evidence implies that, in addition to the well known roles of the 
peroxisome in housing fatty acid oxidation and maintaining hydrogen peroxide homeostasis 
311 – 
313
, this organelle is actively involved in organizing the processes of development, differentiation 
and morphogenesis in evolutionarily distant organisms. In mammalian and plant cells, the rate of 
fatty acid metabolism and the efficiency of ROS and reactive nitrogen species (RNS) turnover 
within the peroxisome define the dynamics of changes in the levels of signaling lipids, ROS and 
RNS outside this organelle 
314 – 317
. Following their release from the peroxisome, these signaling 
molecules bind and activate a distinct set of transcription factors that respond by causing global 
changes in gene expression to initiate certain developmental and differentiation programs 
316 – 329
. 
Thus, the peroxisome functions as an intracellular signaling compartment that can orchestrate 
important developmental decisions from inside the cell by modulating the extra-peroxisomal 
concentrations of several potent cellular messengers 
330 – 333
. Furthermore, the peroxisome can 
operate as an organizing platform for several developmental and differentiation programs by 
compartmentalizing the initial steps of plasmalogen biosynthesis in mammalian and nematode 
cells, providing acetyl-CoA for the biosynthesis of melanin and glycerol in fungal cells, and 
carrying out the oxidative decomposition of very long-chain fatty acids, phytanic acid and 
pristanic acid in mammalian cells 
331, 334 – 346
. Moreover, while the peroxisome-associated pools 
of several bifunctional proteins with dual subcellular localization operate in peroxisome 
biogenesis and function, their pools in other organelles organize certain processes of 
development, differentiation and morphogenesis in mammalian, plant and yeast cells 
330, 347 - 357
. 
In addition, the peroxisome provides a template for the formation of the Woronin body, a 
specialized subcellular compartment that in the filamentous fungi Neurospora crassa and 
Aspergillus oryzae is essential for a multistep process in cell morphogenesis initiated by physical 
damage to hyphae 358 – 363. In human cells, the peroxisome can also serve as an intracellular 
platform for the development of the human immunodeficiency virus and rotavirus 
364, 365
. 
          Recent findings have broadened a spectrum of complex biological processes that depend 
on the functional integrity of the peroxisome. Emergent evidence supports the view that such 
peroxisome-confined metabolic processes as fatty acid oxidation, ROS turnover and anaplerotic 
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replenishment of TCA cycle intermediates play essential roles in defining the replicative and 
chronological age of a eukaryotic cell 
157
. Peroxisomal fatty acid oxidation has been shown to 
regulate cellular aging because it operates as a system controller that modulates levels of non-
esterified fatty acids and diacylglycerol by governing lipid dynamics in peroxisomes, lipid 
bodies and the ER 
145, 153, 157
; non-esterified fatty acids are known to accelerate the age-related 
necrotic and apoptotic cell death mechanisms, whereas the diacylglycerol-activated protein 
kinase C signaling sensitizes cells to age-related stresses 
366 – 370
. Furthermore, peroxisomal fatty 
acid oxidation and anaplerotic reactions have been demonstrated to delay cellular aging by 
potentiating the mitochondrial retrograde (RTG) signaling pathway of longevity regulation 
136, 
157, 259, 371 – 375
. Moreover, ROS homeostasis and the extent of macromolecular oxidative damage 
within the peroxisome govern several anti-aging processes confined to this organelle 
157, 376 – 383
. 
          The peroxisome defines the replicative and chronological age of a eukaryotic cell not only 
by operating as a system controller that modulates levels of non-esterified fatty acids and 
diacylglycerol, replenishes TCA cycle intermediates destined for mitochondria, and contributes 
to the maintenance of peroxisomal ROS homeostasis and macromolecular oxidative damage. 
Recent studies have revealed that this organelle can also regulate cellular aging via its 
communication with other cellular compartments. This dynamic communication involves the 
establishment of extensive physical contact between peroxisomes and lipid bodies, maintenance 
of an ER to peroxisome connectivity system, exchange of certain metabolites between 
peroxisomes and other cellular compartments, and bidirectional flow of some protein and lipid 
constituents between peroxisomes and other organelles. In this Chapter of my thesis I summarize 
the evidence that peroxisomes are dynamically integrated into an endomembrane system that 
governs cellular aging. I discuss various strategies through which peroxisomes are integrated into 
this endomembrane system, critically evaluate the molecular mechanisms underlying each of 
these strategies, and analyze the age-related dynamics of communications between peroxisomes 
and other cellular compartments composing the longevity-defining endomembrane system. I also 
outline recent progress in understanding how communications between peroxisomes and other 
cellular compartments within this system influence the development of a pro- or anti-aging 
cellular pattern. Based on the available evidence, I propose a model for the integration of 
peroxisomes into the endomembrane system governing cellular aging.  
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7.2 A role for cytosol-to-peroxisome targeting of Pnc1p in regulating yeast longevity  
Support for a distinctive mechanism that underlies the essential role of peroxisomes in 
regulating cellular aging comes from the observation that Pnc1p, a 




, is targeted from the cytosol to the peroxisome in response to CR and 
various mild stresses 
385
. CR and all of these other “hormetic” stimuli - the term “hormesis” 
refers to a beneficial defense response of an organism to a low-intensity biological stress 
244, 386 – 
388
 - increase the lifespan of replicatively aging yeast in a Pnc1p-dependent manner 
385
. 
Peroxisomal import of Pnc1p under conditions of such longevity-extending hormesis requires the 
peroxisomal targeting signal 2 (PTS2) shuttling receptor Pex7p and the peroxin Pex6p, but does 
not rely on the PTS1 receptor Pex5p 
385
. Such specific peroxisomal targeting of Pnc1p, one of the 
key regulators of replicative aging in yeast 
389
, in response to their exposure to various anti-aging 
exogenous factors suggests that Pnc1p in the peroxisome could modulate some longevity-related 
processes confined to this organelle. What are these processes? 
          The established function of Pnc1p in the nucleus - an organelle to which this protein is also 
sorted from the cytosol in yeast exposed to CR and other hormetic stimuli 
385
 - provides a useful 
hint on the nature of peroxisome-confined processes that could be modulated by Pnc1p under 
these longevity-extending conditions. In the nucleus, Pnc1p depletes the level of nicotinamide, a 
strong non-competitive inhibitor of the NAD
+
-dependent protein deacetylase Sir2p required for 
lifespan extension in yeast under CR conditions 
390
. The resulting Pnc1p-driven activation of 
Sir2p delays replicative aging by suppressing recombination at the ribosomal DNA (rDNA) 
locus, thereby decreasing the efficiency of extrachromosomal rDNA circle (ERC) formation in 
the nucleolus 
389
. It should be stressed that two of the four members of the Sir2p family of 
NAD
+
-dependent protein deacetylases (i.e., sirtuins) in yeast - called Hst3p and Hst4p for being 
Homologs of SIR Two proteins - drive the metabolism of fatty acids by activating acyl-CoA 
synthetases for their short-chain species 
391
. By converting short-chain fatty acids into their 




Figure 7.1. A proposed role for cytosol-to-peroxisome targeting of Pnc1p in regulating longevity of 
replicatively aging yeast.  
If exposed to caloric restriction (CR) and other hormetic anti-aging stimuli, yeast cells respond by targeting Pnc1p - 
a pyrazinamidase/nicotinamidase 1 that converts nicotinamide to nicotinic acid in the NAD
+
 salvage pathway - not 
only to the nucleus but also to the peroxisome. The delivery of Pnc1p to the peroxisome depends on the peroxisomal 
targeting signal 2 (PTS2) shuttling receptor Pex7p. Inside the peroxisome, Pnc1p activates the sirtuins Hst3p and 
Hst4p by reducing the concentration of their non-competitive inhibitor nicotinamide. Using NAD
+
 generated by the 
peroxisomal malate dehydrogenase Mdh3p as a co-substrate in protein deacetylation and ADP-ribosylation 
reactions, the activated Hst3p and Hst4p stimulate acyl-CoA synthetases required for peroxisomal transport and 
oxidation of short-chain fatty acids (SCFA). By reducing the levels of these fatty acids in the cytosol, peroxisomes 
contribute to the beneficial effect of CR and other hormetic stimuli on longevity. See text for details. 
 
transport and metabolism 
391
. It has been proposed that both Hst3p and Hst4p activate these acyl-
CoA synthetases by deacetylating them and cleaving NAD
+
 in each reaction cycle 
391
. Because 
sirtuins are also known for their NAD
+
-dependent ADP-ribosylation activity 
392, 393
, a possibility 
that Hst3p and Hst4p activate acyl-CoA synthetases for short-chain fatty acids in ADP-
ribosylation reactions is also feasible. Altogether, these findings suggest the following 
hypothesis for a role of cytosol-to-peroxisome targeting of Pnc1p in regulating longevity of 
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replicatively aging yeast (Figure 7.1). In response to their exposure to CR and other hormetic 
anti-aging stimuli, yeast cells target Pnc1p not only to the nucleus but also to the peroxisome. 
Following its PTS2- and Pex7p-dependent import into the peroxisome, Pnc1p depletes the level 
of nicotinamide, a strong non-competitive inhibitor of Hst3p and Hst4p. As a co-substrate in 
protein deacetylation and/or ADP-ribosylation reactions, each of these sirtuins could use NAD
+
 
known to be generated by the peroxisomal malate dehydrogenase Mdh3p 
394
. The Pnc1p-
dependent depletion of nicotinamide activates Hst3p and Hst4p; in turn, these sirtuins stimulate 
acyl-CoA synthetases required for peroxisomal transport and oxidation of short-chain fatty acids 
(Figure 7.1). I hypothesize that, by depleting the levels of these fatty acids in the cytosol and/or 
oxidizing them, peroxisomes make an important contribution to the longevity-extending effect of 
CR and other hormetic stimuli. A critical evaluation of the above hypothesis will require testing 
of the localization of Hst3p and Hst4p to the peroxisome, either permanent or triggered in 
response to CR and mild stresses. Another key challenge for the future will be to evaluate the 
ability of peroxisomal acyl-CoA synthetases to undergo reversible deacetylation and/or ADP-
ribosylation in an Hst3p- and/or Hst4p-dependent fashion following exposure of yeast to these 
longevity-extending stimuli. 
 
7.3 The peroxin Pex6p contributes to the maintenance of age asymmetry between the 
mother and daughter yeast cells with respect to segregation of functional 
mitochondria   
Several peroxisomal proteins are known to possess dual subcellular localization and 
function 
330, 395, 396
. While the major, peroxisome-bound portion of each of these proteins controls 
essential processes confined to this organelle, their pools in other organellar compartments 
govern certain developmental, differentiation and morphogenetic programs 
330, 396
. The 
emergeing compendium of these bifunctional peroxisomal proteins with dual subcellular 
localization is on a fast-growing list of the so-called “moonlighting proteins” 397 – 403. By 
analyzing the information on dynamic changes in metabolic status and/or organelle functional 
state within one subcellular location and then moving to other location(s) for initiating an 
adequate response to such changes, these moonlighting proteins integrate various cellular 
activities in space and time 




          The peroxin Pex6p is an AAA ATPase (ATPase associated with various cellular activities) 
whose peroxisome-associated pool has been implicated in peroxisomal protein import 
406 – 408
. In 
the yeast Yarrowia lipolytica Pex6p is a moonlighting protein whose minor portion is confined to 
the ER 
347, 348
. The ER-associated Pex6p is an essential component of protein machinery that 
orchestrates the dimorphic transition from a round yeast form to a filamentous (mycelial) form 
330, 347
. Pex6p, along with other ER components of this machinery, governs this cell polarization 
and differentiation program by driving the delivery of mycelium-specific proteins from the ER to 
the cell surface 
347
. 
          Recently, a list of the “extra-curricular” activities of Pex6p has been updated by including 
to it the essential role that this peroxin plays in regulating yeast longevity. Because the yeast 
Saccharomyces cerevisiae reproduces by asymmetric cell division, replicatively “young” mother 
cells retain such “senescence factors” (also called “aging factors”) as ERCs, oxidatively 
damaged proteins, protein aggregates and dysfunctional mitochondria (Figure 7.2A) 
408 – 415
. 
Their budding progeny therefore retains the full replicative capacity by not inheriting ERCs or 
damaged/aggregated proteins and receiving only functional mitochondria 
411 – 413
. In replicatively 
“old” mother cells, this age asymmetry between the mother and daughter cells is lost. As a result, 
the daughters inherit all four of the known senescence factors (Figure 7.2A) 
408, 412, 413
. It should 
be stressed that the overexpression of Pex6p suppresses the lack of age asymmetry between 
mother and daughter cells in a strain carrying a point mutation in the nuclear gene ATP2 
encoding the ß-subunit of the F1 sector of mitochondrial F0, F1- ATP synthase 
417, 418
. Moreover, 
not only Pex6p - along with yet-to-be-identified cytosolic proteins - facilitates the import of 
Atp2p into mitochondria, but it also drives the segregation of functional mitochondria to 
daughter cells 
418. Therefore, it is conceivable that Pex6p could operate as one of the “filters” 
sequestering dysfunctional mitochondria in the mother cell and/or segregating functional 
mitochondria to the daughter cell (Figures 7.2B and 7.2C). The challenge remains to define the 
mechanisms underlying the ability of Pex6p to facilitate mitochondrial import of Atp2p and to 
maintain the age-related asymmetrical segregation of functional mitochondria between mother 
and daughter cells. Another key challenge for the future will be to establish the mechanism for 
delivery of Pex6p from peroxisomes to mitochondria. Importantly, not only the biogenesis of 
these two organelles is governed by common transcriptional pathways, but they also share 
161 
 
several key components of their division machineries and are linked through mitochondria-to-
peroxisome vesicular traffic (Figures 7.2B and 7.2C) 




Figure 7.2. A proposed role for the mainly peroxisomal protein Pex6p in sequestering dysfunctional 
mitochondria in the mother cell of replicatively aging yeast and/or segregating functional mitochondria to the 
daughter cell. 
(A) In the reproducing by asymmetric cell division yeast Saccharomyces cerevisiae, the budding progeny of 
replicatively “young” mother cells retains the full replicative capacity by not inheriting such “senescence factors” 
(also called “aging factors”) as extrachromosomal rDNA circles (ERC), oxidatively damaged proteins, protein 
aggregates and dysfunctional mitochondria. In contrast, the daughters of replicatively “old” mother cells inherit 
these senescence factors. (B, C) A peroxisome-associated pool of the peroxin Pex6p has been long known for its 
essential role in peroxisomal protein import. An “extra-curricular” activity of this protein consists in driving the 
segregation of functional mitochondria to daughter cells. Pex6p could operate as a “filter” sequestering 
dysfunctional mitochondria in the mother cell (B) and/or segregating functional mitochondria to the daughter cell 
(C). The mechanism underlying such function of Pex6p may involve a recently discovered vesicular traffic between 




7.4 Two mechanisms for preventing the segregation of dysfunctional, oxidatively 
damaged peroxisomes to the daughter yeast cell during mitosis  
Not only do peroxisomes in replicatively aging yeast contribute to selective segregation of 
functional mitochondria to the daughter cell, but they also possess a protein machine that 
governs their own distribution between mother and daughter cells. Recent studies suggested two 
mechanisms by which this protein machine may operate in preventing the inheritance of 
dysfunctional, oxidatively damaged peroxisomes by the daughter cell during mitosis.  
          In S. cerevisiae, the inheritance of peroxisomes by daughter cells relies on the peroxisomal 
protein Inp2p 
421
. By acting as a receptor for the class V myosin motor Myo2p, Inp2p tags 
peroxisomes for their segregation to the daughter cell 
422
. It is conceivable that such Inp2p-
dependent tagging of peroxisomes plays a longevity-extending role by enabling the inheritance 
of only functional peroxisomes by daughter cells. Importantly, the phosphorylation of Inp2p 
makes it susceptible to degradation, thereby impairing the segregation of Inp2p-less peroxisomes 
to the daughter cell 
422, 423
. One could therefore speculate that such phosphorylation and 
degradation target mainly Inp2p on dysfunctional, oxidatively damaged peroxisomes for 
sequestering them in the mother cell. 
          In another yeast species, Y. lipolytica, the inheritance of only newly formed from the ER 
template peroxisomes may prevent the segregation of their oxidatively damaged, “old” 
counterparts to the daughter cell during mitosis 
423
. By possessing a dual role in the formation of 
new peroxisomes from the ER template and in the recruitment of the class V myosin motor 
Myo2p to their membranes, the peroxins Pex3p and Pex3Bp may enable the selective 
segregation of these newly formed peroxisomes to the daughter cell, thereby allowing to retain 
the entire population of dysfunctional, oxidatively damaged peroxisomes in the mother cell 
423
.    
          The challenge remains to define the molecular mechanisms underlying the proposed 
selectivity in 1) phosphorylating Inp2p only on dysfunctional, oxidatively damaged peroxisomes; 
and 2) targeting Myo2p only to the ER-confined pool of Pex3p. 
 
7.5 A model for the integration of peroxisomes into an endomembrane system that 
governs cellular aging 
The evidence summarized here and elsewhere 
157, 330, 396
 implies that peroxisomes 
contribute to the regulation of cellular aging via several different mechanisms. In each of these 
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mechanisms, peroxisomes communicate with other organelles by establishing extensive physical 
contact with lipid bodies, maintaining the ER-peroxisome connectivity, exchanging certain 
metabolites, and/or being involved in the bidirectional flow of some of their protein and lipid 
constituents. Thus, peroxisomes are dynamically integrated into an endomembrane system that 
governs cellular aging. I propose a model for such integration (Figure 7.3). The central tenet of 
this model is that the age-dependent efficiency of protein import into the peroxisome modulates 
the dynamics of its communication with other cellular compartments, thereby influencing several 
longevity regulation pathways that rely on such communication. The overall efficiency of 
peroxisomal protein import is defined by the efficiencies of binding of Pex5p and Pex7p – the 
PTS1 and PTS2 cytosolic shuttling receptors, respectively – to their cargo proteins in the cytosol, 
translocation of the receptor-cargo complexes across the peroxisomal membrane, and receptor 
recycling 
407, 408
. Importantly, the efficiencies of all these processes are reduced with age 
157, 377, 
424
. In the proposed model, if the overall efficiency of protein import into peroxisomes is actively 
maintained at a sufficiently high level, these organelles trigger certain anti-aging processes 
within the endomembrane system governing cellular aging (Figure 7.3). Conversely, if the 
overall efficiency of peroxisomal protein import is lower than this critical level, peroxisomes 
promote the development of a pro-aging pattern within this endomembrane system (Figure 7.3). 
          The model envisions that the efficient Pex5p-dependent peroxisomal import of the ROS 
scavenging enzymes catalase (Cta1p in yeast) and peroxiredoxin (PrxAp in mammals and 
Pmp20p in yeast) in replicatively and chronologically “young” cells aids in minimizing the 
oxidative damage to peroxisomal proteins and membrane lipids (Figure 7.3) 
157, 326, 327
. At the 
surface of the peroxisome, quality control of the Pex5p-driven protein import in these cells is 
governed by the receptor accumulation and degradation in the absence of recycling (RADAR) 
pathway for the recycling of Pex5p 
157, 407, 425
. Inside the peroxisome, the insulin degrading 




Figure 7.3. A model for the dynamic integration of peroxisomes into an endomembrane system governing 
cellular aging.  
Several mechanisms underlie the essential contribution of peroxisomes to the regulation of cellular aging. Each of 
these mechanisms relies on a network of communications between peroxisomes and other organelles through the 
maintenance of the endoplasmic reticulum-peroxisome connectivity, establishment of the extensive physical contact 
with lipid bodies, exchange of certain metabolites, and/or the bidirectional flow of some of their proteins and lipids. 
Thus, peroxisomes are dynamically integrated into an endomembrane system that governs cellular aging. By 
modulating the dynamics of communication between peroxisomes and other cellular compartments, the age-
dependent efficiency of peroxisomal protein import influences a compendium of longevity regulation pathways 
relying on such communication. Peroxisomes promote the development of a pro-aging pattern within an 
endomembrane system governing cellular aging if the overall efficiency of peroxisomal protein import is actively 
maintained at a sufficiently high level. Conversely, peroxisomes trigger certain pro-aging processes within this 
endomembrane system if the overall efficiency of peroxisomal protein import is lower than this critical level. See 
text for details. IDE, insulin degrading enzyme; PexAD, peroxisome-associated protein degradation; pLon, 
peroxisomal Lon protease; RADAR, receptor accumulation and degradation in the absence of recycling; RTG, 





(PexAD)  system carry out the degradation of oxidatively damaged peroxisomal matrix proteins 
that are incapable of supporting the anti-aging processes orchestrated by functionally active 
peroxisomes 
376, 378, 380, 381
. A healthy population of such peroxisomes in “young” cells is also 
sustained by pexophagy, an autophagy-related process in which dysfunctional peroxisomes 
carrying oxidatively damaged proteins are selectively degraded following their sequestration by 
vacuoles of yeast and plant cells or lysosomes of mammalian cells (Figure 7.3) 
378, 426, 427
. In 
plant cells exposed to oxidative stress, the ER-peroxisome connectivity enables the retro-flow of 
oxidatively damaged matrix proteins as well as of membrane proteins and lipids to the ER - 
thereby contributing to the maintenance of a healthy population of functionally active 
peroxisomes 
382, 383
.   
          In the proposed model, peroxisomes in “young” cells not only actively avoid the oxidative 
damage to their protein and lipid constituents but also operate as a signaling platform that, by 
maintaining ROS concentration at a certain “optimal” level, delays cellular aging by inducing 
stress-response hormesis (Figure 7.3) 
157
. At such a level, ROS are unable to elicit substantial 
oxidative damage to cellular macromolecules but can activate several redox signaling networks 
known to elevate the abundance and/or activity of stress-protecting and other anti-aging proteins 
39, 243, 428
. 
          Furthermore, the PTS1 and PTS2 cytosolic shuttling receptors Pex5p and Pex7p drive 
peroxisomal import of Fox1p, Fox2p and Fox3p 
429
. The efficient import of these core enzymes 
of fatty acid β-oxidation into peroxisomes of “young” cells increases the efficacy with which 
they decompose fatty acids derived from triacylglycerols that are synthesized in the ER and 
deposited within lipid bodies 
145, 153, 430, 431
. Due to such accelerated peroxisomal fatty acid 
oxidation and the resulting decrease in the concentrations of non-esterified fatty acids and 
diacylglycerol, “young” cells escape the premature death by resisting lipid-induced necrosis and 
apoptosis and by sustaining stress resistance through the attenuation of diacylglycerol-activated 
protein kinase C signaling (Figure 7.3) 
145, 153, 157
. Another way for the longevity-extending 
acceleration of peroxisomal fatty acid oxidation in “young” cells is the governed by sirtuins 
Hst3p and Hst4p stimulation of acyl-CoA synthetases that are required for peroxisomal transport 
and oxidation of short-chain fatty acids. This anti-aging process is driven by the efficient Pex5p- 
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and Pex7p-dependent peroxisomal import of Mdh3p and Pnc1p for synthesizing a substrate and 
decomposing an inhibitor of the sirtuins, respectively (Figure 7.3).   
          Moreover, the longevity-extending ability of peroxisomes to promote the anti-aging RTG 
signaling pathway of peroxisomes-mitochondria, mitochondria-nucleus and nucleus-peroxisomes 
communications in “young” cells is enhanced by the highly efficient peroxisomal import of 
Fox1p, Fox2p, Fox3p, Cit2p and Cat2p in these cells (Figure 7.3) 
157
. Fox1p, Fox2p and Fox3p 
are involved in the peroxisomal oxidation of fatty acid to acetyl-CoA following their Pex5p- and 
Pex7p-dependent delivery to peroxisomes, whereas the citrate synthase Cit2p and acetyl-
carnitine synthase Cat2p are imported into these organelles with the help of Pex5p to catalyze the 
anaplerotic conversion of acetyl-CoA to citrate and acetyl-carnitine (Figure 7.3) 
157, 259, 373, 428
. 
The longevity-extending RTG signaling pathway in “young” cells is further amplified through 
the Pex11p-driven proliferation of peroxisomes and the resulting increase in the effectiveness 
with which the confined to these organelles fatty acid oxidation and anaplerotic reactions 
replenish TCA cycle intermediates destined for mitochondria (Figure 7.3) 
157, 375, 408
. It should be 
emphasized that, by maintaining the functionality of mitochondria in “young” cells, the 
peroxisome-driven RTG pathway controls the homeostasis of mitochondrial ROS 
157
. This 
enables the ROS-dependent activation of several redox signaling networks aimed at increasing 
the levels of stress-protecting and other anti-aging proteins or post-translationally activating 
some of them (Figure 7.3) 
39, 243, 427
. In the proposed model, the segregation of functional 
mitochondria to the “young” daughter cell and/or the sequestration of dysfunctional 
mitochondria in the “old” mother cell in replicatively aging yeast are/is driven in part by the 
delivery of the peroxin Pex6p from peroxisomes to mitochondria through a mechanism that 
remains to be established (Figure 7.3) 
416, 417
. 
          According to the proposed model, S. cerevisiae Inp2p - a peroxisome-specific receptor for 
the class V myosin motor Myo2p - tags peroxisomes for their segregation to the “young” 
daughter cell in a process that may play a life-extending role by enabling the inheritance of only 
functional peroxisomes (Figure 7.3) 
421, 422
. Furthermore, by possessing a dual role in the 
formation of new peroxisomes from the ER template and in the recruitment of Myo2p to their 
membranes, the Y. lipolytica peroxins Pex3p and Pex3Bp may enable the inheritance of only 
newly formed from the ER template peroxisomes thus preventing the segregation of their 
oxidatively damaged, “old” counterparts to the daughter cell during mitosis (Figure 7.3) 422. 
167 
 
          The proposed model envisions that the overall efficiency of peroxisomal protein import 
gradually decreases with replicative and chronological age (Figure 7.3). A steady, age-related 
increase in the concentration of peroxisome-confined proteins that are oxidatively damaged by 
peroxisomally produced ROS could be the driving force for such deterioration of peroxisomal 
protein import efficiency. The Pex5p-dependent peroxisomal import of catalase - due to the age-
dependent decline in the efficiency of its binding to Pex5p and in the extent of Pex5p recycling - 
is the most sensitive to oxidative damage peroxisomal process 
377, 423
. The resulting deceleration 
of catalase import into peroxisomes increases the extent of oxidative damage to their proteins 
and lipids, thereby initiating the “deterioration spiral” that eventually lowers the overall 
efficiency of peroxisomal protein import below a critical level. Consequently, the role of 
peroxisomes in the regulation of cellular aging is switching from being a platform for activating 
a compendium of anti-aging processes within the endomembrane system governing cellular 
aging to becoming a platform for the development of a pro-aging pattern within this 
endomembrane system 
157
. Specifically, the RADAR pathway, IDE and pLon proteases, PexAD 
system, and pexophagy eventually fail due to the progressive, age-dependent accumulation of 
oxidatively damaged proteins and lipids in peroxisomes. Thus, cellular aging coincides with the 
build-up of dysfunctional peroxisomes that are unable anymore to support the anti-aging 
processes within the endomembrane system governing such aging. Among these impaired anti-
aging processes are (1) the peroxisome- and mitochondria-driven pathways of stress response 
hormesis; (2) the Hst3p/Hst4p-dependent stimulation of acyl-CoA synthetases for peroxisomal 
transport and oxidation of short-chain fatty acids; (3) the RTG signaling pathway of 
peroxisomes-mitochondria, mitochondria-nucleus and nucleus-peroxisomes communications; (4) 
the Pex6p-dependent sequestration of dysfunctional mitochondria in the “old” mother cell and/or 
segregation of functional mitochondria to the “young” daughter cell; and (5) the Inp2p-, Pex3p- 
and Pex3Bp-dependent segregation of functional peroxisomes to the “young” daughter cell 
(Figure 7.3). Moreover, the model foresees that, by being unable to maintain low levels of non-
esterified fatty acids and diacylglycerol, the dysfunctional, oxidatively damaged peroxisomes 
accumulated in aged cells (1) activate the longevity-shortening necrotic and apoptotic cell death 
mechanisms induced by non-esterified fatty acids ; and (2) are unable to attenuate the 





Growing evidence supports the view that peroxisomes govern cellular aging via several 
different mechanisms involving their dynamic communication with other cellular compartments. 
An important conceptual advance in our understanding of the inherent complexity of cellular 
aging is that the age-related dynamics of communications between peroxisomes and various 
other organelles modulates a compendium of longevity regulation pathways. It is conceivable 
therefore that the peroxisome is dynamically integrated into an endomembrane system governing 
cellular aging. Much progress has recently been made in defining how communications between 
peroxisomes and other cellular compartments influence the development of a pro- or anti-aging 
pattern within this endomembrane system. The challenge remains to define the molecular 
mechanisms underlying the integration of peroxisomes into the endomembrane system governing 
cellular aging. Future work will aim at understanding how peroxisomes switch their role in the 
regulation of cellular aging from being a platform for activating a compendium of anti-aging 
processes confined to this endomembrane system in “young” cells to becoming a platform for the 
development of a pro-aging pattern within this endomembrane system in “old” cells. This 
knowledge will provide greater insight into the mechanisms underlying longevity regulation and 
is expected to reveal novel targets for anti-aging pharmaceuticals that can extend longevity by 






















8 Future Directions 
 
          In this thesis, I have presented yeast mitochondria as a signaling platform through which 
longevity-defining cellular patterns can be established. Further investigation into the effects of 
changes in the mitochondrial lipidome (through genetic manipulation 
273 – 276
) will provide 
valuable insight on how LCA is able to extend lifespan, alter the mitochondrial proteome and 
function, and affect specific age-related proteins outside the mitochondrion. Furthermore, 
employing a quantitative, mass spectrometry-based metabolomic analysis of LCA-treated yeast 
cells will allow us to characterize the metabolomic signature of the anti-aging effect that LCA 
induces. 
 With respect to cell death mechanisms, it would interesting to use the atg32Δ mutat yeast 
strain under CR conditions to uncover the impact on various hallmark events that are 
characteristic of apoptotic and necrotic modes of cell death. In addition, the effects of the atg32Δ 
mutation on several processes, including non-selective autophagy, protein synthesis in the 
cytosol, nuclear import of Msn2p and Msn4p, and transcriptional pattern in yeast cultured under 
CR conditions would provide greater insight. 
          In characterizing the atg32Δ mutation, I have presented several morphological and 
physiological features that amass over time and are exhibited by dysfunctional mitochondria. 
Going forward, teasing out which of these features specific to dysfunctional mitochondria result 
in their selection for mitophagy would help to provide insight on this process of selective 
degradation. In this regard, the phosphorylation state of Atg32p is an interesting target for further 
investigation, in light of dysfunctional mitochondria with phosphorylated Atg32p being selected 
for mitophagy, in response to nitrogen starvation 
309, 310
.  While Atg32p is essential for 
mitophagy 
212, 213
, it is currently unclear which other mitophagy-linked proteins or ATG genes 
are involved in macromitophagy and how altering these proteins would impact mitophagy. 
 Looking at the interplay between peroxisomes and mitochondria, another challenge is to 
establish the mechanism through which Pex6p is shuttled from peroxisomes to mitochondria. 
This is of particular interest, considering that the biogenesis of both peroxisomes and 
mitochondria share not only common transcriptional pathways, but also key components of their 
division machineries and are also linked through mitochondria-to-peroxisome vesicular traffic 




 Finally, it would be useful to examine the ability of peroxisomes to play alternating roles 
withing the endomembrane system in cellular aging, whether activating anti-aging processes in 
“young” cells or stimulating a pro-aging pattern in “old” cells. By harnessing this information, 
we can gain a better understanding of life-extending mechanisms at play with respect to cellular 
aging. In turn, this could lead to the possibility of discovering novel targets for therapeutic use, 
which would ultimately attenuate age-related diseases and disorders by modulating the dynamic 
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10.1 Appendix 1. Relative levels of proteins recovered in mitochondria that were purified 
from wild-type cells cultured in the nutrient-rich YP medium initially containing 
0.2% glucose, with 50 µM LCA or without it 
Mitochondria were purified from cells recovered on days 2, 5 and 9 of culturing (D, PD and ST 
growth phases, respectively) as described in ʺMaterials and Methodsʺ. Proteins were identified 
and quantified using MALDI MS peptide mapping as described in ʺMaterials and Methodsʺ. 
Relative levels of proteins in mitochondria of cells cultured in the presence of LCA are presented 
as fold difference relative to those in the absence of LCA (n = 3). 
 
 
Protein  NCBI 
accession 
no. 
Function Protein level 
LCA concentration (µM)  
50 0 
Day 2 (D phase) 
Aco1p NP_013407 Mitochondrial TCA cycle; mtDNA binding and protection 4.23  0.38 1 
Cit1p NP_014398 Mitochondrial TCA cycle 3.14  0.25 1 
Fum1p NP_015061 Mitochondrial TCA cycle 0.24  0.09  1 
Idh1p NP_014361 Mitochondrial TCA cycle; mtDNA binding and protection 4.07  0.25 1 
Idh2p NP_014779 Mitochondrial TCA cycle 2.18  0.36 1 
Kgd1p NP_012141 Mitochondrial TCA cycle; mtDNA binding and protection 4.42  0.19 1 
Kgd2p NP_010432 Mitochondrial TCA cycle; mtDNA binding and protection 3.25  0.13 1 
Lsc1p NP_014785 Mitochondrial TCA cycle; mtDNA binding and protection 0.21  0.06 1 
Lsc2p NP_011760 Mitochondrial TCA cycle 0.25  0.11 1 
Mdh1p NP_012838 Mitochondrial TCA cycle 2.39  0.42 1 
Sdh1p NP_012774 Mitochondrial TCA cycle and ETC 0.32  0.27 1 
Sdh2p NP_013059 Mitochondrial TCA cycle and ETC 0.23  0.13 1 
Sdh3p NP_012781 Mitochondrial TCA cycle and ETC 0.39  0.05 1 
Sdh4p NP_010463 Mitochondrial TCA cycle and ETC 0.28  0.07 1 
Icl1p NP_010991 Mitochondrial TCA cycle 3.17  0.34 1 
Mls1p NP_014282 Mitochondrial TCA cycle 3.44  0.22 1 
Ald4p NP_015019 Mitochondrial ETC; mtDNA binding and protection 4.37  0.51 1 
Atp1p NP_009453 Mitochondrial ETC; mtDNA binding and protection 3.32  0.39 1 
Atp2p NP_012655 Mitochondrial ETC 3.64  0.43 1 
Atp5p NP_010584 Mitochondrial ETC 3.09  0.17 1 
Atp9p NP_013816 Mitochondrial ETC 3.71  0.32 1 
Cobp NP_015109 Mitochondrial ETC 4.29  0.48 1 
Cor1p NP_009508 Mitochondrial ETC 2.25  0.23 1 
Cox1p NP_009305 Mitochondrial ETC 4.17  0.38 1 
Cox2p NP_009326 Mitochondrial ETC 4.36  0.46 1 
Cox3p NP_009328 Mitochondrial ETC 3.22  0.19  1 
Cox11p NP_015193 Mitochondrial ETC 3.44  0.32 1 
Cox14p NP_013577 Mitochondrial ETC 3.65  0.21 1 
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Cyc1p NP_012582 Mitochondrial ETC 4.49  0.58 1 
Gut2p NP_012111 Mitochondrial ETC 3.09  0.17 1 
Nde1p NP_013865 Mitochondrial ETC 0.21  0.06   1 
Nde2p NP_010198 Mitochondrial ETC 0.25  0.12   1 
Ndi1p NP_013586 Mitochondrial ETC 0.30  0.06   1 
Pet100p NP_010364 Mitochondrial ETC 4.33  0.34   1 
Qcr2p NP_015517 Mitochondrial ETC 3.87  0.42   1 
Rip1p NP_010890 Mitochondrial ETC 3.10  0.28   1 
Aat1p NP_012816 Amino acid synthesis in mitochondria 3.74  0.66   1 
Gdh3p NP_009339 Amino acid synthesis in mitochondria 2.46  0.22   1 
Ilv5p NP_013459 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
4.91  0.50   1 
Ilv6p NP_009918 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
3.48  0.47   1 
Lys12p NP_012172 Amino acid biosynthesis in mitochondria 3.80  0.35   1 
Cox10p NP_015153 Heme synthesis and attachment in mitochondria 3.57  0.63   1 
Cyc3p NP_009361 Heme synthesis and attachment in mitochondria 4.17  0.19   1 
Hem14p NP_010930 Heme synthesis and attachment in mitochondria 3.71  0.47   1 
Grx5p NP_015266 Heme synthesis and attachment in mitochondria; ROS 
detoxification in mitochondria 
1.09  0.14   1 
Pos5p NP_015136 Synthesis of NADPH from NADH in mitochondria 3.20  0.28   1 
Ccp1p NP_012992 ROS detoxification in mitochondria 0.92  0.11   1 
Glr1p NP_015234 ROS detoxification in mitochondria 1.08  0.06   1 
Grx2p NP_010801 ROS detoxification in mitochondria 1.04  0.15   1 
Sod2p NP_011872 ROS detoxification in mitochondria 0.89  0.13   1 
Ecm10p NP_010884 Molecular chaperone/stress response protein in mitochondria 0.97  0.19   1 
Hsp60p NP_013360 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
1.13  0.08   1 
Phb1p NP_011656 Molecular chaperone/stress response protein in mitochondria 0.85  0.11   1 
Ssc1p NP_012579 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
0.92  0.34   1 
Mia40p NP_012726 Protein import into mitochondria 3.07  0.34   1 
Tim23p NP_014421 Protein import into mitochondria 4.23  0.67   1 
Caf4p NP_012962 Mitochondrial fission 1.15  0.13   1 
Mdv1p NP_012423 Mitochondrial fission 0.98  0.12   1 
Ifm1p NP_014619 RNA synthesis, processing and translation in mitochondria 3.84  0.56   1 
Mef1p NP_013170 RNA synthesis, processing and translation in mitochondria 4.40  0.41  1 
Mrpl37p NP_009831 RNA synthesis, processing and translation in mitochondria 3.25  0.24   1 
Mrpl40p NP_015152 RNA synthesis, processing and translation in mitochondria 4.57  0.31 1 
Mrpl49p NP_012439 RNA synthesis, processing and translation in mitochondria 3.49  0.53   1 
Mrps12p NP_014434 RNA synthesis, processing and translation in mitochondria 3.11  0.19   1 
Mrps16p NP_015312 RNA synthesis, processing and translation in mitochondria 3.76  0.44   1 
Mrps17p NP_013913 RNA synthesis, processing and translation in mitochondria 3.52  0.32   1 
Nam2p NP_013488 RNA synthesis, processing and translation in mitochondria 0.23  0.13    1 
Rsm25p NP_012179 RNA synthesis, processing and translation in mitochondria 4.16  0.51    1 
Tuf1p NP_014830 RNA synthesis, processing and translation in mitochondria 3.27  0.20    1 
Abf2p NP_013788 mtDNA binding and protection 0.27  0.06    1 
Day 5 (PD phase) 
Aco1p NP_013407 Mitochondrial TCA cycle; mtDNA binding and protection 3.32  0.43    1 
Cit1p NP_014398 Mitochondrial TCA cycle 2.14  0.16    1 
Fum1p NP_015061 Mitochondrial TCA cycle 0.31  0.14 1 
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Idh1p NP_014361 Mitochondrial TCA cycle; mtDNA binding and protection 2.35  0.27    1 
Idh2p NP_014779 Mitochondrial TCA cycle 2.43  0.39    1 
Kgd1p NP_012141 Mitochondrial TCA cycle; mtDNA binding and protection 3.50  0.23     1 
Kgd2p NP_010432 Mitochondrial TCA cycle; mtDNA binding and protection 2.27  0.19     1 
Lsc1p NP_014785 Mitochondrial TCA cycle; mtDNA binding and protection 0.31  0.12 1 
Lsc2p NP_011760 Mitochondrial TCA cycle 0.35  0.08 1 
Mdh1p NP_012838 Mitochondrial TCA cycle 2.62  0.56 1 
Sdh1p NP_012774 Mitochondrial TCA cycle and ETC 0.26  0.10 1 
Sdh2p NP_013059 Mitochondrial TCA cycle and ETC 0.32  0.17 1 
Sdh3p NP_012781 Mitochondrial TCA cycle and ETC 0.29  0.07 1 
Sdh4p NP_010463 Mitochondrial TCA cycle and ETC 0.27  0.13 1 
Icl1p NP_010991 Mitochondrial TCA cycle 2.34  0.21 1 
Mls1p NP_014282 Mitochondrial TCA cycle 2.69  0.34 1 
Ald4p NP_015019 Mitochondrial ETC; mtDNA binding and protection 4.19  0.53 1 
Atp1p NP_009453 Mitochondrial ETC; mtDNA binding and protection 3.42  0.30 1 
Atp2p NP_012655 Mitochondrial ETC 2.47  0.45 1 
Atp5p NP_010584 Mitochondrial ETC 2.75  0.19 1 
Atp9p NP_013816 Mitochondrial ETC 2.51  0.28 1 
Cobp NP_015109 Mitochondrial ETC 4.67  0.66 1 
Cor1p NP_009508 Mitochondrial ETC 2.16  0.34 1 
Cox1p NP_009305 Mitochondrial ETC 3.30  0.51 1 
Cox2p NP_009326 Mitochondrial ETC 3.72  0.22 1 
Cox3p NP_009328 Mitochondrial ETC 3.58  0.41 1 
Cox11p NP_015193 Mitochondrial ETC 2.21  0.14 1 
Cox14p NP_013577 Mitochondrial ETC 2.33  0.27 1 
Cyc1p NP_012582 Mitochondrial ETC 3.49  0.34 1 
Gut2p NP_012111 Mitochondrial ETC 3.64  0.41 1 
Nde1p NP_013865 Mitochondrial ETC 0.32  0.15  1 
Nde2p NP_010198 Mitochondrial ETC 0.29  0.10 1 
Ndi1p NP_013586 Mitochondrial ETC 0.26  0.07 1 
Pet100p NP_010364 Mitochondrial ETC 3.21  0.32 1 
Qcr2p NP_015517 Mitochondrial ETC 3.44  0.53 1 
Rip1p NP_010890 Mitochondrial ETC 3.69  0.41 1 
Aat1p NP_012816 Amino acid synthesis in mitochondria 2.48  0.26 1 
Gdh3p NP_009339 Amino acid synthesis in mitochondria 2.15  0.14 1 
Ilv5p NP_013459 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
3.34  0.33 1 
Ilv6p NP_009918 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
3.47  0.26 1 
Lys12p NP_012172 Amino acid biosynthesis in mitochondria 2.30  0.42 1 
Cox10p NP_015153 Heme synthesis and attachment in mitochondria 2.57  0.54 1 
Cyc3p NP_009361 Heme synthesis and attachment in mitochondria 3.64  0.18 1 
Hem14p NP_010930 Heme synthesis and attachment in mitochondria 2.45  0.23 1 
Grx5p NP_015266 Heme synthesis and attachment in mitochondria; ROS 
detoxification in mitochondria 
3.27  0.31 1 
Pos5p NP_015136 Synthesis of NADPH from NADH in mitochondria 2.33  0.48 1 
Ccp1p NP_012992 ROS detoxification in mitochondria 3.44  0.22 1 
Glr1p NP_015234 ROS detoxification in mitochondria 2.51  0.19 1 
Grx2p NP_010801 ROS detoxification in mitochondria 3.38  0.50 1 
Sod2p NP_011872 ROS detoxification in mitochondria 2.67  0.34 1 
Ecm10p NP_010884 Molecular chaperone/stress response protein in mitochondria 3.27  0.21 1 
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Hsp60p NP_013360 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
2.23  0.42 1 
Phb1p NP_011656 Molecular chaperone/stress response protein in mitochondria 3.54  0.37 1 
Ssc1p NP_012579 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
3.49  0.53 1 
Mia40p NP_012726 Protein import into mitochondria 2.36  0.26 1 
Tim23p NP_014421 Protein import into mitochondria 3.67  0.45 1 
Caf4p NP_012962 Mitochondrial fission 0.88  0.17 1 
Mdv1p NP_012423 Mitochondrial fission 1.12  0.08 1 
Ifm1p NP_014619 RNA synthesis, processing and translation in mitochondria 2.19  0.23 1 
Mef1p NP_013170 RNA synthesis, processing and translation in mitochondria 3.38  0.41 1 
Mrpl37p NP_009831 RNA synthesis, processing and translation in mitochondria 3.66  0.34 1 
Mrpl40p NP_015152 RNA synthesis, processing and translation in mitochondria 3.27  0.29 1 
Mrpl49p NP_012439 RNA synthesis, processing and translation in mitochondria 2.32  0.18 1 
Mrps12p NP_014434 RNA synthesis, processing and translation in mitochondria 2.46  0.32 1 
Mrps16p NP_015312 RNA synthesis, processing and translation in mitochondria 2.23  0.25 1 
Mrps17p NP_013913 RNA synthesis, processing and translation in mitochondria 3.44  0.11 1 
Nam2p NP_013488 RNA synthesis, processing and translation in mitochondria 0.30  0.09 1 
Rsm25p NP_012179 RNA synthesis, processing and translation in mitochondria 3.56  0.38 1 
Tuf1p NP_014830 RNA synthesis, processing and translation in mitochondria 2.47  0.22 1 
Abf2p NP_013788 mtDNA binding and protection 0.28  0.14 1 
Day 9 (ST phase) 
Aco1p NP_013407 Mitochondrial TCA cycle; mtDNA binding and protection 2.19  0.12 1 
Cit1p NP_014398 Mitochondrial TCA cycle 2.27  0.33 1 
Fum1p NP_015061 Mitochondrial TCA cycle 0.42  0.17 1 
Idh1p NP_014361 Mitochondrial TCA cycle; mtDNA binding and protection 2.42  0.31 1 
Idh2p NP_014779 Mitochondrial TCA cycle 1.13  0.14 1 
Kgd1p NP_012141 Mitochondrial TCA cycle; mtDNA binding and protection 2.34  0.29 1 
Kgd2p NP_010432 Mitochondrial TCA cycle; mtDNA binding and protection 0.91  0.07 1 
Lsc1p NP_014785 Mitochondrial TCA cycle; mtDNA binding and protection 0.40  0.19 1 
Lsc2p NP_011760 Mitochondrial TCA cycle 0.37  0.11 1 
Mdh1p NP_012838 Mitochondrial TCA cycle 1.08  0.24 1 
Sdh1p NP_012774 Mitochondrial TCA cycle and ETC 0.45  0.16 1 
Sdh2p NP_013059 Mitochondrial TCA cycle and ETC 0.39  0.08 1 
Sdh3p NP_012781 Mitochondrial TCA cycle and ETC 0.47  0.13 1 
Sdh4p NP_010463 Mitochondrial TCA cycle and ETC 0.42  0.10 1 
Icl1p NP_010991 Mitochondrial TCA cycle 1.14  0.22 1 
Mls1p NP_014282 Mitochondrial TCA cycle 1.06  0.16 1 
Ald4p NP_015019 Mitochondrial ETC; mtDNA binding and protection 2.42  0.34 1 
Atp1p NP_009453 Mitochondrial ETC; mtDNA binding and protection 1.21  0.27 1 
Atp2p NP_012655 Mitochondrial ETC 1.14  0.11 1 
Atp5p NP_010584 Mitochondrial ETC 1.32  0.36 1 
Atp9p NP_013816 Mitochondrial ETC 0.93  0.18 1 
Cobp NP_015109 Mitochondrial ETC 1.17  0.23 1 
Cor1p NP_009508 Mitochondrial ETC 1.09  0.12 1 
Cox1p NP_009305 Mitochondrial ETC 1.27  0.10 1 
Cox2p NP_009326 Mitochondrial ETC 1.12  0.15 1 
Cox3p NP_009328 Mitochondrial ETC 1.31  0.36 1 
Cox11p NP_015193 Mitochondrial ETC 0.93  0.21 1 
Cox14p NP_013577 Mitochondrial ETC 0.88  0.09 1 
Cyc1p NP_012582 Mitochondrial ETC 2.39  0.31 1 
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Gut2p NP_012111 Mitochondrial ETC 1.18  0.14 1 
Nde1p NP_013865 Mitochondrial ETC 0.39  0.11 1 
Nde2p NP_010198 Mitochondrial ETC 0.34  0.18 1 
Ndi1p NP_013586 Mitochondrial ETC 0.42  0.22 1 
Pet100p NP_010364 Mitochondrial ETC 2.46  0.33 1 
Qcr2p NP_015517 Mitochondrial ETC 1.19  0.21 1 
Rip1p NP_010890 Mitochondrial ETC 1.27  0.13 1 
Aat1p NP_012816 Amino acid synthesis in mitochondria 0.92  0.15 1 
Gdh3p NP_009339 Amino acid synthesis in mitochondria 0.87  0.09 1 
Ilv5p NP_013459 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
2.45  0.21 1 
Ilv6p NP_009918 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
1.19  0.15 1 
Lys12p NP_012172 Amino acid biosynthesis in mitochondria 1.26  0.27 1 
Cox10p NP_015153 Heme synthesis and attachment in mitochondria 0.91  0.12 1 
Cyc3p NP_009361 Heme synthesis and attachment in mitochondria 2.33  0.19 1 
Hem14p NP_010930 Heme synthesis and attachment in mitochondria 1.12  0.11 1 
Grx5p NP_015266 Heme synthesis and attachment in mitochondria; ROS 
detoxification in mitochondria 
4.67  0.43 1 
Pos5p NP_015136 Synthesis of NADPH from NADH in mitochondria 1.08  0.14 1 
Ccp1p NP_012992 ROS detoxification in mitochondria 3.61  0.32 1 
Glr1p NP_015234 ROS detoxification in mitochondria 3.79  0.41 1 
Grx2p NP_010801 ROS detoxification in mitochondria 4.75  0.27 1 
Sod2p NP_011872 ROS detoxification in mitochondria 3.43  0.18 1 
Ecm10p NP_010884 Molecular chaperone/stress response protein in mitochondria 3.51  0.34 1 
Hsp60p NP_013360 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
3.90  0.59 1 
Phb1p NP_011656 Molecular chaperone/stress response protein in mitochondria 4.49  0.21 1 
Ssc1p NP_012579 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
4.56  0.20 1 
Mia40p NP_012726 Protein import into mitochondria 0.88  0.13 1 
Tim23p NP_014421 Protein import into mitochondria 2.37  0.06 1 
Caf4p NP_012962 Mitochondrial fission 0.21  0.10 1 
Mdv1p NP_012423 Mitochondrial fission 0.26  0.11 1 
Ifm1p NP_014619 RNA synthesis, processing and translation in mitochondria 1.14  0.19 1 
Mef1p NP_013170 RNA synthesis, processing and translation in mitochondria 2.63  0.24 1 
Mrpl37p NP_009831 RNA synthesis, processing and translation in mitochondria 1.18  0.07 1 
Mrpl40p NP_015152 RNA synthesis, processing and translation in mitochondria 2.46  0.15 1 
Mrpl49p NP_012439 RNA synthesis, processing and translation in mitochondria 0.92  0.09 1 
Mrps12p NP_014434 RNA synthesis, processing and translation in mitochondria 1.23  0.21 1 
Mrps16p NP_015312 RNA synthesis, processing and translation in mitochondria 1.06  0.12 1 
Mrps17p NP_013913 RNA synthesis, processing and translation in mitochondria 2.34  0.18 1 
Nam2p NP_013488 RNA synthesis, processing and translation in mitochondria 0.40  0.21 1 
Rsm25p NP_012179 RNA synthesis, processing and translation in mitochondria 2.79  0.36 1 
Tuf1p NP_014830 RNA synthesis, processing and translation in mitochondria 1.17  0.11 1 








10.2 Appendix 2. Relative levels of proteins recovered in total lysates of wild-type cells 
cultured in the nutrient-rich YP medium initially containing 0.2% glucose, with 50 
µM LCA or without it 
For making total lysates, cells were collected at days 2, 5 and 9 of culturing (D, PD and ST 
growth phases, respectively). Proteins were identified and quantified using MALDI MS peptide 
mapping as described in ʺMaterials and Methodsʺ. Relative levels of proteins in cells cultured 
with LCA are presented as fold difference relative to those without of LCA (n = 3). 
 
 
Protein  NCBI 
accession 
no. 




Day 2 (D phase) 
Aco1p NP_013407 Mitochondrial TCA cycle; mtDNA binding and protection 4.09  0.21 1 
Cit1p NP_014398 Mitochondrial TCA cycle 3.45  0.19 1 
Idh1p NP_014361 Mitochondrial TCA cycle; mtDNA binding and protection 4.31  0.33 1 
Kgd1p NP_012141 Mitochondrial TCA cycle; mtDNA binding and protection 4.56  0.61 1 
Sdh1p NP_012774 Mitochondrial TCA cycle and ETC 0.29  0.12 1 
Icl1p NP_010991 Mitochondrial TCA cycle 3.24  0.23 1 
Mls1p NP_014282 Mitochondrial TCA cycle 3.38  0.37 1 
Ald4p NP_015019 Mitochondrial ETC; mtDNA binding and protection 4.41  0.25 1 
Atp1p NP_009453 Mitochondrial ETC; mtDNA binding and protection 3.26  0.11 1 
Gut2p NP_012111 Mitochondrial ETC 3.67  0.54 1 
Ndi1p NP_013586 Mitochondrial ETC 0.28  0.09 1 
Aat1p NP_012816 Amino acid synthesis in mitochondria 3.24  0.22 1 
Gdh3p NP_009339 Amino acid synthesis in mitochondria 2.29  0.16 1 
Ilv5p NP_013459 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
4.42  0.29 1 
Ccp1p NP_012992 ROS detoxification in mitochondria 0.93  0.10 1 
Glr1p NP_015234 ROS detoxification in mitochondria 1.14  0.18 1 
Grx2p NP_010801 ROS detoxification in mitochondria 1.06  0.21 1 
Grx5p NP_015266 ROS detoxification in mitochondria 0.89  0.07 1 
Sod2p NP_011872 ROS detoxification in mitochondria 0.97  0.25 1 
Hsp60p NP_013360 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
1.21  0.13  1 
Ssc1p NP_012579 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
0.86  0.05 1 
Gdb1p NP_015510 Glycogen degradation 3.49  0.24 1 
Gph1p NP_015486 Glycogen degradation 3.27  0.38 1 
Glk1p NP_009890 Glycolysis 4.19  0.16 1 
Hxk1p NP_116711 Glycolysis 4.46  0.29 1 
Pgi1p NP_009755 Glycolysis 3.72  0.53 1 
Tdh2p NP_012542 Glycolysis 3.35  0.24 1 
Rki1p NP_014738 Pentose phosphate pathway 1.19  0.11 1 
Tal1p NP_013458 Pentose phosphate pathway 1.07  0.16 1 
Zwf1p NP_014158 Pentose phosphate pathway 0.92  0.10 1 
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Ach1p NP_009538 Conversion of pyruvate to Ac-CoA 0.28  0.07 1 
Acs2p NP_013254 Conversion of pyruvate to Ac-CoA 1.16  0.12 1 
Ald6p NP_015264 Conversion of pyruvate to Ac-CoA 0.89  0.17 1 
Cat2p NP_013670 Carnitine shuttle 0.97  0.09 1 
Crc1p NP_014743 Carnitine shuttle 1.13  0.18 1 
Yat2p NP_010941 Carnitine shuttle 0.92  0.06 1 
Gpd2p NP_014582 Glycerol-3-P shuttle 0.96  0.11 1 
Gpx2p NP_009803 ROS detoxification in the cytosol 0.90  0.09 1 
Gpx3p NP_012303 ROS detoxification in the cytosol 1.22  0.15 1 
Sod1p NP_012638 ROS detoxification in the cytosol 1.11  0.16 1 
Trr1p NP_010640 ROS detoxification in the cytosol 1.07  0.23 1 
Hsp42p NP_010456 Molecular chaperone/stress response protein in the cytosol 0.88  0.17 1 
Hsp104p NP_013074 Molecular chaperone/stress response protein in the cytosol 0.91  0.06 1 
Ssa1p NP_009396 Molecular chaperone/stress response protein in the cytosol 1.15  0.19 1 
Ssa2p NP_013076 Molecular chaperone/stress response protein in the cytosol 1.19  0.21 1 
Gsh1p NP_012434 Glutathione synthesis in the cytosol 0.83  0.09 1 
Gsh2p NP_014593 Glutathione synthesis in the cytosol 0.96  0.14 1 
Fbp1p NP_013481 Gluconeogenesis in the cytosol 0.22  0.17 1 
Pck1p NP_013023 Gluconeogenesis in the cytosol 0.29  0.06 1 
Pyc1p NP_011453 Gluconeogenesis in the cytosol 0.32  0.14 1 
Adh1p NP_014555 Ethanol synthesis in the cytosol 0.26  0.07 1 
Are1p NP_009978 Synthesis of TAG and EE in the ER and lipid droplets 3.36  0.25 1 
Dga1p NP_014888 Synthesis of TAG in the ER and lipid droplets 4.64  0.41 1 
Gpt2p NP_012993 Synthesis of TAG in the ER and lipid droplets 3.67  0.34 1 
Slc1p NP_010231 Synthesis of TAG in the ER and lipid droplets 4.79  0.19 1 
Tgl1p NP_012782 Lipolysis of TAG and EE in lipid droplets 0.27  0.12 1 
Tgl3p NP_014044 Lipolysis of TAG in lipid droplets 0.26  0.05 1 
Tgl4p NP_013015 Lipolysis of TAG in lipid droplets 0.31  0.16 1 
Tgl5p NP_014724 Lipolysis of TAG in lipid droplets 0.29  0.11 1 
Yeh1p NP_013089 Lipolysis of TAG and EE in lipid droplets 0.32  0.09 1 
Arg1p NP_014583 Amino acid synthesis in the cytosol 0.84  0.15 1 
Aro4p NP_009808 Amino acid synthesis in the cytosol 1.16  0.09 1 
Asn1p NP_015471 Amino acid synthesis in the cytosol 0.94  0.13 1 
Cys4p NP_011671 Amino acid synthesis in the cytosol 0.97  0.18 1 
Gln1p NP_015360 Amino acid synthesis in the cytosol 1.23  0.10  1 
Gly1p NP_010868 Amino acid synthesis in the cytosol 0.91  0.07 1 
Hom3p NP_010972 Amino acid synthesis in the cytosol 1.16  0.15 1 
Met17p NP_013406 Amino acid synthesis in the cytosol 1.07  0.19 1 
Sam4p NP_015050 Amino acid synthesis in the cytosol 1.12  0.11 1 
Trp4p NP_010641 Amino acid synthesis in the cytosol 0.85  0.09 1 
Thr1p NP_011890 Amino acid synthesis in the cytosol 0.93  0.13 1 
Ade12p NP_014179 Nucleotide synthesis in the cytosol 0.96  0.21 1 
Amd1p NP_013677 Nucleotide synthesis in the cytosol 1.19  0.08 1 
Hpt1p NP_010687 Nucleotide synthesis in the cytosol 1.08  0.17 1 
Ppr1p NP_013114 Nucleotide synthesis in the cytosol 0.91  0.13 1 
Prs3p NP_011852 Nucleotide synthesis in the cytosol 0.88  0.06 1 
Ura1p NP_012706 Nucleotide synthesis in the cytosol 0.95  0.12 1 
Ura7p NP_009514 Nucleotide synthesis in the cytosol 1.21  0.15 1 
Dim1p NP_015057 Biogenesis of the 40S ribosomal subunit 1.09  0.21 1 
Emg1p NP_013287 Biogenesis of the 40S ribosomal subunit 1.14  0.08 1 
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Ltv1p NP_012779 Biogenesis of the 40S ribosomal subunit 0.83  0.21 1 
Nop1p NP_010270 Biogenesis of the 40S ribosomal subunit 0.92  0.13 1 
Nsr1p NP_011675 Biogenesis of the 40S ribosomal subunit 1.19  0.11 1 
Rps0A/Bp NP_011730 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
0.90  0.17 1 
Rps3p NP_014221 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
1.22  0.07 1 
Rps15p NP_014602 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
1.05  0.19 1 
Rps26A/Bp NP_011326 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
1.17  0.22 1 
Tsr1p NP_010223 Biogenesis of the 40S ribosomal subunit 0.91  0.13 1 
Brx1p NP_014565 Biogenesis of the 60S ribosomal subunit 0.82  0.16 1 
Dbp7p NP_012949 Biogenesis of the 60S ribosomal subunit 1.24  0.09 1 
Nog1p NP_015232 Biogenesis of the 60S ribosomal subunit 1.12  0.27 1 
Nog2p NP_014451 Biogenesis of the 60S ribosomal subunit 0.90  0.11 1 
Nop2p NP_014338 Biogenesis of the 60S ribosomal subunit 0.97  0.19 1 
Nop7p NP_011617 Biogenesis of the 60S ribosomal subunit 1.18  0.13 1 
Nop8p NP_014497 Biogenesis of the 60S ribosomal subunit 1.05  0.22 1 
Nsa1p NP_011404 Biogenesis of the 60S ribosomal subunit 0.88  0.13 1 
Nug1p NP_010921 Biogenesis of the 60S ribosomal subunit 1.26  0.08 1 
Rpf1p NP_011956 Biogenesis of the 60S ribosomal subunit  0.92  0.15 1 
Rpf2p NP_013007 Biogenesis of the 60S ribosomal subunit 1.14  0.18 1 
Rps6A/Bp NP_015235 A protein component of the 40S ribosomal subunit 0.96  0.21 1 
Rps11A/Bp NP_010308 A protein component of the 40S ribosomal subunit 1.22  0.10 1 
Rps23A/Bp NP_015457 A protein component of the 40S ribosomal subunit 1.15  0.24 1 
Rpl6Ap NP_013638 A protein component of the 60S ribosomal subunit 0.91  0.19 1 
Rpl8A/Bp NP_011830 A protein component of the 60S ribosomal subunit 1.26  0.13 1 
Rpl9A/Bp NP_011368 A protein component of the 60S ribosomal subunit 0.87  0.11 1 
Rpl10p NP_013176 A protein component of the 60S ribosomal subunit 1.18  0.15 1 
Rpl21A/Bp NP_009750 A protein component of the 60S ribosomal subunit 0.95  0.23 1 
Rpl27A/Bp NP_011874 A protein component of the 60S ribosomal subunit 1.12  0.17 1 
Rpl31A/Bp NP_010208 A protein component of the 60S ribosomal subunit 0.88  0.20 1 
Rpl34A/Bp NP_010977 A protein component of the 60S ribosomal subunit 1.13  0.05 1 
Npl4p NP_009729 Proteasomal protein degradation 1.17  0.08 1 
Pup1p NP_014800 Proteasomal protein degradation 1.22  0.13 1 
Pup3p NP_011020 Proteasomal protein degradation 0.95  0.16 1 
Rpn5p NP_010134 Proteasomal protein degradation 0.98  0.19 1 
Rpt6p NP_011467 Proteasomal protein degradation 0.87  0.25 1 
Ufd1p NP_011562 Proteasomal protein degradation 1.11  0.09 1 
Pep4p NP_015171 Vacuolar protein degradation 0.89  0.13 1 
Day 5 (PD phase) 
Aco1p NP_013407 Mitochondrial TCA cycle; mtDNA binding and protection 3.43  0.34 1 
Cit1p NP_014398 Mitochondrial TCA cycle 2.35  0.17 1 
Idh1p NP_014361 Mitochondrial TCA cycle; mtDNA binding and protection 2.78  0.21 1 
Kgd1p NP_012141 Mitochondrial TCA cycle; mtDNA binding and protection 3.36  0.11 1 
Sdh1p NP_012774 Mitochondrial TCA cycle and ETC 0.27  0.07 1 
Icl1p NP_010991 Mitochondrial TCA cycle 2.54  0.31 1 
Mls1p NP_014282 Mitochondrial TCA cycle 2.79  0.19 1 
Ald4p NP_015019 Mitochondrial ETC; mtDNA binding and protection 4.71  0.62 1 
Atp1p NP_009453 Mitochondrial ETC; mtDNA binding and protection 3.65  0.40 1 
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Gut2p NP_012111 Mitochondrial ETC 3.28  0.14 1 
Ndi1p NP_013586 Mitochondrial ETC 0.26  0.11 1 
Aat1p NP_012816 Amino acid synthesis in mitochondria 2.77  0.33 1 
Gdh3p NP_009339 Amino acid synthesis in mitochondria 2.49  0.24 1 
Ilv5p NP_013459 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
3.67  0.14 1 
Ccp1p NP_012992 ROS detoxification in mitochondria 3.34  0.21 1 
Glr1p NP_015234 ROS detoxification in mitochondria 2.55  0.19 1 
Grx2p NP_010801 ROS detoxification in mitochondria 3.79  0.35 1 
Grx5p NP_015266 ROS detoxification in mitochondria 3.42  0.27 1 
Sod2p NP_011872 ROS detoxification in mitochondria 2.67  0.16 1 
Hsp60p NP_013360 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
2.39  0.11 1 
Ssc1p NP_012579 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
3.63  0.24 1 
Gdb1p NP_015510 Glycogen degradation 3.40  0.31 1 
Gph1p NP_015486 Glycogen degradation 3.55  0.17 1 
Glk1p NP_009890 Glycolysis 3.74  0.46 1 
Hxk1p NP_116711 Glycolysis 3.39  0.13 1 
Pgi1p NP_009755 Glycolysis 3.68  0.28 1 
Tdh2p NP_012542 Glycolysis 3.85  0.11 1 
Rki1p NP_014738 Pentose phosphate pathway 3.21  0.19 1 
Tal1p NP_013458 Pentose phosphate pathway 2.53  0.32 1 
Zwf1p NP_014158 Pentose phosphate pathway 3.44  0.23 1 
Ach1p NP_009538 Conversion of pyruvate to Ac-CoA 0.27  0.09 1 
Acs2p NP_013254 Conversion of pyruvate to Ac-CoA 3.59  0.17 1 
Ald6p NP_015264 Conversion of pyruvate to Ac-CoA 3.68  0.31 1 
Cat2p NP_013670 Carnitine shuttle 3.75  0.25 1 
Crc1p NP_014743 Carnitine shuttle 3.29  0.07 1 
Yat2p NP_010941 Carnitine shuttle 3.38  0.19 1 
Gpd2p NP_014582 Glycerol-3-P shuttle 2.77  0.42 1 
Gpx2p NP_009803 ROS detoxification in the cytosol 0.93  0.13 1 
Gpx3p NP_012303 ROS detoxification in the cytosol 1.22  0.24 1 
Sod1p NP_012638 ROS detoxification in the cytosol 1.18  0.07 1 
Trr1p NP_010640 ROS detoxification in the cytosol 0.87  0.11 1 
Hsp42p NP_010456 Molecular chaperone/stress response protein in the cytosol 0.96  0.09 1 
Hsp104p NP_013074 Molecular chaperone/stress response protein in the cytosol 0.91  0.15 1 
Ssa1p NP_009396 Molecular chaperone/stress response protein in the cytosol 1.33  0.21 1 
Ssa2p NP_013076 Molecular chaperone/stress response protein in the cytosol 1.25  0.33 1 
Gsh1p NP_012434 Glutathione synthesis in the cytosol 1.17  0.18 1 
Gsh2p NP_014593 Glutathione synthesis in the cytosol 0.85  0.12 1 
Fbp1p NP_013481 Gluconeogenesis in the cytosol 0.28  0.11 1 
Pck1p NP_013023 Gluconeogenesis in the cytosol 0.39  0.09 1 
Pyc1p NP_011453 Gluconeogenesis in the cytosol 0.27  0.15 1 
Adh1p NP_014555 Ethanol synthesis in the cytosol 0.42  0.20 1 
Are1p NP_009978 Synthesis of TAG and EE in the ER and lipid droplets 2.34  0.31 1 
Dga1p NP_014888 Synthesis of TAG in the ER and lipid droplets 3.69  0.44 1 
Gpt2p NP_012993 Synthesis of TAG in the ER and lipid droplets 2.48  0.23 1 
Slc1p NP_010231 Synthesis of TAG in the ER and lipid droplets 3.77  0.17 1 
Tgl1p NP_012782 Lipolysis of TAG and EE in lipid droplets 0.40  0.19 1 
Tgl3p NP_014044 Lipolysis of TAG in lipid droplets 0.33  0.08 1 
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Tgl4p NP_013015 Lipolysis of TAG in lipid droplets 0.29  0.13 1 
Tgl5p NP_014724 Lipolysis of TAG in lipid droplets 0.42  0.10 1 
Yeh1p NP_013089 Lipolysis of TAG and EE in lipid droplets 0.27  0.14 1 
Arg1p NP_014583 Amino acid synthesis in the cytosol 1.12  0.21 1 
Aro4p NP_009808 Amino acid synthesis in the cytosol 0.87  0.19 1 
Asn1p NP_015471 Amino acid synthesis in the cytosol 0.95  0.23 1 
Cys4p NP_011671 Amino acid synthesis in the cytosol 1.24  0.31 1 
Gln1p NP_015360 Amino acid synthesis in the cytosol 1.16  0.08 1 
Gly1p NP_010868 Amino acid synthesis in the cytosol 1.07  0.14 1 
Hom3p NP_010972 Amino acid synthesis in the cytosol 0.91  0.11 1 
Met17p NP_013406 Amino acid synthesis in the cytosol 1.19  0.20 1 
Sam4p NP_015050 Amino acid synthesis in the cytosol 0.85  0.23 1 
Trp4p NP_010641 Amino acid synthesis in the cytosol 0.94  0.12 1 
Thr1p NP_011890 Amino acid synthesis in the cytosol 0.97  0.28 1 
Ade12p NP_014179 Nucleotide synthesis in the cytosol 1.23  0.17 1 
Amd1p NP_013677 Nucleotide synthesis in the cytosol 1.16  0.21 1 
Hpt1p NP_010687 Nucleotide synthesis in the cytosol 0.92  0.14 1 
Ppr1p NP_013114 Nucleotide synthesis in the cytosol 1.12  0.15 1 
Prs3p NP_011852 Nucleotide synthesis in the cytosol 1.19  0.23 1 
Ura1p NP_012706 Nucleotide synthesis in the cytosol 0.84  0.19 1 
Ura7p NP_009514 Nucleotide synthesis in the cytosol 0.95  0.12 1 
Dim1p NP_015057 Biogenesis of the 40S ribosomal subunit 0.88  0.09 1 
Emg1p NP_013287 Biogenesis of the 40S ribosomal subunit 1.22  0.16 1 
Ltv1p NP_012779 Biogenesis of the 40S ribosomal subunit 1.06  0.23 1 
Nop1p NP_010270 Biogenesis of the 40S ribosomal subunit 1.11  0.26 1 
Nsr1p NP_011675 Biogenesis of the 40S ribosomal subunit 0.84  0.11 1 
Rps0A/Bp NP_011730 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
1.15  0.14 1 
Rps3p NP_014221 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
1.23  0.18 1 
Rps15p NP_014602 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
0.92  0.07 1 
Rps26A/Bp NP_011326 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
0.96  0.15 1 
Tsr1p NP_010223 Biogenesis of the 40S ribosomal subunit 1.14  0.23 1 
Brx1p NP_014565 Biogenesis of the 60S ribosomal subunit 1.21  0.12 1 
Dbp7p NP_012949 Biogenesis of the 60S ribosomal subunit 1.06  0.16 1 
Nog1p NP_015232 Biogenesis of the 60S ribosomal subunit 1.28  0.07 1 
Nog2p NP_014451 Biogenesis of the 60S ribosomal subunit 0.94  0.11 1 
Nop2p NP_014338 Biogenesis of the 60S ribosomal subunit 0.91  0.23 1 
Nop7p NP_011617 Biogenesis of the 60S ribosomal subunit 0.86  0.15 1 
Nop8p NP_014497 Biogenesis of the 60S ribosomal subunit 0.97  0.19 1 
Nsa1p NP_011404 Biogenesis of the 60S ribosomal subunit 1.13  0.21 1 
Nug1p NP_010921 Biogenesis of the 60S ribosomal subunit 1.19  0.17 1 
Rpf1p NP_011956 Biogenesis of the 60S ribosomal subunit  1.08  0.12 1 
Rpf2p NP_013007 Biogenesis of the 60S ribosomal subunit 0.94  0.16 1 
Rps6A/Bp NP_015235 A protein component of the 40S ribosomal subunit 0.91  0.27 1 
Rps11A/Bp NP_010308 A protein component of the 40S ribosomal subunit 0.83  0.11 1 
Rps23A/Bp NP_015457 A protein component of the 40S ribosomal subunit 0.88  0.13 1 
Rpl6Ap NP_013638 A protein component of the 60S ribosomal subunit 0.97  0.19 1 
Rpl8A/Bp NP_011830 A protein component of the 60S ribosomal subunit 1.28  0.15 1 
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Rpl9A/Bp NP_011368 A protein component of the 60S ribosomal subunit 1.14  0.18 1 
Rpl10p NP_013176 A protein component of the 60S ribosomal subunit 1.17  0.22 1 
Rpl21A/Bp NP_009750 A protein component of the 60S ribosomal subunit 1.33  0.14 1 
Rpl27A/Bp NP_011874 A protein component of the 60S ribosomal subunit 1.26  0.10 1 
Rpl31A/Bp NP_010208 A protein component of the 60S ribosomal subunit 1.16  0.23 1 
Rpl34A/Bp NP_010977 A protein component of the 60S ribosomal subunit 1.28  0.11 1 
Npl4p NP_009729 Proteasomal protein degradation 1.20  0.18 1 
Pup1p NP_014800 Proteasomal protein degradation 0.94  0.14 1 
Pup3p NP_011020 Proteasomal protein degradation 1.17  0.21 1 
Rpn5p NP_010134 Proteasomal protein degradation 1.31  0.19 1 
Rpt6p NP_011467 Proteasomal protein degradation 1.24  0.13 1 
Ufd1p NP_011562 Proteasomal protein degradation 1.16  0.15 1 
Pep4p NP_015171 Vacuolar protein degradation 1.09  0.27 1 
Day 9 (ST phase) 
Aco1p NP_013407 Mitochondrial TCA cycle; mtDNA binding and protection 2.53  0.34 1 
Cit1p NP_014398 Mitochondrial TCA cycle 2.39  0.26 1 
Idh1p NP_014361 Mitochondrial TCA cycle; mtDNA binding and protection 2.27  0.18 1 
Kgd1p NP_012141 Mitochondrial TCA cycle; mtDNA binding and protection 2.44  0.09 1 
Sdh1p NP_012774 Mitochondrial TCA cycle and ETC 0.41  0.16 1 
Icl1p NP_010991 Mitochondrial TCA cycle 1.18  0.19 1 
Mls1p NP_014282 Mitochondrial TCA cycle 1.23  0.31 1 
Ald4p NP_015019 Mitochondrial ETC; mtDNA binding and protection 2.67  0.43 1 
Atp1p NP_009453 Mitochondrial ETC; mtDNA binding and protection 0.89  0.12 1 
Gut2p NP_012111 Mitochondrial ETC 0.94  0.08 1 
Ndi1p NP_013586 Mitochondrial ETC 0.41  0.15 1 
Aat1p NP_012816 Amino acid synthesis in mitochondria 1.24  0.21 1 
Gdh3p NP_009339 Amino acid synthesis in mitochondria 1.09  0.17 1 
Ilv5p NP_013459 Amino acid biosynthesis in mitochondria; mtDNA binding 
and protection 
2.33  0.13 1 
Ccp1p NP_012992 ROS detoxification in mitochondria 3.41  0.25 1 
Glr1p NP_015234 ROS detoxification in mitochondria 3.28  0.19 1 
Grx2p NP_010801 ROS detoxification in mitochondria 4.65  0.43 1 
Grx5p NP_015266 ROS detoxification in mitochondria 4.34  0.32 1 
Sod2p NP_011872 ROS detoxification in mitochondria 3.42  0.09 1 
Hsp60p NP_013360 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
3.29  0.15 1 
Ssc1p NP_012579 Molecular chaperone/stress response protein in 
mitochondria; mtDNA binding and protection 
4.47  0.21 1 
Gdb1p NP_015510 Glycogen degradation 0.87  0.13 1 
Gph1p NP_015486 Glycogen degradation 1.15  0.19 1 
Glk1p NP_009890 Glycolysis 2.42  0.16 1 
Hxk1p NP_116711 Glycolysis 2.37  0.31 1 
Pgi1p NP_009755 Glycolysis 1.19  0.25 1 
Tdh2p NP_012542 Glycolysis 0.91  0.14 1 
Rki1p NP_014738 Pentose phosphate pathway 3.76  0.42 1 
Tal1p NP_013458 Pentose phosphate pathway 3.47  0.29 1 
Zwf1p NP_014158 Pentose phosphate pathway 3.33  0.12 1 
Ach1p NP_009538 Conversion of pyruvate to Ac-CoA 0.44  0.08 1 
Acs2p NP_013254 Conversion of pyruvate to Ac-CoA 2.49  0.24 1 
Ald6p NP_015264 Conversion of pyruvate to Ac-CoA 2.26  0.17 1 
Cat2p NP_013670 Carnitine shuttle 0.93  0.11 1 
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Crc1p NP_014743 Carnitine shuttle 0.90  0.23 1 
Yat2p NP_010941 Carnitine shuttle 1.32  0.20 1 
Gpd2p NP_014582 Glycerol-3-P shuttle 1.15  0.31 1 
Gpx2p NP_009803 ROS detoxification in the cytosol 2.56  0.27 1 
Gpx3p NP_012303 ROS detoxification in the cytosol 3.43  0.19 1 
Sod1p NP_012638 ROS detoxification in the cytosol 4.65  0.36 1 
Trr1p NP_010640 ROS detoxification in the cytosol 4.79  0.41 1 
Hsp42p NP_010456 Molecular chaperone/stress response protein in the cytosol 3.51  0.13 1 
Hsp104p NP_013074 Molecular chaperone/stress response protein in the cytosol 3.34  0.21 1 
Ssa1p NP_009396 Molecular chaperone/stress response protein in the cytosol 4.87  0.33 1 
Ssa2p NP_013076 Molecular chaperone/stress response protein in the cytosol 4.28  0.16 1 
Gsh1p NP_012434 Glutathione synthesis in the cytosol 3.65  0.24 1 
Gsh2p NP_014593 Glutathione synthesis in the cytosol 3.37  0.18 1 
Fbp1p NP_013481 Gluconeogenesis in the cytosol 1.24  0.06 1 
Pck1p NP_013023 Gluconeogenesis in the cytosol 0.93  0.11 1 
Pyc1p NP_011453 Gluconeogenesis in the cytosol 1.18  0.14 1 
Adh1p NP_014555 Ethanol synthesis in the cytosol 0.97  0.22 1 
Are1p NP_009978 Synthesis of TAG and EE in the ER and lipid droplets 2.52  0.31 1 
Dga1p NP_014888 Synthesis of TAG in the ER and lipid droplets 2.34  0.17 1 
Gpt2p NP_012993 Synthesis of TAG in the ER and lipid droplets 0.86  0.26 1 
Slc1p NP_010231 Synthesis of TAG in the ER and lipid droplets 2.63  0.20 1 
Tgl1p NP_012782 Lipolysis of TAG and EE in lipid droplets 1.13  0.11 1 
Tgl3p NP_014044 Lipolysis of TAG in lipid droplets 0.39  0.09 1 
Tgl4p NP_013015 Lipolysis of TAG in lipid droplets 0.41  0.15 1 
Tgl5p NP_014724 Lipolysis of TAG in lipid droplets 0.91  0.13 1 
Yeh1p NP_013089 Lipolysis of TAG and EE in lipid droplets 0.44  0.18 1 
Arg1p NP_014583 Amino acid synthesis in the cytosol 0.43  0.07 1 
Aro4p NP_009808 Amino acid synthesis in the cytosol 0.35  0.16 1 
Asn1p NP_015471 Amino acid synthesis in the cytosol 0.27  0.13  1 
Cys4p NP_011671 Amino acid synthesis in the cytosol 0.26  0.05 1 
Gln1p NP_015360 Amino acid synthesis in the cytosol 0.44  0.11 1 
Gly1p NP_010868 Amino acid synthesis in the cytosol 0.41  0.17 1 
Hom3p NP_010972 Amino acid synthesis in the cytosol 0.30  0.08 1 
Met17p NP_013406 Amino acid synthesis in the cytosol 0.45  0.14 1 
Sam4p NP_015050 Amino acid synthesis in the cytosol 0.35  0.10 1 
Trp4p NP_010641 Amino acid synthesis in the cytosol 0.47  0.05 1 
Thr1p NP_011890 Amino acid synthesis in the cytosol 0.40  0.12 1 
Ade12p NP_014179 Nucleotide synthesis in the cytosol 0.43  0.16 1 
Amd1p NP_013677 Nucleotide synthesis in the cytosol 0.29  0.04 1 
Hpt1p NP_010687 Nucleotide synthesis in the cytosol 0.30  0.13 1 
Ppr1p NP_013114 Nucleotide synthesis in the cytosol 0.27  0.08 1 
Prs3p NP_011852 Nucleotide synthesis in the cytosol 0.44  0.11 1 
Ura1p NP_012706 Nucleotide synthesis in the cytosol 0.35  0.20 1 
Ura7p NP_009514 Nucleotide synthesis in the cytosol 0.29  0.16 1 
Dim1p NP_015057 Biogenesis of the 40S ribosomal subunit 0.43  0.12 1 
Emg1p NP_013287 Biogenesis of the 40S ribosomal subunit 0.46  0.09 1 
Ltv1p NP_012779 Biogenesis of the 40S ribosomal subunit 0.40  0.14 1 
Nop1p NP_010270 Biogenesis of the 40S ribosomal subunit 0.35  0.10 1 
Nsr1p NP_011675 Biogenesis of the 40S ribosomal subunit 0.31  0.06 1 
Rps0A/Bp NP_011730 Biogenesis of the 40S ribosomal subunit; a protein 0.27  0.12 1 
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component of the 40S ribosomal subunit 
Rps3p NP_014221 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
0.38  0.17 1 
Rps15p NP_014602 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
0.26  0.08 1 
Rps26A/Bp NP_011326 Biogenesis of the 40S ribosomal subunit; a protein 
component of the 40S ribosomal subunit 
0.40 0.08 1 
Tsr1p NP_010223 Biogenesis of the 40S ribosomal subunit 0.30  0.11 1 
Brx1p NP_014565 Biogenesis of the 60S ribosomal subunit 0.32  0.16 1 
Dbp7p NP_012949 Biogenesis of the 60S ribosomal subunit 0.39  0.13 1 
Nog1p NP_015232 Biogenesis of the 60S ribosomal subunit 0.34  0.06 1 
Nog2p NP_014451 Biogenesis of the 60S ribosomal subunit 0.26  0.15 1 
Nop2p NP_014338 Biogenesis of the 60S ribosomal subunit 0.31  0.10 1 
Nop7p NP_011617 Biogenesis of the 60S ribosomal subunit 0.44  0.13 1 
Nop8p NP_014497 Biogenesis of the 60S ribosomal subunit 0.39  0.08 1 
Nsa1p NP_011404 Biogenesis of the 60S ribosomal subunit 0.35  0.14 1 
Nug1p NP_010921 Biogenesis of the 60S ribosomal subunit 0.31  0.19 1 
Rpf1p NP_011956 Biogenesis of the 60S ribosomal subunit  0.47  0.22 1 
Rpf2p NP_013007 Biogenesis of the 60S ribosomal subunit 0.39  0.06 1 
Rps6A/Bp NP_015235 A protein component of the 40S ribosomal subunit 0.44  0.14 1 
Rps11A/Bp NP_010308 A protein component of the 40S ribosomal subunit 0.35  0.09 1 
Rps23A/Bp NP_015457 A protein component of the 40S ribosomal subunit 0.42  0.11 1 
Rpl6Ap NP_013638 A protein component of the 60S ribosomal subunit 0.31  0.15 1 
Rpl8A/Bp NP_011830 A protein component of the 60S ribosomal subunit 0.27  0.13 1 
Rpl9A/Bp NP_011368 A protein component of the 60S ribosomal subunit 0.40  0.22 1 
Rpl10p NP_013176 A protein component of the 60S ribosomal subunit 0.28  0.10 1 
Rpl21A/Bp NP_009750 A protein component of the 60S ribosomal subunit 0.42  0.17 1 
Rpl27A/Bp NP_011874 A protein component of the 60S ribosomal subunit 0.36  0.06 1 
Rpl31A/Bp NP_010208 A protein component of the 60S ribosomal subunit 0.37  0.15  1 
Rpl34A/Bp NP_010977 A protein component of the 60S ribosomal subunit 0.40  0.11 1 
Npl4p NP_009729 Proteasomal protein degradation 2.75  0.32 1 
Pup1p NP_014800 Proteasomal protein degradation 2.44  0.27 1 
Pup3p NP_011020 Proteasomal protein degradation 3.39  0.43 1 
Rpn5p NP_010134 Proteasomal protein degradation 3.61  0.18 1 
Rpt6p NP_011467 Proteasomal protein degradation 3.78  0.10 1 
Ufd1p NP_011562 Proteasomal protein degradation 2.37  0.32 1 













10.3 Appendix 3. List of individual protein components of digitonin-solubilized 
mitochondrial membrane protein supercomplexes separated by 1-D BN-PAGE, 
resolved by 2-D SDS-PAGE and stained by silver 
Following silver staining, protein bands were excised from the gel, reduced, alkylated and in-gel 
digested with trypsin. The resulting peptides were separated by RP-HPLC/MS using an LTQ 
Orbitrap. The raw MS data file obtained by Xcalibur was analyzed using the Thermo Scientific 
Xcalibur Proteome Discoverer application (version 1.3), which was used to identify individual 
protein components of the isolated mitochondrial respiratory supercomplexes by comparing the 
raw data of mass spectra of digested fragments to the mass spectra of peptides within the Uniprot 
FASTA database. The analysis by the Thermo Scientific Xcalibur Proteome Discoverer coupled 
to the FASTA database was enabled by using the peak-finding search engine SEQUEST, which 
processes MS data using a peak-finding algorithm to search the raw data for generating a peak 




















Protein supercomplex 1 
Aac2p Major ADP/ATP 
carrier of the 
mitochondrial 
inner membrane 





P04840 251.47 43.46% 12 30.4 7.93 
Ndi1p NADH:ubiquinone 
oxidoreductase 




P40215 56.52 34.64% 25 62.7 9.28 
Pda1p E1 alpha subunit 
of the pyruvate 
dehydrogenase 
complex 
P16387 99.69 26.43% 15 46.3 8.1 




P32473 84.43 34.43% 9 40 5.3 
Lat1p Dihydrolipoamide 
acetyltransferase 
component (E2) of 



















Q00711 112.55 38.59% 24 70.2 7.5 





P21801 212.02 31.20% 12 30.2 8.82 






P33421 97.47 22.73% 6 22.1 10.23 






P37298 129.27 24.31% 6 20.2 8.9 






P07143 49.94 27.83% 5 34 8.12 





P07256 154.4 32.82% 19 50.2 7.3 




subunit 2  
P07257 
 
188.18 54.62% 26 40.5 7.96 





P00128 106.36 22.83% 5 14.6 5.88 
Qcr8p Cytochrome b-c1 
complex 


















complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 












complex V), d 
subunit 





complex V), f 
subunit 
Q06405 91.74 41.58% 5 11.3 10.1 
Protein supercomplex 2 
Aac2p Major ADP/ATP 
carrier of the 









P04840 199.73 39.22% 10 30.4 7.93 






P20967 409.94 56.21% 53 114.3 7.21 






P07143 35.71 27.83% 5 34 8.12 





P07256 636.69 36.32% 20 50.2 7.3 





P07257 248.78 67.12% 33 40.5 7.96 





P00128 122.57 22.83% 5 14.6 5.88 





P08525 26.43 24.47% 4 11 9.7 







P08067 61.51 28.37% 6 23.3 8.07 
Protein supercomplex 3 






P07143 40.02 22.98% 6 34 8.12 
Qcr1p Cytochrome b-c1 
complex 
(respiratory 










P07257 156.88 57.61% 25 40.5 7.96 





P00128 142.84 51.97% 7 14.6 5.88 





P08525 40.05 24.47% 4 11 9.7 












complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 







P09457 91.52 55.19% 11 22.8 9.57 












complex V), f 
subunit 
Q06405 83.21 32.67% 4 11.3 10.1 
Protein supercomplex 4 
Aac2p Major ADP/ATP 
carrier of the 
mitochondrial 
inner membrane 





complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 












complex V), d 
subunit 
P30902 125.76 51.15% 14 19.8 8.94 
Protein supercomplex 5 
Yme2p Integral inner 
mitochondrial 









Protein supercomplex 6 
Aac2p Major ADP/ATP 
carrier of the 
mitochondrial 
inner membrane 





complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 












complex V), d 
subunit 
P30902 101.36 58.05% 16 19.8 8.94 
Protein supercomplex 7 






P07143 36.2 22.65% 5 34 8.12 












P07257 178.59 74.46% 33 40.5 7.96 





P00128 131.52 22.83% 5 14.6 5.88 





P08525 26.82 24.47% 4 11 9.7 







P08067 77.37 36.28% 10 23.3 8.07 





P04037 14.78 31.61% 3 17.1 6.9 




subunit 5A  
P00424 160.43 47.71% 11 17.1 9.82 





P00425 103.71 28.48% 5 17.2 9.8 










complex V), alpha 
subunit 





















complex V), b 
subunit 












complex V), d 
subunit 
P30902 196.03 44.25% 13 19.8 8.94 









P04840 114.07 42.05% 11 30.4 7.93 






P07143 32.23 29.77% 6 34 8.12 





P07256 206.37 30.85% 17 50.2 7.3 





P07257 152.45 48.10% 21 40.5 7.96 













P08525 92.45 24.47% 3 11 9.7 












complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 












complex V), d 
subunit 
P30902 112.24 40.80% 9 19.8 8.94 






P28834 415.06 47.22% 19 39.3 9 
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P28241 238.75 39.84% 13 39.7 8.69 
atg32Δ strain 
Protein supercomplex 1 
Aac2p Major ADP/ATP 
carrier of the 
mitochondrial 
inner membrane 





P04840 135.62 43.46% 12 30.4 7.93 
Lat1p Dihydrolipoamide 
acetyltransferase 




P12695 71.58 26.97% 14 51.8 7.8 
Lpd1p Dihydrolipoamide 
dehydrogenase 




P09624 171.86 37.07% 21 54 8.03 






P07143 68.38 31.07% 7 34 8.12 





P07256 216.4 34.79% 18 50.2 7.3 





P07257 134.35 56.25% 24 40.5 7.96 





P00128 160.32 36.22% 6 14.6 5.88 





P08525 26.43 24.47% 4 11 9.7 













complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 












complex V), d 
subunit 
P30902 190.75 72.99% 15 19.8 8.94 
Protein supercomplex 2 
Aac2p Major ADP/ATP 
carrier of the 
mitochondrial 
inner membrane 





P04840 296.37 50.18% 14 30.4 7.93 














P07256 110.93 39.17% 20 50.2 7.3 





P07257 152.7 54.08% 24 40.5 7.96 





P00128 101.24 36.22% 6 14.6 5.88 





P08525 13.41 21.28% 2 11 9.7 







P08067 52.77 46.05% 11 23.3 8.07 





complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 
P05626 242.42 58.20% 22 26.9 9.13 












complex V), d 
subunit 
P30902 348.32 79.89% 20 19.8 8.94 
Protein supercomplex 4 
Aac2p Major ADP/ATP 
carrier of the 
mitochondrial 
inner membrane 
P18239 91.45 33.02% 11 34.4 9.79 
Protein supercomplex 6 
Aac2p Major ADP/ATP 
carrier of the 
mitochondrial 
inner membrane 
P18239 176.99 45.60% 18 34.4 9.79 





complex V), alpha 
subunit 





complex V), beta 
subunit 












complex V), b 
subunit 















complex V), d 
subunit 









P04840 141.79 40.64% 10 30.4 7.93 






P28834 367.21 43.06% 16 39.3 9 
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10.4.3 Invited presentations 
 
1. The 12th Euro Fed Lipid Congress in Montpellier (France), September 2014. Title of the 
talk: "Mechanism of “liponecrosis”, a novel form of programmed cell death". 
 
2. The 10th Euro Fed Lipid Congress in Cracow (Poland), September 2012. Title of the talk: 
"Lithocholic acid delays aging and exhibits a potent anti-cancer effect by altering 
mitochondrial composition, structure, metabolism, dynamics and function". 
 
3. The 2012 Yeast Genetics and Molecular Biology Meeting in Princeton University, 
August 2012. Title of the talk: "Chemical genetic screen identifies a compound that 
delays aging in yeast and exhibits a potent anti-tumor effect in human cells by altering 
mitochondrial composition, structure, metabolism, dynamics, and function". 
 
4. The Journée Phare 2010 Meeting at Sherbrooke University, November 2010. Title of the 
talk: "A novel anti-aging compound extends longevity by altering the age-related 
dynamics of reactive oxygen species". 
 
5. The 2010 Northeast Regional Yeast Meeting at the State University of New York – 
Buffalo, New York, USA, May 2010. Title of the talk: "A novel anti-aging compound 
extends longevity by altering the age-related dynamics of reactive oxygen species". 
 
6. The Montreal Yeast Meeting, March 2010. Title of the talk: "A novel anti-aging 
compound extends longevity by altering the age-related dynamics of reactive oxygen 
species". 
 
 
 
 
